US20210113257A1 - Method and Apparatus for Tissue Ablation - Google Patents
Method and Apparatus for Tissue Ablation Download PDFInfo
- Publication number
- US20210113257A1 US20210113257A1 US17/073,972 US202017073972A US2021113257A1 US 20210113257 A1 US20210113257 A1 US 20210113257A1 US 202017073972 A US202017073972 A US 202017073972A US 2021113257 A1 US2021113257 A1 US 2021113257A1
- Authority
- US
- United States
- Prior art keywords
- catheter
- vapor
- ablation
- heating
- heating component
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000002679 ablation Methods 0.000 title claims abstract description 270
- 238000000034 method Methods 0.000 title description 18
- 238000010438 heat treatment Methods 0.000 claims abstract description 163
- 239000007788 liquid Substances 0.000 claims abstract description 58
- 238000006243 chemical reaction Methods 0.000 claims abstract description 7
- 239000012530 fluid Substances 0.000 claims description 70
- 239000002184 metal Substances 0.000 claims description 22
- 229910052751 metal Inorganic materials 0.000 claims description 22
- 230000006698 induction Effects 0.000 claims description 18
- 238000004891 communication Methods 0.000 claims description 17
- 239000000463 material Substances 0.000 claims description 12
- 230000005291 magnetic effect Effects 0.000 claims description 9
- 238000012546 transfer Methods 0.000 claims description 9
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 claims description 7
- 229910052802 copper Inorganic materials 0.000 claims description 7
- 239000010949 copper Substances 0.000 claims description 7
- 238000009833 condensation Methods 0.000 claims description 4
- 230000005494 condensation Effects 0.000 claims description 4
- 229910001220 stainless steel Inorganic materials 0.000 claims description 4
- 239000010935 stainless steel Substances 0.000 claims description 4
- 238000002604 ultrasonography Methods 0.000 claims description 3
- 230000004913 activation Effects 0.000 abstract description 3
- 239000003795 chemical substances by application Substances 0.000 description 96
- 210000001519 tissue Anatomy 0.000 description 92
- 238000001802 infusion Methods 0.000 description 33
- 210000000056 organ Anatomy 0.000 description 31
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 24
- 208000023514 Barrett esophagus Diseases 0.000 description 21
- 238000011282 treatment Methods 0.000 description 20
- 208000023665 Barrett oesophagus Diseases 0.000 description 19
- 210000003238 esophagus Anatomy 0.000 description 16
- 208000037062 Polyps Diseases 0.000 description 15
- 201000010260 leiomyoma Diseases 0.000 description 14
- 210000004291 uterus Anatomy 0.000 description 14
- 239000000523 sample Substances 0.000 description 13
- 239000012528 membrane Substances 0.000 description 12
- 208000014081 polyp of colon Diseases 0.000 description 12
- 230000002357 endometrial effect Effects 0.000 description 11
- 230000003902 lesion Effects 0.000 description 11
- 230000006378 damage Effects 0.000 description 10
- RNAMYOYQYRYFQY-UHFFFAOYSA-N 2-(4,4-difluoropiperidin-1-yl)-6-methoxy-n-(1-propan-2-ylpiperidin-4-yl)-7-(3-pyrrolidin-1-ylpropoxy)quinazolin-4-amine Chemical compound N1=C(N2CCC(F)(F)CC2)N=C2C=C(OCCCN3CCCC3)C(OC)=CC2=C1NC1CCN(C(C)C)CC1 RNAMYOYQYRYFQY-UHFFFAOYSA-N 0.000 description 9
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 9
- 210000000621 bronchi Anatomy 0.000 description 8
- 210000003679 cervix uteri Anatomy 0.000 description 8
- 210000001072 colon Anatomy 0.000 description 8
- 208000032843 Hemorrhage Diseases 0.000 description 7
- 206010046798 Uterine leiomyoma Diseases 0.000 description 7
- 208000034158 bleeding Diseases 0.000 description 7
- 230000000740 bleeding effect Effects 0.000 description 7
- 238000013461 design Methods 0.000 description 7
- 210000002438 upper gastrointestinal tract Anatomy 0.000 description 7
- 210000003708 urethra Anatomy 0.000 description 7
- XKRFYHLGVUSROY-UHFFFAOYSA-N Argon Chemical compound [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 6
- 208000027418 Wounds and injury Diseases 0.000 description 6
- 210000002318 cardia Anatomy 0.000 description 6
- 238000001816 cooling Methods 0.000 description 6
- 230000007423 decrease Effects 0.000 description 6
- 201000010099 disease Diseases 0.000 description 6
- 208000014674 injury Diseases 0.000 description 6
- 238000007674 radiofrequency ablation Methods 0.000 description 6
- 230000009467 reduction Effects 0.000 description 6
- 239000007921 spray Substances 0.000 description 6
- 201000005242 bronchial neoplasm Diseases 0.000 description 5
- 238000010586 diagram Methods 0.000 description 5
- 238000009826 distribution Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 210000000981 epithelium Anatomy 0.000 description 5
- 210000003236 esophagogastric junction Anatomy 0.000 description 5
- 239000011810 insulating material Substances 0.000 description 5
- 238000009413 insulation Methods 0.000 description 5
- 230000007246 mechanism Effects 0.000 description 5
- 230000002685 pulmonary effect Effects 0.000 description 5
- 238000002271 resection Methods 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- 208000000461 Esophageal Neoplasms Diseases 0.000 description 4
- 206010030155 Oesophageal carcinoma Diseases 0.000 description 4
- 208000031481 Pathologic Constriction Diseases 0.000 description 4
- 230000015572 biosynthetic process Effects 0.000 description 4
- 238000005345 coagulation Methods 0.000 description 4
- 230000015271 coagulation Effects 0.000 description 4
- 230000009977 dual effect Effects 0.000 description 4
- 201000004101 esophageal cancer Diseases 0.000 description 4
- 238000005259 measurement Methods 0.000 description 4
- 230000001613 neoplastic effect Effects 0.000 description 4
- 239000003504 photosensitizing agent Substances 0.000 description 4
- 210000002307 prostate Anatomy 0.000 description 4
- 230000008016 vaporization Effects 0.000 description 4
- 231100000216 vascular lesion Toxicity 0.000 description 4
- 206010013908 Dysfunctional uterine bleeding Diseases 0.000 description 3
- 206010027514 Metrorrhagia Diseases 0.000 description 3
- 206010028980 Neoplasm Diseases 0.000 description 3
- 206010051482 Prostatomegaly Diseases 0.000 description 3
- 229910052786 argon Inorganic materials 0.000 description 3
- 230000005779 cell damage Effects 0.000 description 3
- 208000037887 cell injury Diseases 0.000 description 3
- 238000002591 computed tomography Methods 0.000 description 3
- 230000001419 dependent effect Effects 0.000 description 3
- 208000035475 disorder Diseases 0.000 description 3
- 210000001180 ethmoid sinus Anatomy 0.000 description 3
- 210000001214 frontal sinus Anatomy 0.000 description 3
- 230000002496 gastric effect Effects 0.000 description 3
- 210000001035 gastrointestinal tract Anatomy 0.000 description 3
- 208000007106 menorrhagia Diseases 0.000 description 3
- 238000002428 photodynamic therapy Methods 0.000 description 3
- 239000008223 sterile water Substances 0.000 description 3
- 230000002792 vascular Effects 0.000 description 3
- 206010009944 Colon cancer Diseases 0.000 description 2
- 239000004812 Fluorinated ethylene propylene Substances 0.000 description 2
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
- 208000000592 Nasal Polyps Diseases 0.000 description 2
- 206010050171 Oesophageal dysplasia Diseases 0.000 description 2
- 239000004696 Poly ether ether ketone Substances 0.000 description 2
- 229920002614 Polyether block amide Polymers 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 208000002352 blister Diseases 0.000 description 2
- 201000011510 cancer Diseases 0.000 description 2
- 210000000038 chest Anatomy 0.000 description 2
- 230000000112 colonic effect Effects 0.000 description 2
- 208000029742 colonic neoplasm Diseases 0.000 description 2
- 238000002405 diagnostic procedure Methods 0.000 description 2
- 210000004696 endometrium Anatomy 0.000 description 2
- 230000006870 function Effects 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 208000021302 gastroesophageal reflux disease Diseases 0.000 description 2
- 230000023597 hemostasis Effects 0.000 description 2
- 238000009802 hysterectomy Methods 0.000 description 2
- 238000007373 indentation Methods 0.000 description 2
- 230000000977 initiatory effect Effects 0.000 description 2
- 230000001788 irregular Effects 0.000 description 2
- 230000002427 irreversible effect Effects 0.000 description 2
- 238000013532 laser treatment Methods 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 210000004877 mucosa Anatomy 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- 210000003101 oviduct Anatomy 0.000 description 2
- 229920009441 perflouroethylene propylene Polymers 0.000 description 2
- 229920002530 polyetherether ketone Polymers 0.000 description 2
- 229920001343 polytetrafluoroethylene Polymers 0.000 description 2
- 239000004810 polytetrafluoroethylene Substances 0.000 description 2
- 230000010349 pulsation Effects 0.000 description 2
- 230000029058 respiratory gaseous exchange Effects 0.000 description 2
- 230000004044 response Effects 0.000 description 2
- -1 such as Substances 0.000 description 2
- 238000001356 surgical procedure Methods 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 238000009827 uniform distribution Methods 0.000 description 2
- 230000002485 urinary effect Effects 0.000 description 2
- 208000010579 uterine corpus leiomyoma Diseases 0.000 description 2
- 201000007954 uterine fibroid Diseases 0.000 description 2
- 238000009834 vaporization Methods 0.000 description 2
- 238000012800 visualization Methods 0.000 description 2
- 208000037853 Abnormal uterine bleeding Diseases 0.000 description 1
- 208000036764 Adenocarcinoma of the esophagus Diseases 0.000 description 1
- 206010004446 Benign prostatic hyperplasia Diseases 0.000 description 1
- 208000035984 Colonic Polyps Diseases 0.000 description 1
- 201000009273 Endometriosis Diseases 0.000 description 1
- 208000005489 Esophageal Perforation Diseases 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- 208000012671 Gastrointestinal haemorrhages Diseases 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010051589 Large intestine polyp Diseases 0.000 description 1
- 206010030137 Oesophageal adenocarcinoma Diseases 0.000 description 1
- 206010030181 Oesophageal perforation Diseases 0.000 description 1
- 206010052211 Oesophageal rupture Diseases 0.000 description 1
- 206010034972 Photosensitivity reaction Diseases 0.000 description 1
- 239000004642 Polyimide Substances 0.000 description 1
- 208000006994 Precancerous Conditions Diseases 0.000 description 1
- 208000004403 Prostatic Hyperplasia Diseases 0.000 description 1
- 206010038776 Retching Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 238000011298 ablation treatment Methods 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 230000002411 adverse Effects 0.000 description 1
- 210000003484 anatomy Anatomy 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000005540 biological transmission Effects 0.000 description 1
- 238000001574 biopsy Methods 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 210000000746 body region Anatomy 0.000 description 1
- 230000036760 body temperature Effects 0.000 description 1
- 238000003763 carbonization Methods 0.000 description 1
- 230000000747 cardiac effect Effects 0.000 description 1
- 238000002052 colonoscopy Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 239000012809 cooling fluid Substances 0.000 description 1
- 230000001351 cycling effect Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 230000000881 depressing effect Effects 0.000 description 1
- 238000004980 dosimetry Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 230000005684 electric field Effects 0.000 description 1
- 238000009297 electrocoagulation Methods 0.000 description 1
- 238000012143 endoscopic resection Methods 0.000 description 1
- 208000028653 esophageal adenocarcinoma Diseases 0.000 description 1
- HQQADJVZYDDRJT-UHFFFAOYSA-N ethene;prop-1-ene Chemical group C=C.CC=C HQQADJVZYDDRJT-UHFFFAOYSA-N 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 210000005002 female reproductive tract Anatomy 0.000 description 1
- 239000002902 ferrimagnetic material Substances 0.000 description 1
- 239000000835 fiber Substances 0.000 description 1
- 230000004907 flux Effects 0.000 description 1
- 208000030304 gastrointestinal bleeding Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 238000003384 imaging method Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000002757 inflammatory effect Effects 0.000 description 1
- 229910052742 iron Inorganic materials 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000003211 malignant effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 210000003928 nasal cavity Anatomy 0.000 description 1
- 208000016366 nasal cavity polyp Diseases 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000001672 ovary Anatomy 0.000 description 1
- 230000008855 peristalsis Effects 0.000 description 1
- 230000036211 photosensitivity Effects 0.000 description 1
- 229920001721 polyimide Polymers 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000002028 premature Effects 0.000 description 1
- 230000001855 preneoplastic effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 210000003456 pulmonary alveoli Anatomy 0.000 description 1
- 210000004879 pulmonary tissue Anatomy 0.000 description 1
- 230000001850 reproductive effect Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 230000000452 restraining effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 230000000630 rising effect Effects 0.000 description 1
- 238000004513 sizing Methods 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000011477 surgical intervention Methods 0.000 description 1
- 239000004557 technical material Substances 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 208000037816 tissue injury Diseases 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 210000001215 vagina Anatomy 0.000 description 1
- 230000001755 vocal effect Effects 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B18/12—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
- A61B18/14—Probes or electrodes therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/103—Detecting, measuring or recording devices for testing the shape, pattern, colour, size or movement of the body or parts thereof, for diagnostic purposes
- A61B5/107—Measuring physical dimensions, e.g. size of the entire body or parts thereof
- A61B5/1076—Measuring physical dimensions, e.g. size of the entire body or parts thereof for measuring dimensions inside body cavities, e.g. using catheters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/68—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient
- A61B5/6846—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive
- A61B5/6847—Arrangements of detecting, measuring or recording means, e.g. sensors, in relation to patient specially adapted to be brought in contact with an internal body part, i.e. invasive mounted on an invasive device
- A61B5/6852—Catheters
- A61B5/6853—Catheters with a balloon
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/24—Surgical instruments, devices or methods, e.g. tourniquets for use in the oral cavity, larynx, bronchial passages or nose; Tongue scrapers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00022—Sensing or detecting at the treatment site
- A61B2017/00084—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00017—Electrical control of surgical instruments
- A61B2017/00203—Electrical control of surgical instruments with speech control or speech recognition
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00743—Type of operation; Specification of treatment sites
- A61B2017/00809—Lung operations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B2017/00973—Surgical instruments, devices or methods, e.g. tourniquets pedal-operated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B17/00—Surgical instruments, devices or methods, e.g. tourniquets
- A61B17/42—Gynaecological or obstetrical instruments or methods
- A61B2017/4216—Operations on uterus, e.g. endometrium
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00053—Mechanical features of the instrument of device
- A61B2018/00214—Expandable means emitting energy, e.g. by elements carried thereon
- A61B2018/0022—Balloons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00321—Head or parts thereof
- A61B2018/00327—Ear, nose or throat
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00482—Digestive system
- A61B2018/00488—Esophagus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00482—Digestive system
- A61B2018/00494—Stomach, intestines or bowel
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00541—Lung or bronchi
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00547—Prostate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00315—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
- A61B2018/00559—Female reproductive organs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00571—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
- A61B2018/00577—Ablation
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00642—Sensing and controlling the application of energy with feedback, i.e. closed loop control
- A61B2018/00648—Sensing and controlling the application of energy with feedback, i.e. closed loop control using more than one sensed parameter
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00714—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00696—Controlled or regulated parameters
- A61B2018/00744—Fluid flow
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B2018/00636—Sensing and controlling the application of energy
- A61B2018/00773—Sensed parameters
- A61B2018/00791—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B18/00—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
- A61B18/04—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
- A61B2018/044—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid
- A61B2018/048—Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating the surgical action being effected by a circulating hot fluid in gaseous form
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
- A61B90/06—Measuring instruments not otherwise provided for
- A61B2090/064—Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M2205/00—General characteristics of the apparatus
- A61M2205/33—Controlling, regulating or measuring
- A61M2205/3368—Temperature
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/01—Introducing, guiding, advancing, emplacing or holding catheters
- A61M25/02—Holding devices, e.g. on the body
- A61M25/04—Holding devices, e.g. on the body in the body, e.g. expansible
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61M—DEVICES FOR INTRODUCING MEDIA INTO, OR ONTO, THE BODY; DEVICES FOR TRANSDUCING BODY MEDIA OR FOR TAKING MEDIA FROM THE BODY; DEVICES FOR PRODUCING OR ENDING SLEEP OR STUPOR
- A61M25/00—Catheters; Hollow probes
- A61M25/10—Balloon catheters
- A61M25/1011—Multiple balloon catheters
Definitions
- the present invention relates to medical apparatus and procedures. More particularly, the present invention relates to a device for ablation of tissue comprising a centering or positioning attachment in order to position the device at a consistent distance from the tissue to be ablated.
- Colon polyps affect almost 25% of the population over the age of 50. While most polyps are detected on colonoscopy and easily removed using a snare, flat sessile polyps are hard to remove using the snare technique and carry a high risk of complications, such as bleeding and perforation. Recently, with improvement in imaging techniques, more flat polyps are being detected. Endoscopically unresectable polyps require surgical removal. Most colon cancer arises from colon polyps and, safe and complete resection of these polyps is imperative for the prevention of colon cancer.
- Barrett's esophagus is a precancerous condition effecting 10-14% of the US population with gastro esophageal reflux disease (GERD) and is the proven precursor lesion of esophageal adenocarcinoma, the fastest rising cancer in the developed countries.
- the incidence of the cancer has risen over 6 fold in the last 2 decades and mortality has risen by 7 fold.
- the 5-year mortality from esophageal cancer is 85%.
- Ablation of Barrett's epithelium has shown to prevent its progression to esophageal cancer.
- Dysfunctional uterine bleeding (DUB), or menorrhagia affects 30% of women in reproductive age.
- the associated symptoms have considerable impact on a woman's health and quality of life.
- the condition is typically treated with endometrial ablation or a hysterectomy.
- the rates of surgical intervention in these women are high. Almost 30% of women in the US will undergo hysterectomy by the age of 60, with menorrhagia or DUB being the cause for surgery in 50-70% of these women.
- Endometrial ablation techniques have been FDA approved for women with abnormal uterine bleeding and with intramural fibroids less than 2 cm.
- microwave ablation microwave ablation
- the known ablation treatments for Barrett's esophagus include laser treatment (Ertan et al, Am. J. Gastro., 90:2201-2203 [1995]), ultrasonic ablation (Bremner et al, Gastro. Endo., 43:6 [1996]), photodynamic therapy (PDT) using photo-sensitizer drugs (Overholt et al, Semin. Surq. Oncol., 1:372-376 (1995), multipolar electrocoagulation, such as by use of a bicap probe (Sampliner et al,), argon plasma coagulation (APC;), radiofrequency ablation (Sharma et al. Gastrointest Endosc) and cryoablation (Johnston et al. Gastrointest Endosc).
- the treatments are delivered with the aid of an endoscope and devices passed through the channel of the endoscope or alongside the endoscope.
- radiofrequency ablation uses a rigid bipolar balloon based electrode and radiofrequency thermal energy.
- the thermal energy is delivered by direct contact of the electrode with the diseased Barrett's epithelium allowing for a relatively uniform, large area ablation.
- the rigid electrode does not accommodate for variations in esophageal size and is ineffective in ablating lesions within a tortuous esophagus, proximal esophageal lesions as an esophagus narrows toward the top, and lesions in the esophagus at the gastroesophageal junction due to changes in the esophageal diameter.
- Nodular disease in Barrett's esophagus also cannot be treated using the rigid bipolar RF electrode.
- the electrode Due to its size and rigidity, the electrode cannot be passed through the scope. In addition, sticking of sloughed tissue to the electrode impedes delivery of radiofrequency energy resulting in incomplete ablation.
- the electrode size is limited to 3 cm, thus requiring repeat applications to treat larger lengths of Barrett's esophagus.
- Photodynamic therapy is a two part procedure that involves injecting a photo-sensitizer that is absorbed and retained by the neoplastic and pre-neoplastic tissue. The tissue is then exposed to a selected wavelength of light which activates the photo-sensitizer and results in tissue destruction. PDT is associated with complications such as stricture formation and photo-sensitivity which has limited its use to the most advanced stages of the disease. In addition, patchy uptake of the photosensitizer results in incomplete ablation and residual neoplastic tissue.
- a spray catheter that directly sprays liquid N 2 or CO 2 (cryoablation) or argon (APC) to ablate Barrett's tissue in the esophagus has been described.
- These techniques suffer the shortcoming of the traditional hand-held devices. Treatment using this probe is cumbersome and requires operator control under direct endoscopic visualization. Continuous movement in the esophagus due to respiration or cardiac or aortic pulsations or movement causes an uneven distribution of the ablative agent and results in non-uniform and/or incomplete ablation. Close or direct contact of the catheter to the surface epithelium may cause deeper tissue injury, resulting in perforation, bleeding or stricture formation.
- Colon polyps are usually resected using snare resection with or without the use of monopolar cautery.
- Flat polyps or residual polyps after snare resection have been treated with argon plasma coagulation or laser treatment. Both of these treatments are inadequate due to the previously mentioned limitations.
- most large flat polyps undergo surgical resection due to high risk of bleeding, perforation and residual disease using traditional endoscopic resection or ablation techniques.
- balloon catheters traditionally used for tissue ablation either heat or cool the balloon itself or a heating element such as radio frequency (RF) coils mounted on the balloon. This requires direct contact of the balloon catheter with the ablated surface.
- RF radio frequency
- the balloon catheter When the balloon catheter is deflated, the epithelium sticks to the catheter and sloughs off, thereby causing bleeding. Blood can interfere with the delivery of energy, and therefore acts as an energy sink.
- reapplication of energy will result in deeper burn in the area where superficial lining has sloughed.
- balloon catheters cannot be employed for treatment in non-cylindrical organs, like the uterus or sinuses, and also do not provide non-circumferential or focal ablation in a hollow organ.
- cryogens as ablative agents, which expand exponentially upon being heated, balloon catheters may result in a closed cavity and trap the escape of cryogen, resulting in complications such as perforations and tears.
- the present specification discloses a device to be used in conjunction with a tissue ablation system, comprising: a handle with a pressure-resistant port on its distal end, a flow channel through which an ablative agent can travel, and one or more connection ports on its proximal end for the inlet of said ablative agent and for an RF feed; an insulated catheter that attaches to said pressure-resistant port of said snare handle, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and one or more positioning elements attached to said catheter shaft at one or more separate positions, wherein said positioning element(s) is configured to position said catheter at a predefined distance from the tissue to be ablated.
- the handle has one pressure-resistant port for the attachment of both an ablative agent inlet and an RF feed.
- the handle has one separate pressure-resistant port for the attachment of an ablative agent inlet and one separate port for the attachment of an RF feed or an electrical feed.
- the present specification discloses a device to be used in conjunction with a tissue ablation system, comprising: a handle with a pressure-resistant port on its distal end, a flow channel passing through said handle which is continuous with a pre-attached cord through which an ablative agent can travel, and a connection port on its proximal end for an RF feed or an electrical field; an insulated catheter that attaches to said pressure-resistant port of said handle, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and one or more positioning elements attached to said catheter shaft at one or more separate positions, wherein said positioning element(s) is configured to position said catheter at a predefined distance from the tissue to be ablated.
- the distal end of said catheter is designed to puncture the target.
- the present specification discloses a device to be used in conjunction with a tissue ablation system, comprising: an esophageal probe with a pressure-resistant port on its distal end, a flow channel through which an ablative agent can travel, and one or more connection ports on its proximal end for the inlet of said ablative agent and for an RF feed or an electrical feed; an insulated catheter that attaches to said pressure-resistant port of said esophageal probe, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and one or more inflatable positioning balloons at either end of said catheter positioned beyond said one or more ports, wherein said positioning balloons are configured to position said catheter at a predefined distance from the tissue to be ablated.
- the catheter is dual lumen, wherein a first lumen facilitates the transfer of ablative agent and a second lumen contains an electrode for RF ablation.
- the catheter has differential insulation along its length.
- a tissue ablation device comprising: a liquid reservoir, wherein said reservoir includes an outlet connector that can resist at least 1 atm of pressure for the attachment of a reusable cord; a heating component comprising: a length of coiled tubing contained within a heating element, wherein activation of said heating element causes said coiled tubing to increase from a first temperature to a second temperature and wherein said increase causes a conversion of liquid within said coiled tubing to vapor; and an inlet connected to said coiled tubing; an outlet connected to said coiled tubing; and at least one pressure-resistant connection attached to the inlet and/or outlet; a cord connecting the outlet of said reservoir to the inlet of the heating component; a single use cord connecting a pressure-resistant inlet port of a vapor based ablation device to the outlet of said heating component.
- the liquid reservoir is integrated within an operating room equipment generator.
- the liquid is water and the vapor is steam.
- the pressure-resistant connections are luer lock connections.
- the coiled tubing is copper.
- the tissue ablation device further comprises a foot pedal, wherein only when said foot pedal is pressed, vapor is generated and passed into said single use cord. In another embodiment, only when pressure is removed from said foot pedal, vapor is generated and passed into said single use cord.
- the present specification discloses a vapor ablation system used for supplying vapor to an ablation device, comprising; a single use sterile fluid container with attached compressible tubing used to connect the fluid source to a heating unit in the handle of a vapor ablation catheter.
- the tubing passes through a pump that delivers the fluid into the heating unit at a predetermined speed.
- There is present a mechanism such as a unidirectional valve between the fluid container and the heating unit to prevent the backflow of vapor from the heating unit.
- the heating unit is connected to the ablation catheter to deliver the vapor from the heating unit to the ablation site.
- the flow of vapor is controlled by a microprocessor.
- the microprocessor uses a pre-programmed algorithm in an open-loop system or uses information from one or more sensors incorporated in the ablation system in a closed-loop system or both to control delivery of vapor.
- the handle of the ablation device is made of a thermally insulating material to prevent thermal injury to the operator.
- the heating unit is enclosed in the handle.
- the handle locks into the channel of an endoscope after the catheter is passed through the channel of the endoscope. The operator can than manipulate the catheter by holding the insulated handle or by manipulating the catheter proximal to the insulating handle.
- the present specification is also directed toward a vapor ablation system comprising: a container with a sterile liquid therein; a pump in fluid communication with said container; a first filter disposed between and in fluid communication with said container and said pump; a heating component in fluid communication with said pump; a valve disposed between and in fluid communication with said pump and heating container; a catheter in fluid communication with said heating component, said catheter comprising at least one opening at its operational end; and, a microprocessor in operable communication with said pump and said heating component, wherein said microprocessor controls the pump to control a flow rate of the liquid from said container, through said first filter, through said pump, and into said heating component, wherein said liquid is converted into vapor via the transfer of heat from said heating component to said fluid, wherein said conversion of said fluid into said vapor results is a volume expansion and a rise in pressure where said rise in pressure forces said vapor into said catheter and out said at least one opening, and wherein a temperature of said heating component is controlled by said microprocessor.
- the vapor ablation system further comprises at least one sensor on said catheter, wherein information obtained by said sensor is transmitted to said microprocessor, and wherein said information is used by said microprocessor to regulate said pump and said heating component and thereby regulate vapor flow.
- the at least one sensor includes one or more of a temperature sensor, flow sensor, or pressure sensor.
- the vapor ablation system further comprises a screw cap on said liquid container and a puncture needle on said first filter, wherein said screw cap is punctured by said puncture needle to provide fluid communication between said container and said first filter.
- liquid container and catheter are disposable and configured for a single use.
- the fluid container, first filter, pump, heating component, and catheter are connected by sterile tubing and the connections between said pump and said heating component and said heating component and said catheter are pressure resistant.
- a tissue ablation system comprising: a catheter with a proximal end and a distal end and a lumen therebetween, said catheter comprising: a handle proximate the proximal end of said catheter and housing a fluid heating chamber and a heating element enveloping said chamber, a wire extending distally from said heating element and leading to a controller; an insulating sheath extending and covering the length of said catheter and disposed between said handle and said heating element at said distal end of said catheter; and, at least one opening proximate the distal end of said catheter for the passage of vapor; and, a controller operably connected to said heating element via said wire, wherein said controller is capable of modulating energy supplied to said heating element and further wherein said controller is capable of adjusting a flow rate of liquid supplied to said catheter; wherein liquid is supplied to said heating chamber and then converted to vapor within said heating chamber by a transfer of heat from said heating element to said chamber, wherein said conversion of said liquid to vapor
- the tissue ablation system further comprises a pressure resistant fitting attached to the fluid supply and a one-way valve in said pressure resistant fitting to prevent a backflow of vapor into the fluid supply.
- the tissue ablation system further comprises at least one sensor on said catheter, wherein information obtained by said sensor is transmitted to said microprocessor, and wherein said information is used by said microprocessor to regulate said pump and said heating component and thereby regulate vapor flow.
- the tissue ablation system further comprises a metal frame within said catheter, wherein said metal frame is in thermal contact with said heating chamber and conducts heat to said catheter lumen, thereby preventing condensation of said vapor.
- the metal frame comprises a metal skeleton with outwardly extending fins at regularly spaced intervals, a metal spiral, or a metal mesh and the metal frame comprises at least one of copper, stainless steel, or another ferric material.
- the heating element comprises a heating block, wherein said heating block is supplied power by said controller.
- the heating element uses one of magnetic induction, microwave, high intensity focused ultrasound, or infrared energy to heat said heating chamber and the fluid therein.
- FIG. 1 illustrates an ablation device, in accordance with an embodiment of the present invention
- FIG. 2A illustrates a longitudinal section of an ablation device with ports distributed thereon
- FIG. 2B illustrates a cross section of a port on the ablation device, in accordance with an embodiment of the present invention
- FIG. 2C illustrates a cross section of a port on the ablation device, in accordance with another embodiment of the present invention.
- FIG. 2D illustrates a catheter of the ablation device, in accordance with an embodiment of the present invention
- FIG. 2E illustrates an ablation device in the form of a catheter extending from a conventional snare handle, in accordance with an embodiment of the present invention
- FIG. 2F illustrates a cross section of an ablation device in the form of a catheter extending from a conventional snare handle with a pre-attached cord, in accordance with another embodiment of the present invention
- FIG. 2G illustrates an ablation device in the form of a catheter extending from a conventional esophageal probe, in accordance with an embodiment of the present invention
- FIG. 3A illustrates the ablation device placed in an upper gastrointestinal tract with Barrett's esophagus to selectively ablate the Barrett's tissue, in accordance with an embodiment of the present invention
- FIG. 3B illustrates the ablation device placed in an upper gastrointestinal tract with Barrett's esophagus to selectively ablate the Barrett's tissue, in accordance with another embodiment of the present invention
- FIG. 3C is a flowchart illustrating the basic procedural steps for using the ablation device, in accordance with an embodiment of the present invention.
- FIG. 4A illustrates the ablation device placed in a colon to ablate a flat colon polyp, in accordance with an embodiment of the present invention
- FIG. 4B illustrates the ablation device placed in a colon to ablate a flat colon polyp, in accordance with another embodiment of the present invention
- FIG. 5A illustrates the ablation device with a coaxial catheter design, in accordance with an embodiment of the present invention
- FIG. 5B illustrates a partially deployed positioning device, in accordance with an embodiment of the present invention
- FIG. 5C illustrates a completely deployed positioning device, in accordance with an embodiment of the present invention
- FIG. 5D illustrates the ablation device with a conical positioning element, in accordance with an embodiment of the present invention
- FIG. 5E illustrates the ablation device with a disc shaped positioning element, in accordance with an embodiment of the present invention
- FIG. 6 illustrates an upper gastrointestinal tract with a bleeding vascular lesion being treated by the ablation device, in accordance with an embodiment of the present invention
- FIG. 7 illustrates endometrial ablation being performed in a female uterus by using the ablation device, in accordance with an embodiment of the present invention
- FIG. 8 illustrates sinus ablation being performed in a nasal passage by using the ablation device, in accordance with an embodiment of the present invention
- FIG. 9 illustrates bronchial and bullous ablation being performed in a pulmonary system by using the ablation device, in accordance with an embodiment of the present invention
- FIG. 10 illustrates prostate ablation being performed on an enlarged prostrate in a male urinary system by using the device, in accordance with an embodiment of the present invention
- FIG. 11 illustrates fibroid ablation being performed in a female uterus by using the ablation device, in accordance with an embodiment of the present invention
- FIG. 12 illustrates a vapor delivery system using an RF heater for supplying vapor to the ablation device, in accordance with an embodiment of the present invention
- FIG. 13 illustrates a vapor delivery system using a resistive heater for supplying vapor to the ablation device, in accordance with an embodiment of the present invention
- FIG. 14 illustrates a vapor delivery system using a heating coil for supplying vapor to the ablation device, in accordance with an embodiment of the present invention
- FIG. 15 illustrates the heating component and coiled tubing of the heating coil vapor delivery system of FIG. 14 , in accordance with an embodiment of the present invention
- FIG. 16A illustrates the unassembled interface connection between the ablation device and the single use cord of the heating coil vapor delivery system of FIG. 14 , in accordance with an embodiment of the present invention
- FIG. 16B illustrates the assembled interface connection between the ablation device and the single use cord of the heating coil vapor delivery system of FIG. 14 , in accordance with an embodiment of the present invention
- FIG. 17 illustrates a vapor ablation system using a heater or heat exchange unit for supplying vapor to the ablation device, in accordance with another embodiment of the present invention
- FIG. 18 illustrates the fluid container, filter member, and pump of the vapor ablation system of FIG. 17 ;
- FIG. 19 illustrates a first view of the fluid container, filter member, pump, heater or heat exchange unit, and microcontroller of the vapor ablation system of FIG. 17 ;
- FIG. 20 illustrates a second view of the fluid container, filter member, pump, heater or heat exchange unit, and microcontroller of the vapor ablation system of FIG. 17 ;
- FIG. 21 illustrates the unassembled filter member of the vapor ablation system of FIG. 17 , depicting the filter positioned within;
- FIG. 22 illustrates one embodiment of the microcontroller of the vapor ablation system of FIG. 17 ;
- FIG. 23 illustrates one embodiment of a catheter assembly for use with the vapor ablation system of FIG. 17 ;
- FIG. 24 illustrates one embodiment of a heat exchange unit for use with the vapor ablation system of FIG. 17 ;
- FIG. 25 illustrates another embodiment of a heat exchange unit for use with the vapor ablation system of the present invention
- FIG. 26 illustrates the use of induction heating to heat a chamber
- FIG. 27A illustrates one embodiment of a coil used with induction heating in the vapor ablation system of the present invention
- FIG. 27B illustrates one embodiment of a catheter handle used with induction heating in the vapor ablation system of the present invention
- FIG. 28A is a front view cross sectional diagram illustrating one embodiment of a catheter used with induction heating in the vapor ablation system of the present invention
- FIG. 28B is a longitudinal view cross sectional diagram illustrating one embodiment of a catheter used with induction heating in the vapor ablation system of the present invention.
- FIG. 28C is a longitudinal view cross sectional diagram illustrating another embodiment of a catheter with a metal spiral used with induction heating in the vapor ablation system of the present invention.
- FIG. 28D is a longitudinal view cross sectional diagram illustrating another embodiment of a catheter with a mesh used with induction heating in the vapor ablation system of the present invention.
- FIG. 29 illustrates one embodiment of a heating unit using microwaves to convert fluid to vapor in the vapor ablation system of the present invention.
- the present invention is directed toward an ablation device comprising a catheter with one or more centering or positioning attachments at one or more ends of the catheter to affix the catheter and its infusion port at a fixed distance from the ablative tissue which is not affected by the movements of the organ.
- the arrangement of one or more spray ports allows for uniform spray of the ablative agent producing a uniform ablation of a large area, such as encountered in Barrett's esophagus.
- the flow of ablative agent is controlled by the microprocessor and depends upon one or more of the length or area of tissue to be ablated, type and depth of tissue to be ablated, and distance of the infusion port from or in the tissue to be ablated.
- the present invention is also directed toward a device to be used in conjunction with a tissue ablation system, comprising: a handle with a pressure-resistant port on its distal end, a flow channel through which an ablative agent can travel, and one or more connection ports on its proximal end for the inlet of said ablative agent and for an RF feed or an electrical feed; an insulated catheter that attaches to said pressure-resistant port of said handle, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and, one or more positioning elements attached to said catheter shaft at one or more separate positions, wherein said positioning element(s) is configured to position said catheter at a predefined distance from or in the tissue to be ablated.
- the handle has one pressure-resistant port for the attachment of both an ablative agent inlet and an RF feed. In another embodiment, the handle has one separate pressure-resistant port for the attachment of an ablative agent inlet and one separate port for the attachment of an RF feed or an electrical feed.
- the present invention is also directed toward a device to be used in conjunction with a tissue ablation system, comprising: a handle with a pressure-resistant port on its distal end, a flow channel passing through said handle which is continuous with a pre-attached cord through which an ablative agent can travel, and a connection port on its proximal end for an RF feed or an electrical feed; an insulated catheter that attaches to said pressure-resistant port of said handle, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and, one or more positioning elements attached to said catheter shaft at one or more separate positions, wherein said positioning element(s) is configured to position said catheter at a predefined distance from or in the tissue to be ablated.
- the distal end of said catheter is designed to puncture the target tissue to deliver ablative agent to the correct depth and location.
- the present invention is also directed toward a device to be used in conjunction with a tissue ablation system, comprising: an esophageal probe with a pressure-resistant port on its distal end, a flow channel through which an ablative agent can travel, and one or more connection ports on its proximal end for the inlet of said ablative agent and for an RF feed; an insulated catheter that attaches to said pressure-resistant port of said esophageal probe, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and, one or more inflatable positioning balloons at either end of said catheter positioned beyond said one or more ports, wherein said positioning balloons are configured to position said catheter at a predefined distance from the tissue to be ablated.
- the catheter is dual lumen, wherein a first lumen facilitates the transfer of ablative agent and a second lumen contains an electrode for RF ablation.
- the catheter has differential insulation along its length.
- the present invention is also directed toward a vapor delivery system used for supplying vapor to an ablation device, comprising: a liquid reservoir, wherein said reservoir includes a pressure-resistant outlet connector for the attachment of a reusable cord; a reusable cord connecting the outlet of said reservoir to the inlet of a heating component; a powered heating component containing a length of coiled tubing within for the conversion of liquid to vapor and pressure-resistant connections on both the inlet and outlet ends of said heating component; and, a single use cord connecting a pressure-resistant inlet port of a vapor based ablation device to the outlet of said heating component.
- the liquid reservoir is integrated within an operating room equipment generator.
- the liquid is water and resultant said vapor is steam.
- the pressure-resistant connections are of a luer lock type.
- the coiled tubing is copper.
- the vapor delivery system used for supplying vapor to an ablation device further comprises a foot pedal used by the operator to deliver more vapor to the ablation device.
- Treatment refers to any reduction in the extent, frequency, or severity of one or more symptoms or signs associated with a condition.
- “Duration” and variations thereof refer to the time course of a prescribed treatment, from initiation to conclusion, whether the treatment is concluded because the condition is resolved or the treatment is suspended for any reason. Over the duration of treatment, a plurality of treatment periods may be prescribed during which one or more prescribed stimuli are administered to the subject.
- Period refers to the time over which a “dose” of stimulation is administered to a subject as part of the prescribed treatment plan.
- the steps may be conducted in any feasible order. And, as appropriate, any combination of two or more steps may be conducted simultaneously.
- Ablative agents such as steam, heated gas or cryogens, such as, but not limited to, liquid nitrogen are inexpensive and readily available and are directed via the infusion port onto the tissue, held at a fixed and consistent distance, targeted for ablation. This allows for uniform distribution of the ablative agent on the targeted tissue.
- the flow of the ablative agent is controlled by a microprocessor according to a predetermined method based on the characteristic of the tissue to be ablated, required depth of ablation, and distance of the port from the tissue.
- the microprocessor may use temperature, pressure or other sensing data to control the flow of the ablative agent.
- one or more suction ports are provided to suction the ablation agent from the vicinity of the targeted tissue.
- the targeted segment can be treated by a continuous infusion of the ablative agent or via cycles of infusion and removal of the ablative agent as determined and controlled by the microprocessor.
- controller that comprises a microprocessor executing control instructions.
- the controller can be in the form of any computing device, including desktop, laptop, and mobile device, and can communicate control signals to the ablation devices in wired or wireless form.
- FIG. 1 illustrates an ablation device, in accordance with an embodiment of the present invention.
- the ablation device comprises a catheter 10 having a distal centering or positioning attachment which is an inflatable balloon 11 .
- the catheter 10 is made of or covered with an insulated material to prevent the escape of ablative energy from the catheter body.
- the ablation device comprises one or more infusion ports 12 for the infusion of ablative agent and one or more suction ports 13 for the removal of ablative agent.
- the infusion port 12 and suction port 13 are the same.
- the infusion ports 12 can direct the ablative agent at different angles.
- Ablative agent is stored in a reservoir 14 connected to the catheter 10 .
- a microprocessor 15 Delivery of the ablative agent is controlled by a microprocessor 15 and initiation of the treatment is controlled by a treating physician using an input device, such as a foot-paddle 16 .
- the input device could be a voice recognition system (that is responsive to commands such as “start”, “more”, “less”, etc.), a mouse, a switch, footpad, or any other input device known to persons of ordinary skill in the art.
- microprocessor 15 translates signals from the input device, such as pressure being placed on the foot-paddle or vocal commands to provide “more” or “less” ablative agent, into control signals that determine whether more or less ablative agent is dispensed.
- Optional sensor 17 monitors changes in an ablative tissue or its vicinity to guide flow of ablative agent.
- optional sensor 17 also includes a temperature sensor.
- Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors 18 measure the dimensions of the hollow organ.
- a user interface included with the microprocessor 15 allows a physician to define device, organ, and condition which in turn creates default settings for temperature, cycling, volume (sounds), and standard RF settings. In one embodiment, these defaults can be further modified by the physician.
- the user interface also includes standard displays of all key variables, along with warnings if values exceed or go below certain levels.
- the ablation device also includes safety mechanisms to prevent users from being burned while manipulating the catheter, including insulation, and optionally, cool air flush, cool water flush, and alarms/tones to indicate start and stop of treatment.
- the inflatable balloon has a diameter of between 1 mm and 10 cm. In one embodiment, the inflatable balloon is separated from the ports by a distance of 1 mm to 10 cm. In one embodiment, the size of the port openings is between 1 ⁇ m and 1 cm. It should be appreciated that the inflatable balloon is used to fix the device and therefore is configured to not contact the ablated area.
- the inflatable balloon can be any shape that contacts the hollow organ at 3 or more points. One of ordinary skill in the art will recognize that, using triangulation, one can calculate the distance of the catheter from the lesion. Alternatively, the infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors 18 can measure the dimensions of the hollow organ.
- the infrared, electromagnetic, acoustic or radiofrequency energy is emitted from the emitter 18 and is reflected back from the tissue to the detector in the emitter 18 .
- the reflected data can be used to determine the dimension of the hollow cavity. It should be appreciated that the emitter and sensor 18 can be incorporated into a single transceiver that is capable of both emitting energy and detecting the reflected energy.
- FIG. 2A illustrates a longitudinal section of the ablation device, depicting a distribution of infusion ports.
- FIG. 2B illustrates a cross section of a distribution of infusion ports on the ablation device, in accordance with an embodiment of the present invention.
- the longitudinal and cross sectional view of the catheter 10 as illustrated in FIGS. 2A and 2B respectively, show one arrangement of the infusion ports 12 to produce a uniform distribution of ablative agent 21 (shown in FIG. 2B ) in order to provide a circumferential area of ablation in a hollow organ 20 .
- FIG. 2C illustrates a cross section of a distribution of infusion ports on the ablation device, in accordance with another embodiment of the present invention.
- the arrangement of the infusion ports 12 as illustrated in FIG. 2C produce a focal distribution of ablative agent 21 and a focal area of ablation in a hollow organ 20 .
- the size of the port, number of ports, and distance between the ports will be determined by the volume of ablative agent needed, pressure that the hollow organ can withstand, size of the hollow organ as measured by the distance of the surface from the port, length of the tissue to be ablated (which is roughly the surface area to be ablated), characteristics of the tissue to be ablated and depth of ablation needed.
- FIG. 2D illustrates another embodiment of the ablation device.
- the vapor ablation catheter comprises an insulated catheter 21 with one or more positioning attachments 22 of known length 23 .
- the vapor ablation catheter has one or more vapor infusion ports 25 .
- the length 24 of the vapor ablation catheter 21 with infusion ports 25 is determined by the length or area of the tissue to be ablated.
- Vapor 29 is delivered through the vapor infusion ports 25 .
- the catheter 21 is preferably positioned in the center of the positioning attachment 22 , and the infusion ports 25 are arranged circumferentially for circumferential ablation and delivery of vapor.
- the catheter 21 can be positioned toward the periphery of the positioning attachment 22 and the infusion ports 25 can be arranged non-circumferentially, preferably linearly on one side for focal ablation and delivery of vapor.
- the positioning attachment 22 is one of an inflatable balloon, a wire mesh disc with or without an insulated membrane covering the disc, a cone shaped attachment, a ring shaped attachment or a freeform attachment designed to fit the desired hollow body organ or hollow body passage, as further described below.
- Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors 28 are incorporated to measure the dimensions of the hollow organ.
- the vapor ablation catheter may also comprise an optional coaxial sheet 27 to restrain the positioning attachment 22 in a manner comparable to a coronary metal stent.
- the sheet is made of memory metal or memory material with a compressed linear form and a non-compressed form in the shape of the positioning attachment.
- the channel of an endoscope may perform the function of restraining the positioning attachment 22 by, for example, acting as a constraining sheath.
- Optional sensor 26 is deployed on the catheter to measure changes associated with vapor delivery or ablation.
- the sensor is one of temperature, pressure, photo or chemical sensor.
- one or more, infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors 28 can measure the dimensions of the hollow organ.
- the infrared, electromagnetic, acoustic or radiofrequency energy is emitted from the emitter 28 and is reflected back from the tissue to the detector in the emitter 28 .
- the reflected data can be used to determine the dimension of the hollow cavity.
- the measurement is performed at one or multiple points to get an accurate estimate of the dimension of the hollow organ.
- the data can also be used to create a topographic representation of the hollow organ. Additional data from diagnostic tests can be used to validate or add to the data from the above measurements.
- FIG. 2E illustrates an ablation device 220 in the form of a catheter 221 extending from a conventional handle 222 , in accordance with an embodiment of the present invention.
- the catheter 221 is of a type as described above and extends from and attaches to the handle 222 .
- the catheter 221 is insulated to protect the user from burns that could result from hot vapor heating the catheter.
- the catheter is composed of a material that will ensure that the outer temperature of the catheter will remain below 60° C. during use.
- the handle 222 includes a pressure resistant port at the point of attachment with the catheter 221 .
- the handle 222 also includes a flow channel within that directs vapor through to the catheter 221 .
- the snare handle 222 includes a single attachment port 223 for the connection of a vapor stream and an RF feed. In another embodiment (not shown), the snare handle includes two separate attachment ports for the connection of a vapor stream and an RF feed.
- the attachment port 223 interfaces with the vapor supply cord via pressure-resistant connectors.
- the connectors are of a luer lock type.
- the catheter 221 is a dual lumen catheter. The first lumen serves to deliver vapor to the site of ablation. In one embodiment, the vapor is released through small ports 224 positioned proximate the distal end of the catheter 221 .
- the distal end of the catheter 221 is designed so that it can puncture the tissue to deliver vapor to the desired depth and location within the target tissue.
- the distal end of the catheter 221 tapers to a point.
- the second lumen houses the electrode used for RF ablation.
- the delivery of vapor or RF waves is achieved through the use of a microprocessor.
- the user can release vapor or subject the target tissue to RF waves by the use of actuators (not shown) on the handle 222 .
- the catheter has varying or differential insulation along its length.
- the ablation device 220 includes a mechanism in which a snare to grasp the tissue to be ablated and sizing the tissue in the snare is used to determine the amount of vapor to be delivered.
- FIG. 2F illustrates a cross section of an ablation device 227 in the form of a catheter 231 extending from a conventional handle 232 with a pre-attached cord 235 , in accordance with another embodiment of the present invention.
- the cord 235 attaches directly to the vapor delivery system, eliminating one interface between the system and the ablation device and thereby decreasing the chance of system failure as a result of disconnection.
- the handle 232 includes a separate attachment port (not shown) for the RF or an electric feed.
- FIG. 2G illustrates an ablation device 229 in the form of a catheter 241 extending from a conventional esophageal probe 226 , in accordance with an embodiment of the present invention.
- the catheter 241 is insulated and receives vapor from a flow channel contained within the probe 226 .
- the catheter 241 includes a multitude of small ports 244 for the delivery of vapor to the target tissue. The delivery of vapor is controlled by a microprocessor.
- the catheter 241 also includes two inflatable balloons 228 , one at its distal end beyond the last vapor port 244 , and one at its proximal end, proximate the catheter's 241 attachment to the probe 226 . All vapor ports are positioned between these two balloons.
- the balloons 228 are inflated to keep the catheter 241 positioned and to contain the vapor within the desired treatment area.
- the balloons must be separated from the ablation region by a distance of greater than 0 mm, preferably 1 mm and ideally 1 cm.
- the diameter of each balloon when inflated is in the range of 10 to 100 mm, preferably 15-40 mm, although one of ordinary skill in the art would appreciate that the precise dimensions are dependent on the size of the patient's esophagus.
- the catheter 241 attached to the esophageal probe 226 is a dual lumen catheter.
- the first lumen serves to deliver vapor to the site of ablation as described above.
- the second lumen houses the electrode used for RF ablation.
- FIG. 3A illustrates the ablation device placed in an upper gastrointestinal tract with Barrett's esophagus to selectively ablate the Barrett's tissue, in accordance with an embodiment of the present invention.
- the upper gastrointestinal tract comprises Barrett's esophagus 31 , gastric cardia 32 , gastroesophageal junction 33 and displaced squamo-columnar junction 34 .
- the area between the gastroesophageal junction 33 and the displaced squamo-columnar junction 34 is Barrett's esophagus 31 , which is targeted for ablation.
- Distal to the cardia 32 is the stomach 35 and proximal to the cardia 32 is the esophagus 36 .
- the ablation device is passed into the esophagus 36 and the positioning device 11 is placed in the gastric cardia 32 abutting the gastroesophageal junction 33 .
- This affixes the ablation catheter 10 and its ports 12 in the center of the esophagus 36 and allows for uniform delivery of the ablative agent 21 to the Barrett's esophagus 31 .
- the positioning device is first affixed to an anatomical structure, not being subjected to ablation, before ablation occurs.
- the positioning attachment is preferably placed in the gastric cardia, abutting the gastroesophageal junction.
- the positioning attachment must be separated from the ablation region by a distance of greater than 0 mm, preferably 1 mm and ideally 1 cm.
- the size of the positioning device is in the range of 10 to 100 mm, preferably 20-40 mm, although one of ordinary skill in the art would appreciate that the precise dimensions are dependent on the size of the patient's esophagus.
- the delivery of ablative agent 21 through the infusion port 12 is controlled by the microprocessor 15 coupled with the ablation device.
- the delivery of ablative agent is guided by predetermined programmatic instructions, depending on the tissue to be ablated and the depth of ablation required.
- the target procedural temperature will need to be between ⁇ 100 degrees Celsius and 200 degrees Celsius, preferably between 50 degrees Celsius and 75 degrees Celsius, as further shown in the dosimetery table below.
- esophageal pressure should not exceed 5 atm, and is preferably below 0.5 atm.
- the target procedural temperature is achieved in less than 1 minute, preferably in less than 5 seconds, and is capable of being maintained for up to 10 minutes, preferably 1 to 10 seconds, and then cooled to body temperature.
- the treatment can be repeated until the desired ablation effect is achieved.
- Optional sensor 17 monitors intraluminal parameters such as temperature and pressure and can increase or decrease the flow of ablative agent 21 through the infusion port 12 to obtain adequate heating or cooling, resulting in adequate ablation.
- the sensor 17 monitors intraluminal parameters such as temperature and pressure and can increase or decrease the removal of ablative agent 21 through the optional suction port 13 to obtain adequate heating or cooling resulting in adequate ablation of Barrett's esophagus 31 .
- FIG. 3B illustrates the ablation device placed in an upper gastrointestinal tract with Barrett's esophagus to selectively ablate the Barrett's tissue, in accordance with another embodiment of the present invention. As illustrated in FIG. 3B , the positioning device 11 is a wire mesh disc.
- the positioning attachment must be separated from the ablation region by a distance of greater than 0 mm, preferably 1 mm and ideally 1 cm.
- the positioning attachment is removably affixed to the cardia or gastroesophageal (EG) junction (for the distal attachment) or in the esophagus by a distance of greater than 0.1 mm, preferably around 1 cm, above the proximal most extent of the Barrett's tissue (for the proximal attachment).
- EG gastroesophageal
- FIG. 3B is another embodiment of the Barrett's ablation device where the positioning element 11 is a wire mesh disc.
- the wire mesh may have an optional insulated membrane to prevent the escape of the ablative agent.
- two wire mesh discs are used to center the ablation catheter in the esophagus. The distance between the two discs is determined by the length of the tissue to be ablated which, in this case, would be the length of the Barrett's esophagus.
- Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors 18 are incorporated to measure the diameter of the esophagus.
- FIG. 3C is a flowchart illustrating the basic procedural steps for using the ablation device, in accordance with an embodiment of the present invention.
- a catheter of the ablation device is inserted into an organ which is to be ablated.
- the catheter is inserted into the Barrett's esophagus via the esophagus of the patient.
- a positioning element of the ablation device is deployed and organ dimensions are measured.
- the positioning element is a balloon
- the balloon is inflated in order to position the ablation device at a known fixed distance from the tissue to be ablated.
- the diameter of the hollow organ may be predetermined by using radiological tests such as barium X-rays or computer tomography (CT) scan, or by using pressure volume cycle, i.e. by determining volume needed to raise pressure to a fixed level (for example, 1 atm) in a fixed volume balloon.
- CT computer tomography
- pressure volume cycle i.e. by determining volume needed to raise pressure to a fixed level (for example, 1 atm) in a fixed volume balloon.
- the positioning device is disc shaped
- circumferential rings are provided in order to visually communicate to an operating physician the diameter of the hollow organ.
- the positioning device enables centering of the catheter of the ablation device in a non-cylindrical body cavity, and the volume of the cavity is measured by the length of catheter or
- one or more infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors can be used to measure the dimensions of the hollow organ.
- the infrared, electromagnetic, acoustic or radiofrequency energy is emitted from the emitter and is reflected back from the tissue to a detector in the emitter.
- the reflected data can be used to determine the dimensions of the hollow cavity.
- the measurement can be performed at one or multiple points to get an accurate estimate of the dimensions of the hollow organ.
- the data from multiple points can also be used to create a topographic representation of the hollow organ or to calculate the volume of the hollow organ.
- the positioning attachment must be separated from the ports by a distance of 0 mm or greater, preferably greater than 0.1 mm, and more preferably 1 cm.
- the size of the positioning device depends on the hollow organ being ablated and ranges from 1 mm to 10 cm.
- the diameter of the positioning element is between 0.01 mm and 100 mm.
- the first positioning element comprises a circular body with a diameter between 0.01 mm and 10 cm.
- the organ is ablated by automated delivery of an ablative agent, such as steam, via infusion ports provided on the catheter.
- the delivery of the ablative agent through the infusion ports is controlled by a microprocessor coupled with the ablation device.
- the delivery of ablative agent is guided by predetermined programmatic instructions depending on the tissue to be ablated and the depth of ablation required.
- the dose of the ablative agent is determined by conducting dosimetery study to determine the dose to ablate endometrial tissue.
- the variable that enables determination of total dose of ablative agent is the volume (or mass) of the tissue to be treated which is calculated by using the length of the catheter and diameter of the organ (for cylindrical organs).
- the determined dose of ablative agent is then delivered using a micro-processor controlled steam generator.
- the delivery of the ablative agent can be controlled by the operator using predetermined dosimetry parameters.
- the dose is provided by first determining what the disorder being treated is and what the desired tissue effect is, and then finding the corresponding temperature, as shown in Tables 1 and 2, below.
- the depth of ablation desired determines the holding time at the maximum temperature.
- the holding time at the maximum temperature is very short (flash burn) and does not allow for heat to transfer to the deeper layers. This will prevent damage to deeper normal tissue and hence prevent patient discomfort and complications.
- the holding time at the maximum temperature will be longer, thereby allowing the heat to percolate deeper.
- FIG. 4A illustrates the ablation device placed in a colon to ablate a flat colon polyp, in accordance with an embodiment of the present invention.
- the ablation catheter 10 is passed through a colonoscope 40 .
- the positioning device 11 is placed proximal, with respect to the patient's GI tract, to a flat colonic polyp 41 which is to be ablated, in the normal colon 42 .
- the positioning device 11 is one of an inflatable balloon, a wire mesh disc with or without an insulated membrane covering the disc, a cone shaped attachment, a ring shaped attachment or a freeform attachment designed to fit the colonic lumen.
- the positioning device 11 has the catheter 10 located toward the periphery of the positioning device 11 placing it closer to the polyp 41 targeted for non-circumferential ablation. Hence, the positioning device 11 fixes the catheter to the colon 42 at a predetermined distance from the polyp 41 for uniform and focused delivery of the ablative agent 21 .
- the delivery of ablative agent 21 through the infusion port 12 is controlled by the microprocessor 15 attached to the ablation device and depends on tissue and the depth of ablation required.
- the delivery of ablative agent 21 is guided by predetermined programmatic instructions depending on the tissue to be ablated and the area and depth of ablation required.
- Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors 18 are incorporated to measure the diameter of the colon.
- the ablation device allows for focal ablation of diseased polyp mucosa without damaging the normal colonic mucosa located away from the catheter ports.
- the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, ideally more than 5 mm.
- the positioning element is proximal, with respect to the patient's GI tract, to the colon polyp.
- FIG. 4B illustrates the ablation device placed in a colon 42 to ablate a flat colon polyp 41 , in accordance with another embodiment of the present invention.
- the positioning device 11 is a conical attachment at the tip of the catheter 10 .
- the conical attachment has a known length ‘l’ and diameter ‘d’ that is used to calculate the amount of thermal energy needed to ablate the flat colon polyp 41 .
- Ablative agent 21 is directed from the infusion port 12 to polyp 41 by the positioning device 11 .
- the positioning attachment 11 must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm.
- the length ‘l’ is greater than 0.1 mm, preferably between 5 and 10 mm.
- diameter ‘d’ depends on the size of the polyp and can be between 1 mm and 10 cm, preferably 1 to 5 cm.
- Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors 18 are incorporated to measure the diameter of the colon. This embodiment can also be used to ablate residual neoplastic tissue at the edges after endoscopic snare resection of a large sessile colon polyp.
- FIG. 5A illustrates the ablation device with a coaxial catheter design, in accordance with an embodiment of the present invention.
- the coaxial design has a handle 52 a , an infusion port 53 a , an inner sheath 54 a and an outer sheath 55 a .
- the outer sheath 55 a is used to constrain the positioning device 56 a in the closed position and encompasses ports 57 a .
- FIG. 5B shows a partially deployed positioning device 56 b , with the ports 57 b still within the outer sheath 55 b .
- the positioning device 56 b is partially deployed by pushing the catheter 54 b out of sheath 55 b.
- FIG. 5C shows a completely deployed positioning device 56 c .
- the infusion ports 57 c are out of the sheath 55 c .
- the length ‘l’ of the catheter 54 c that contains the infusion ports 57 c and the diameter ‘d’ of the positioning element 56 c are predetermined/known and are used to calculate the amount of thermal energy needed.
- FIG. 5D illustrates a conical design of the positioning element.
- the positioning element 56 d is conical with a known length ‘l’ and diameter ‘d’ that is used to calculate the amount of thermal energy needed for ablation.
- FIG. 5E illustrates a disc shaped design of the positioning element 56 e comprising circumferential rings 59 e .
- the circumferential rings 59 e are provided at a fixed predetermined distance from the catheter 54 e and are used to estimate the diameter of a hollow organ or hollow passage in a patient's body.
- FIG. 6 illustrates an upper gastrointestinal tract with a bleeding vascular lesion being treated by the ablation device, in accordance with an embodiment of the present invention.
- the vascular lesion is a visible vessel 61 in the base of an ulcer 62 .
- the ablation catheter 63 is passed through the channel of an endoscope 64 .
- the conical positioning element 65 is placed over the visible vessel 61 .
- the conical positioning element 65 has a known length ‘l’ and diameter ‘d’, which are used to calculate the amount of thermal energy needed for coagulation of the visible vessel to achieve hemostasis.
- the conical positioning element has an optional insulated membrane that prevents escape of thermal energy or vapor away from the disease site.
- the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm.
- the length ‘l’ is greater than 0.1 mm, preferably between 5 and 10 mm.
- diameter ‘d’ depends on the size of the lesion and can be between 1 mm and 10 cm, preferably 1 to 5 cm.
- FIG. 7 illustrates endometrial ablation being performed in a female uterus by using the ablation device, in accordance with an embodiment of the present invention.
- a cross-section of the female genital tract comprising a vagina 70 , a cervix 71 , a uterus 72 , an endometrium 73 , fallopian tubes 74 , ovaries 75 and the fundus of the uterus 76 is illustrated.
- a catheter 77 of the ablation device is inserted into the uterus 72 through the cervix 71 .
- the catheter 77 has two positioning elements, a conical positioning element 78 and a disc shaped positioning element 79 .
- the positioning element 78 is conical with an insulated membrane covering the conical positioning element 78 .
- the conical element 78 positions the catheter 77 in the center of the cervix 71 and the insulated membrane prevents the escape of thermal energy or ablative agent through the cervix 71 .
- the second disc shaped positioning element 79 is deployed close to the fundus of the uterus 76 positioning the catheter 77 in the middle of the cavity.
- An ablative agent 778 is passed through infusion ports 777 for uniform delivery of the ablative agent 778 into the uterine cavity.
- Predetermined length “l” of the ablative segment of the catheter and diameter ‘d’ of the positioning element 79 allows for estimation of the cavity size and is used to calculate the amount of thermal energy needed to ablate the endometrial lining.
- Optional temperature sensors 7 deployed close to the endometrial surface are used to control the delivery of the ablative agent 778 .
- Optional topographic mapping using multiple infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors can be used to define cavity size and shape in patients with an irregular or deformed uterine cavity due to conditions such as fibroids. Additionally data from diagnostic testing can be used to ascertain the uterine cavity size, shape or other characteristics.
- the ablative agent is vapor or steam which contracts on cooling.
- Steam turns to water which has a lower volume as compared to a cryogen that will expand or a hot fluid used in hydrothermal ablation whose volume stays constant.
- cryogens and hot fluids increasing energy delivery is associated with increasing volume of the ablative agent which, in turn, requires mechanisms for removing the agent, otherwise the medical provider will run into complications, such as perforation.
- steam, on cooling turns into water which occupies significantly less volume; therefore, increasing energy delivery is not associated with an increase in volume of the residual ablative agent, thereby eliminating the need for continued removal. This further decreases the risk of leakage of the thermal energy via the fallopian tubes 74 or the cervix 71 , thus reducing any risk of thermal injury to adjacent healthy tissue.
- the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm. In another embodiment, the positioning attachment can be in the ablated region as long as it does not cover a significant surface area. For endometrial ablation, 100% of the tissue does not need to be ablated to achieve the desired therapeutic effect.
- the preferred distal positioning attachment is an uncovered wire mesh that is positioned proximate to the mid body region.
- the preferred proximal positioning device is a covered wire mesh that is pulled into the cervix, centers the device, and occludes the cervix.
- One or more such positioning devices may be helpful to compensate for the anatomical variations in the uterus.
- the proximal positioning device is preferably oval, with a long axis between 0.1 mm and 10 cm (preferably 1 cm to 5 cm) and a short axis between 0.1 mm and 5 cm (preferably 0.5 cm to 1 cm).
- the distal positioning device is preferably circular with a diameter between 0.1 mm and 10 cm, preferably 1 cm to 5 cm.
- FIG. 8 illustrates sinus ablation being performed in a nasal passage by using the ablation device, in accordance with an embodiment of the present invention.
- a cross-section of the nasal passage and sinuses comprising nares 81 , nasal passages 82 , frontal sinus 83 , ethmoid sinus 84 , and diseased sinus epithelium 85 is illustrated.
- the catheter 86 is inserted into the frontal sinus 83 or the ethmoid sinus 84 through the nares 81 and nasal passages 82 .
- the catheter 86 has two positioning elements, a conical positioning element 87 and a disc shaped positioning element 88 .
- the positioning element 87 is conical and has an insulated membrane covering.
- the conical element 87 positions the catheter 86 in the center of the sinus opening 80 and the insulated membrane prevents the escape of thermal energy or ablative agent through the opening.
- the second disc shaped positioning element 88 is deployed in the frontal sinus cavity 83 or ethmoid sinus cavity 84 , positioning the catheter 86 in the middle of either sinus cavity.
- the ablative agent 8 is passed through the infusion port 89 for uniform delivery of the ablative agent 8 into the sinus cavity.
- the predetermined length “l” of the ablative segment of the catheter and diameter of the positioning element 88 allows for estimation of the sinus cavity size and is used to calculate the amount of thermal energy needed to ablate the diseased sinus epithelium 85 .
- Optional temperature sensors 888 are deployed close to the diseased sinus epithelium 85 to control the delivery of the ablative agent 8 .
- the ablative agent 8 is steam which contracts on cooling. This further decreases the risk of leakage of the thermal energy thus reducing any risk of thermal injury to adjacent healthy tissue.
- the dimensional ranges of the positioning elements are similar to those in the endometrial application, with preferred maximum ranges being half thereof.
- Optional topographic mapping using multiple infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors can be used to define cavity size and shape in patients with an irregular or deformed nasal cavity due to conditions such as nasal polyps.
- FIG. 9 illustrates bronchial and bullous ablation being performed in a pulmonary system by using the ablation device, in accordance with an embodiment of the present invention.
- a cross-section of the pulmonary system comprising bronchus 91 , normal alveolus 92 , bullous lesion 93 , and a bronchial neoplasm 94 is illustrated.
- the catheter 96 is inserted through the channel of a bronchoscope 95 into the bronchus 91 and advanced into a bullous lesion 93 .
- the catheter 96 has two positioning elements, a conical positioning element 97 and a disc shaped positioning element 98 .
- the positioning element 97 is conical having an insulated membrane covering.
- the conical element 97 positions the catheter 96 in the center of the bronchus 91 and the insulated membrane prevents the escape of thermal energy or ablative agent through the opening into the normal bronchus.
- the second disc shaped positioning element 98 is deployed in the bullous cavity 93 positioning the catheter 96 in the middle of the bullous cavity 93 .
- An ablative agent 9 is passed through the infusion port 99 for uniform delivery into the sinus cavity.
- Predetermined length “l” of the ablative segment of the catheter 96 and diameter of the positioning element 98 allow for estimation of the bullous cavity size and is used to calculate the amount of thermal energy needed to ablate the diseased bullous cavity 93 .
- the size of the cavity can be calculated from radiological evaluation using a chest CAT scan or MRI.
- Optional temperature sensors are deployed close to the surface of the bullous cavity 93 to control the delivery of the ablative agent 9 .
- the ablative agent is steam which contracts on cooling. This further decreases the risk of leakage of the thermal energy into the normal bronchus thus reducing any risk of thermal injury to adjacent normal tissue.
- the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm. In another embodiment, the positioning attachment can be in the ablated region as long as it does not cover a significant surface area.
- the endoscope is used as one fixation point with one positioning element.
- the positioning device is between 0.1 mm and 5 cm (preferably 1 mm to 2 cm).
- the distal positioning device is preferably circular with a diameter between 0.1 mm and 10 cm, preferably 1 cm to 5 cm.
- the catheter 96 is inserted through the channel of a bronchoscope 95 into the bronchus 91 and advanced across the bronchial neoplasm 94 .
- the positioning element 98 is disc shaped having an insulated membrane covering. The positioning element 98 positions the catheter in the center of the bronchus 91 and the insulated membrane prevents the escape of thermal energy or ablative agent through the opening into the normal bronchus.
- the ablative agent 9 is passed through the infusion port 99 in a non-circumferential pattern for uniform delivery of the ablative agent to the bronchial neoplasm 94 .
- the predetermined length “l” of the ablative segment of the catheter and diameter ‘d’ of the positioning element 98 are used to calculate the amount of thermal energy needed to ablate the bronchial neoplasm 94 .
- the catheter could be advanced to the desired location of ablation using endoscopic, laparoscopic, stereotactic or radiological guidance.
- the catheter could be advanced to the desired location using magnetic navigation.
- FIG. 10 illustrates prostate ablation being performed on an enlarged prostrate in a male urinary system by using the device, in accordance with an embodiment of the present invention.
- a cross-section of a male genitourinary tract having an enlarged prostate 1001 , bladder 1002 , and urethra 1003 is illustrated.
- the urethra 1003 is compressed by the enlarged prostate 1001 .
- the ablation catheter 1005 is passed through the cystoscope 1004 positioned in the urethra 1003 distal to the obstruction.
- the positioning elements 1006 are deployed to center the catheter in the urethra 1003 and one or more insulated needles 1007 are passed to pierce the prostate 1001 .
- the vapor ablative agent 1008 is passed through the insulated needles 1007 thus causing ablation of the diseased prostatic tissue resulting in shrinkage of the prostate.
- the size of the enlarged prostate could be calculated by using the differential between the extra-prostatic and intra-prostatic urethra. Normative values could be used as baseline. Additional ports for infusion of a cooling fluid into the urethra can be provided to prevent damage to the urethra while the ablative energy is being delivered to the prostrate for ablation, thus preventing complications such as stricture formation.
- the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm to 5 mm and no more than 2 cm. In another embodiment, the positioning attachment can be deployed in the bladder and pulled back into the urethral opening/neck of the bladder thus fixing the catheter. In one embodiment, the positioning device is between 0.1 mm and 10 cm in diameter.
- FIG. 11 illustrates fibroid ablation being performed in a female uterus by using the ablation device, in accordance with an embodiment of the present invention.
- a cross-section of a female genitourinary tract comprising a uterine fibroid 1111 , uterus 1112 , and cervix 1113 is illustrated.
- the ablation catheter 1115 is passed through the hysteroscope 1114 positioned in the uterus distal to the fibroid 1111 .
- the ablation catheter 1115 has a puncturing tip 1120 that helps puncture into the fibroid 1111 .
- the positioning elements 1116 are deployed to center the catheter in the fibroid and insulated needles 1117 are passed to pierce the fibroid tissue 1111 .
- the vapor ablative agent 1118 is passed through the needles 1117 thus causing ablation of the uterine fibroid 1111 resulting in shrinkage of the fibroid.
- FIG. 12 illustrates a vapor delivery system using an RF heater for supplying vapor to the ablation device, in accordance with an embodiment of the present invention.
- the vapor is used as an ablative agent in conjunction with the ablation device described in the present invention.
- RF heater 1264 is located proximate a pressure vessel 1242 containing a liquid 1244 .
- RF heater 1264 heats vessel 1242 , in turn heating the liquid 1244 .
- the liquid 1244 heats up and begins to evaporate causing an increase in pressure inside the vessel 1242 .
- the pressure inside vessel 1242 can be kept fairly constant by providing a thermal switch 1246 that controls resistive heater 1264 .
- the thermal switch 1246 shuts off RF heater 1264 .
- the vapor created in pressure vessel 1242 may be released via a control valve 1250 .
- a pressure drop is created in the vessel resulting in a reduction in temperature.
- the reduction of temperature is measured by thermal switch 1246 , and RF heater 1264 is turned back on to heat liquid 1244 .
- the target temperature of vessel 1242 may be set to approximately 108° C., providing a continuous supply of vapor. As the vapor is released, it undergoes a pressure drop, which reduces the temperature of the vapor to a range of approximately 90-100° C.
- the vessel 1242 is optionally connected to reservoir 1243 containing liquid 1244 via a pump 1249 which can be turned on by the controller 1224 upon sensing a fall in pressure or temperature in vessel 1242 , delivering additional liquid 1244 to the vessel 1242 .
- Vapor delivery catheter 1216 is connected to vessel 1242 via a fluid connector 1256 .
- control valve 1250 When control valve 1250 is open, vessel 1242 is in fluid communication with delivery catheter 1216 via connector 1256 .
- Control switch 1260 may serve to turn vapor delivery on and off via actuator 1248 .
- control switch 1260 may physically open and close the valve 1250 , via actuator 1248 , to control delivery of vapor stream from the vessel 1242 .
- Switch 1260 may be configured to control other attributes of the vapor such as direction, flow, pressure, volume, spray diameter, or other parameters.
- switch 1260 may electrically communicate with a controller 1224 .
- Controller 1224 controls the RF heater 1264 , which in turn controls attributes of the vapor, in response to actuation of switch 1260 by the operator.
- controller 1224 may control valves temperature or pressure regulators associated with catheter 1216 or vessel 1242 .
- a flow meter 1252 may be used to measure the flow, pressure, or volume of vapor delivery via the catheter 1216 .
- the controller 1224 controls the temperature and pressure in the vessel 1242 and the time, rate, flow, and volume of vapor flow through the control valve 1250 . These parameters are set by the operator 1211 .
- the pressure created in vessel 1242 using the target temperature of 108° C., may be in the order of 25 pounds per square inch (psi) (1.72 bars).
- FIG. 13 illustrates a vapor delivery system using a resistive heater for supplying vapor to the ablation device, in accordance with an embodiment of the present invention.
- the generated vapor is used as an ablative agent in conjunction with the ablation device described in the present invention.
- Resistive heater 1340 is located proximate a pressure vessel 1342 .
- Vessel 1342 contains a liquid 1344 .
- Resistive heater 1340 heats vessel 1342 , in turn heating liquid 1344 . Accordingly, liquid 1344 heats and begins to evaporate. As liquid 1344 begins to evaporate, the vapor inside vessel 1342 causes an increase in pressure in the vessel.
- the pressure in vessel 1342 can be kept fairly constant by providing a thermal switch 1346 that controls resistive heater 1340 .
- thermal switch 1346 shuts off resistive heater 1340 .
- the vapor created in pressure vessel 1342 may be released via a control valve 1350 .
- vessel 1342 experiences a pressure drop.
- the pressure drop of vessel 1342 results in a reduction of temperature.
- the reduction of temperature is measured by thermal switch 1346 , and resistive heater 1340 is turned back on to heat liquid 1344 .
- the target temperature of vessel 1342 may be set to approximately 108° C., providing a continuous supply of vapor. As the vapor is released, it undergoes a pressure drop, which reduces the temperature of the vapor to a range of approximately 90-100° C.
- the vessel 1342 is connected to another vessel 1343 containing liquid 1344 via a pump 1349 which can be turned on by the controller 1324 upon sensing a fall in pressure or temperature in vessel 1342 delivering additional liquid 1344 to the vessel 1342 .
- Vapor delivery catheter 1316 is connected to vessel 1342 via a fluid connector 1356 .
- control valve 1350 When control valve 1350 is open, vessel 1342 is in fluid communication with delivery catheter 1316 via connector 1356 .
- Control switch 1360 may serve to turn vapor delivery on and off via actuator 1348 .
- control switch 1360 may physically open and close the valve 1350 , via actuator 1348 , to control delivery of vapor stream from the vessel 1342 .
- Switch 1360 may be configured to control other attributes of the vapor such as direction, flow, pressure, volume, spray diameter, or other parameters. Instead of, or in addition to, physically controlling attributes of the vapor, switch 1360 may electrically communicate with a controller 1324 .
- Controller 1324 controls the resistive heater 1340 , which in turn controls attributes of the vapor, in response to actuation of switch 1360 by the operator.
- controller 1324 may control valves temperature or pressure regulators associated with catheter 1316 or vessel 1342 .
- a flow meter 1352 may be used to measure the flow, pressure, or volume of vapor delivery via the catheter 1316 .
- the controller 1324 controls the temperature and pressure in the vessel 1342 as well as time, rate, flow, and volume of vapor flow through the control valve 1350 . These parameters are set by the operator 1311 .
- the pressure created in vessel 1342 using the target temperature of 108° C., may be on the order of 25 pounds per square inch (psi) (1.72 bars).
- FIG. 14 illustrates a vapor delivery system using a heating coil for supplying vapor to the ablation device, in accordance with an embodiment of the present invention.
- the generated vapor is used as an ablative agent in conjunction with the ablation device described in the present invention.
- the vapor delivery system includes a conventional generator 1400 that is commonly used in operating rooms to provide power to specialized tools, i.e., cutters.
- the generator 1400 is modified to include an integrated liquid reservoir 1401 .
- the reservoir 1401 is filled with room temperature pure water.
- the reservoir 1401 portion of the generator 1400 is connected to the heating component 1405 via a reusable active cord 1403 .
- the reusable active cord 1403 may be used up to 200 times.
- the cord 1403 is fixedly attached via connections at both ends to withstand operational pressures, and preferably a maximum pressure, such that the cord does not become disconnected.
- the connections can resist at least 1 atm of pressure.
- the connections are of a luer lock type.
- the cord 1403 has a lumen through which liquid flows to the heating component 1405 .
- the heating component 1405 contains a coiled length of tubing 1406 . As liquid flows through the coiled tubing 1406 , it is heated by the surrounding heating component 1405 in a fashion similar to a conventional heat exchanger. As the liquid is heated, it becomes vaporized.
- the heating component contains a connector 1407 that accommodates the outlet of vapor from the coiled tubing 1406 .
- One end of a single use cord 1408 attaches to the heating component 1405 at the connector 1407 .
- the connector 1407 is designed to withstand pressures generated by the vapor inside the coiled tubing 1406 during operation.
- the connector 1407 is of a luer lock type.
- An ablation device 1409 is attached to the other end of the single use cord 1408 via a connection able to withstand the pressures generated by the system.
- the ablation device is integrated with a catheter.
- the ablation device is integrated with a probe.
- the single use cord 1408 has a specific luminal diameter and is of a specific length to ensure that the contained vapor does not condense into liquid while simultaneously providing the user enough slack to operate.
- the single use cord 1408 provides sufficient insulation so that personnel will not suffer burns when coming into contact with the cord.
- the single use cord has a luminal diameter of less than 3 mm, preferably less than 2.6 mm, and is longer than 1 meter in length.
- the system includes a foot pedal 1402 by which the user can supply more vapor to the ablation device. Depressing the foot pedal 1402 allows liquid to flow from the reservoir 1401 into the heating component 1405 where it changes into vapor within the coiled tubing 1406 . The vapor then flows to the ablation device via the single use tube 1408 .
- the ablation device includes an actuator by which the user can open small ports on the device, releasing the vapor and ablating the target tissue.
- FIG. 15 illustrates the heating component 1505 and coiled tubing 1506 of the heating coil vapor delivery system of FIG. 14 , in accordance with an embodiment of the present invention.
- Liquid arrives through a reusable active cord (not shown) at a connection 1502 on one side of the heating component 1505 .
- the liquid then travels through the coiled tubing 1506 within the heating component 1505 .
- the coiled tubing is composed of a material and configured specifically to provide optimal heat transfer to the liquid.
- the coiled tubing 1506 is copper.
- the temperature of the heating component 1505 is set to a range so that the liquid is converted to vapor as it passes through the coiled tubing 1506 .
- the temperature of the heating component 1505 can be set by the user through the use of a temperature setting dial 1508 .
- the heating component contains an on/off switch 1509 and is powered through the use of an attached AC power cord 1503 .
- the heating component receives power through an electrical connection integrated into and/or facilitated by the active cord connection to the reservoir.
- the vapor passes through the end of the coiled tubing 1506 and out of the heating component 1505 through a connector 1507 .
- the connector 1507 is located on the opposite side of the heating component 1505 from the inlet connection 1502 .
- a single use cord attaches to the connector 1507 and supplies vapor to the ablation device.
- FIG. 16A illustrates the unassembled interface connection between the ablation device 1608 and the single use cord 1601 of the heating coil vapor delivery system of FIG. 14 , in accordance with an embodiment of the present invention.
- the ablation device 1608 and single use cord 1601 are connected via a male-to-male double luer lock adapter 1605 .
- the end of the single use cord 1601 is threaded to form a female end 1602 of a luer lock interface and connects to one end of the adapter 1605 .
- the ablation device 1608 includes a small protrusion at its non-operational end which is also threaded to form a female end 1607 of a luer lock interface and connects to the other end of the adapter 1605 .
- the threading luer lock interface provides a secure connection and is able to withstand the pressures generated by the heating coil vapor delivery system without becoming disconnected.
- FIG. 16B illustrates the assembled interface connection between the ablation device 1608 and the single use cord 1601 of the heating coil vapor delivery system of FIG. 14 , in accordance with an embodiment of the present invention.
- the male-to-male double luer lock adapter 1605 is pictured securing the two components together.
- the double luer lock interface provides a stable seal, allows interchangeability between ablation devices, and enables users to quickly replace single use cords.
- FIG. 17 illustrates a vapor ablation system using a heater or heat exchange unit for supplying vapor to the ablation device, in accordance with another embodiment of the present invention.
- water for conversion to vapor is supplied in a disposable, single use sterile fluid container 1705 .
- the container 1705 is sealed with a sterile screw top 1710 that is punctured by a needle connector 1715 provided on a first end of a first filter member 1720 .
- the second end of the first filter member 1720 opposite the first end, is connected to a pump 1725 for drawing the water from the fluid container 1705 , through the first filter member 1720 , and into the heater or heat exchange unit 1730 .
- the system includes a microcontroller or microprocessor 1735 for controlling the actions of the pump 1725 and heater or heat exchange unit 1730 .
- the heater or heat exchange unit 1730 converts the water into vapor (steam).
- the increase in pressure generated during the heating step drives the vapor through an optional second filter member 1740 and into the ablation catheter 1750 .
- the heater or heat exchange unit 1730 includes a one-way valve at its proximal end to prevent the passage of vapor back toward the pump 1725 .
- optional sensors 1745 positioned proximate the distal end of the catheter 1750 measure one or more of temperature, pressure, or flow of vapor and transmit the information to the microcontroller 1735 , which in turn controls the rate of the pump 1725 and the level of vaporizing energy provided by the heater or heat exchange unit 1730 .
- FIG. 18 illustrates the fluid container 1805 , first filter member 1820 , and pump 1825 of the vapor ablation system of FIG. 17 .
- the system includes a water-filled, disposable, single use sterile fluid container 1805 and a pump 1825 with a first filter member 1820 disposed therebetween.
- the first filter member 1820 is connected to the container 1805 and pump 1825 by two first and second lengths of sterile tubing 1807 , 1822 respectively, and includes a filter for purifying the water used in the ablation system.
- FIGS. 19 and 20 illustrate first and second views respectively, of the fluid container 1905 , 2005 , first filter member 1920 , 2020 , pump 1925 , 2025 , heater or heat exchange unit 1930 , 2030 , and microcontroller 1935 , 2035 of the vapor ablation system of FIG. 17 .
- the container 1905 , 2005 is connected to the first filter member 1920 , 2020 by a first length of sterile tubing 1907 , 2007 and the first filter member 1920 , 2020 is connected to the pump 1925 , 2025 by a second length of sterile tubing 1922 , 2022 .
- a third length of sterile tubing 1927 , 2027 connects the pump 1925 , 2025 to the heater or heat exchange unit 1930 , 2030 .
- the microcontroller 1935 , 2035 is operably connected to the pump 1925 , 2025 by a first set of control wires 1928 , 2028 and to the heater or heat exchange unit 1930 , 2030 by a second set of control wires 1929 , 2029 .
- the arrows 1901 , 2001 depict the direction of the flow of water from the container 1905 , 2005 , through the first filter member 1920 , 2020 and pump 1925 , 2025 and into the heater or heat exchange member 1930 , 2030 where it is converted to vapor.
- Arrow 1931 , 2031 depicts the direction of flow of vapor from the heater or heat exchange unit 1930 , 2030 into the ablation catheter (not shown) for use in the ablation procedure.
- FIG. 21 illustrates the unassembled first filter member 2120 of the vapor ablation system of FIG. 17 , depicting the filter 2122 positioned within.
- the first filter member 2120 includes a proximal portion 2121 , a distal portion 2123 , and a filter 2122 .
- the proximal portion 2121 and distal portion 2123 secure together and hold the filter 2122 within.
- Also depicted in FIG. 21 are the disposable, single use sterile fluid container 2105 and the first length of sterile tubing 2107 connecting the container 2105 to the proximal portion 2121 of the first filter member 2120 .
- FIG. 22 illustrates one embodiment of the microcontroller 2200 of the vapor ablation system of FIG. 17 .
- the microcontroller 2200 includes a plurality of control wires 2228 connected to the pump and heater or heat exchange unit for controlling said components and a plurality of transmission wires 2247 for receiving flow, pressure, and temperature information from optional sensors positioned proximate the distal end of the ablation catheter.
- FIG. 23 illustrates one embodiment of a catheter assembly 2350 for use with the vapor ablation system of FIG. 17 .
- Vapor is delivered from the heater or heat exchange unit to the catheter assembly 2350 via a tube 2348 attached to the proximal end of a connector component 2352 of the assembly 2350 .
- a disposable catheter 2356 with a fixedly attached disposable length of flexible tubing 2358 at its distal end is fitted over the connector component 2352 .
- a second filter member 2354 is positioned between the connector component 2352 and the disposable catheter 2356 for purifying the vapor supplied by the heater or heat exchange unit.
- the connector component 2352 includes two washers 2353 positioned apart a short distance at its distal end to engage the overlaying disposable catheter 2356 and form a double-stage seal, thereby preventing vapor leakage between the components.
- a catheter connector 2357 is slid over the disposable flexible tubing 2358 and disposable catheter 2356 and is then snapped into place onto the connector component 2352 .
- the catheter connector 2357 acts to keep the disposable catheter 2356 in place and also assists in preventing vapor leakage.
- the disposable flexible tubing 2358 includes one or more holes or ports 2359 at or proximate its distal end for the delivery of ablative vapor to target tissues.
- FIG. 24 illustrates one embodiment of a heat exchange unit 2430 for use with the vapor ablation system of FIG. 17 .
- the heat exchange unit 2430 comprises a length of coiled tubing 2435 surrounded by a heating element 2434 .
- Water 2432 enters the coiled tubing 2435 of the heat exchange unit 2430 at an entrance port 2433 proximate a first end of said heat exchange unit 2430 .
- As the water 2432 flows within the coiled tubing 2435 it is converted into vapor (steam) 2438 by the heat emanating from said coiled tubing 2435 which has been heated by the heating element 2434 .
- the vapor 2438 exits the coiled tubing 2435 of the heat exchange unit 2430 at an exit port 2437 proximate a second end of said heat exchange unit 2430 and is then delivered to the ablation catheter (not shown) for use in the ablation procedure.
- FIG. 25 illustrates another embodiment of a heat exchange unit 2560 for use with the vapor ablation system of the present invention.
- the heat exchange unit 2560 comprises a cylindrically shaped, pen sized ‘clamshell’ style heating block.
- the heating block of the heat exchange unit 2560 includes a first half 2561 and a second half 2562 fixedly attached by a hinge 2563 along one side, wherein the halves 2561 , 2562 fold together and connect on the opposite side.
- the sides of the halves opposite sides with the hinge include a clasp for holding the two halves together.
- one of the halves includes a handle 2564 for manipulating the heat exchange unit 2560 .
- the heat exchange unit 2560 snugly envelopes a cylindrically shaped catheter fluid heating chamber 2551 attached to, in-line and in fluid communication with, the proximal end of the ablation catheter 2550 .
- Each half 2561 , 2562 of the heat exchange unit 2560 includes a plurality of heating elements 2565 for heating the block. The positioning and fit of the heating block place it in close thermal contact with the catheter fluid heating chamber 2551 .
- the heating elements 2565 heat the heating block which transfers heat to the catheter fluid heating chamber 2551 , which in turn heats the water inside the chamber 2551 , converting said water to vapor.
- the heating block does not directly contact the water.
- the catheter fluid heating chamber 2551 comprises a plurality of linear indentations 2591 stretching along the length of the component and in parallel with the heating elements 2565 .
- the heating elements 2565 which optionally protrude from the internal surfaces of the halves 2561 , 2562 contact, and fit within, the linear indentations 2591 . This also increases the surface area of contact between the heating block and the heating chamber, improving the efficiency of heat exchange.
- a luer fitting coupler 2549 is provided at the proximal end of the catheter fluid heating chamber 2551 for connecting a tube supplying sterile water.
- a one-way valve is included at the proximal end of the catheter fluid heating chamber 2551 , distal to the luer fitting 2549 , to prevent the passage of vapor under pressure toward the water supply.
- the catheter fluid heating chamber is designed as part of the ablation catheter and, along with the remainder of the catheter, is single use and disposable.
- the chamber is reusable, in which case the luer fitting is positioned in between the catheter shaft and the chamber.
- the heating block is designed to be axially aligned with the heating chamber when in use, is reusable, and will not be damaged in the event that it falls to the floor.
- the weight and dimensions of the heating block are designed such that it can be integrated into a pen-sized and shaped handle of the ablation catheter.
- the handle is thermally insulated to prevent injury to the operator.
- the heating block receives its power from a console which is itself line powered and designed to provide 700-1000 W of power, as determined by the fluid vaporization rate.
- the heating block and all output connections are electrically isolated from line voltage.
- the console includes a user interface allowing adjustment of power with a commensurate fluid flow rate.
- a pump such as a syringe pump, is used to control the flow of fluid to the heating chamber and heating element.
- the volume of the syringe is at least 10 ml and is ideally 60 ml.
- the catheter to be used with the vapor ablation system is designed using materials intended to minimize cost.
- the tubing used with the catheter is able to withstand a temperature of at least 125° C. and can flex through an endoscope's bend radius (approximately 1 inch) without collapse.
- the section of the catheter that passes through an endoscope is 7 French (2.3 mm) diameter and has a minimum length of 215 cm.
- thermal resistance is provided by the catheter shaft material which shields the endoscope from the super-heated vapor temperature.
- the heat exchange unit is designed to interface directly with, or in very close proximity to, an endoscope's biopsy channel to minimize the likelihood of a physician handling heated components. Having the heat exchange unit in close proximity to the endoscope handle also minimizes the length of the catheter through which the vapor needs to travel, thus minimizing heat loss and premature condensation.
- FIG. 26 illustrates the use of induction heating to heat a chamber 2605 .
- an alternating electric current is passed through a coil of wire within the chamber 2605 , the coil creates a magnetic field.
- the magnetic lines of flux 2610 cut through the air around the coil.
- the chamber 2605 is composed of a ferrous material, such as, iron, stainless steel, or copper, electrical currents known as eddy currents are induced to flow in the chamber 2605 , resulting in localized heating of the chamber 2605 .
- FIG. 27A illustrates one embodiment of a coil 2770 used with induction heating in the vapor ablation system of the present invention.
- the coil is positioned surrounding the catheter fluid heating chamber 2751 .
- An alternating current passing through the coil creates a magnetic field and results in heating of the catheter fluid heating chamber 2751 .
- the heated chamber heats the fluid within, converting it into a vapor, which passes into the catheter 2750 for use in the ablation procedure.
- the coil itself does not heat, making it safe to touch.
- a luer fitting coupler 2749 is provided at the proximal end of the catheter fluid heating chamber 2751 for connecting a tube supplying sterile water.
- a one-way valve (not shown) is included at the proximal end of the catheter fluid heating chamber 2751 , distal to the luer fitting 2749 , to prevent the passage of vapor toward the water supply.
- thermal insulating material (not shown) is positioned between the coil 2770 and the heating chamber 2751 .
- the chamber 2751 is suspended in the center of the coil 2770 with no physical contact between the two. In this embodiment, the intervening air acts as a thermally insulating material.
- the design of the chamber is optimized to increase its surface area to maximize contact and heat transfer, in turn resulting in more efficient vapor generation.
- FIG. 27B illustrates one embodiment of a catheter handle 2772 used with induction heating in the vapor ablation system of the present invention.
- the handle 2772 is thermally insulated and incorporates an induction coil.
- the handle 2772 includes an insulated tip 2773 at its distal end that engages with an endoscope channel after the catheter is inserted into the endoscope.
- the catheter 2750 is connected to the heating chamber 2751 which in turn is connected with the pump via an insulated connector 2774 .
- the heating chamber 2751 length and diameter are less than those of the handle 2772 and the induction coil, thus the heating chamber 2751 can slide inside the handle 2772 in a coaxial fashion while maintaining a constant position within the magnetic field generated by the induction coil.
- the operator can manipulate the catheter 2750 by grasping on the insulated connector 2774 and moving it in and out of the handle 2772 which in turn moves the catheter tip in and out of the distal end of the endoscope.
- the heated portions of the catheter 2750 are within the channel of the endoscope and in the insulated handle 2772 , thus not coming into contact with the operator at anytime during the operation.
- An optional sensor 2775 on the insulated tip 2773 can sense when the catheter is not engaged with the endoscope and temporarily disable the heating function of the catheter to prevent accidental activation and thermal injury to the operator.
- the catheter 2750 and heating chamber 2751 are the heated components of the system while the handle 2772 , insulated tip 2773 , and insulated connector 2774 are the cool components and therefore safe to touch by the user.
- FIGS. 28A and 28B are front and longitudinal view cross sectional diagrams respectively, illustrating one embodiment of a catheter 2880 used with induction heating in the vapor ablation system of the present invention.
- the catheter 2880 includes an insulated handle 2886 that contains a heating chamber 2851 and an induction coil 2884 .
- the heating chamber 2851 includes a luer lock 2849 at its proximal end.
- the luer lock 2849 has a one-way valve that prevents the backward flow of vapor from the chamber 2851 . Vaporization of fluid in the chamber results in volume expansion and an increase in pressure which pushes the vapor out of the chamber 2849 and into the catheter body.
- the induction coil 2884 includes a wire 2886 that extends from the proximal end of the catheter 2880 for the delivery of an alternating current.
- the handle 2886 is connected to the catheter 2880 with an outer insulating sheath 2881 made of a thermally insulating material.
- the insulating material is polyether ether ketone (PEEK), polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), polyether block amide (PEBA), polyimide, or a similar material.
- optional sensors 2887 positioned proximate the distal end of the catheter 2880 measure one or more of temperature, pressure, or flow of vapor and transmit the information to a microprocessor, which in turn controls the flow rate of the fluid and the level of vaporizing energy provided to the chamber 2851 .
- the microcontroller adjusts fluid flow rate and chamber temperature based on the sensed information, thereby controlling the flow of vapor and in turn, the flow of ablative energy to the target tissue.
- the catheter 2880 includes an inner flexible metal skeleton 2883 .
- the skeleton 2883 is composed of copper, stainless steel, or another ferric material.
- the skeleton 2883 is in thermal contact with the heating chamber 2851 so that the heat from the chamber 2851 is passively conducted through the metal skeleton 2883 to heat the inside of the catheter 2880 , thus maintaining the steam in a vaporized state and at a relatively constant temperature.
- the skeleton 2883 extends through a particular portion or the entire length of the catheter 2880 .
- the skeleton 2883 includes fins 2882 at regular intervals that keep the skeleton 2883 in the center of the catheter 2880 for uniform heating of the catheter lumen.
- the catheter in another embodiment, as seen in FIG. 28C , the catheter includes an inner metal spiral 2888 in place of the skeleton. In yet another embodiment, as seen in FIG. 28D , the catheter includes an inner metal mesh 2889 in place of the skeleton.
- water 2832 enters the luer lock 2849 at a predetermined rate. It is converted to vapor 2838 in the heating chamber 2851 .
- the metal skeleton 2883 , spiral 2888 , and mesh 2889 all conduct heat from the heating chamber 2851 into the catheter lumen to prevent condensation of the vapor in the catheter and insure that ablating vapor will exit the catheter from one or more holes or ports at its distal end.
- FIG. 29 illustrates one embodiment of a heating unit 2990 using microwaves 2991 to convert fluid to vapor in the vapor ablation system of the present invention.
- the microwaves 2991 are directed toward the catheter fluid heating chamber 2951 , heating the chamber 2951 and converting the fluid within into vapor.
- the vapor passes into the catheter 2950 for use in the ablation procedure.
- a luer fitting coupler 2949 is provided at the proximal end of the catheter fluid heating chamber 2951 for connecting a tube supplying sterile water.
- a one-way valve (not shown) is included at the proximal end of the catheter fluid heating chamber 2951 , distal to the luer fitting 2949 , to prevent the passage of vapor toward the water supply.
- HIFU High Intensity Focused Ultrasound
- infrared energy are used to heat the fluid in the catheter fluid heating chamber.
- a vapor delivery system utilizing a heating coil is that the vapor is generated closer to the point of use.
- Traditional vapor delivery systems often generate vapor close to or at the point in the system where the liquid is stored. The vapor must then travel through a longer length of tubing, sometimes over 2 meters, before reaching the point of use. As a result of the distance traveled, the system can sometimes deliver hot liquid as the vapor cools in the tubing from the ambient temperature.
- the device and method of the present invention can be used to cause controlled focal or circumferential ablation of targeted tissue to varying depth in a manner in which complete healing with re-epithelialization can occur. Additionally, the vapor could be used to treat/ablate benign and malignant tissue growths resulting in destruction, liquefaction and absorption of the ablated tissue. The dose and manner of treatment can be adjusted based on the type of tissue and the depth of ablation needed.
- the ablation device can be used not only for the treatment of Barrett's esophagus and esophageal dysplasia, flat colon polyps, gastrointestinal bleeding lesions, endometrial ablation, pulmonary ablation, but also for the treatment of any mucosal, submucosal or circumferential lesion, such as inflammatory lesions, tumors, polyps and vascular lesions.
- the ablation device can also be used for the treatment of focal or circumferential mucosal or submucosal lesions of any hollow organ or hollow body passage in the body.
- the hollow organ can be one of gastrointestinal tract, pancreaticobiliary tract, genitourinary tract, respiratory tract or a vascular structure such as blood vessels.
- the ablation device can be placed endoscopically, radiologically, surgically or under direct visualization.
- wireless endoscopes or single fiber endoscopes can be incorporated as a part of the device.
- magnetic or stereotactic navigation can be used to navigate the catheter to the desired location.
- Radio-opaque or sonolucent material can be incorporated into the body of the catheter for radiological localization.
- Ferro- or ferrimagnetic materials can be incorporated into the catheter to help with magnetic navigation.
Abstract
Description
- The present application is a division application of U.S. patent application Ser. No. 15/400,759, entitled “Vapor Ablation System with a Catheter Having More Than One Positioning Element and Configured to Treat Pulmonary Tissue” and filed on Jan. 6, 2017, which is a division application of U.S. patent application Ser. No. 13/486,980, entitled “Method and Apparatus for Tissue Ablation”, filed on Jun. 1, 2012, and issued as U.S. Pat. No. 9,561,066 on Feb. 2, 2017, which is a continuation in-part application of U.S. patent application Ser. No. 12/573,939, of the same title and filed on Oct. 6, 2009, which relies on U.S. Provisional Patent Application No. 61/102,885, filed on Oct. 6, 2008, for priority, all of which are herein incorporated by reference in their entirety.
- U.S. patent application Ser. No. 13/486,980 also relies on U.S. Provisional Patent Application No. 61/493,344, entitled “Method and Apparatus for Tissue Ablation” and filed on Jun. 3, 2011, for priority, which is herein incorporated by reference in its entirety.
- The present invention relates to medical apparatus and procedures. More particularly, the present invention relates to a device for ablation of tissue comprising a centering or positioning attachment in order to position the device at a consistent distance from the tissue to be ablated.
- Colon polyps affect almost 25% of the population over the age of 50. While most polyps are detected on colonoscopy and easily removed using a snare, flat sessile polyps are hard to remove using the snare technique and carry a high risk of complications, such as bleeding and perforation. Recently, with improvement in imaging techniques, more flat polyps are being detected. Endoscopically unresectable polyps require surgical removal. Most colon cancer arises from colon polyps and, safe and complete resection of these polyps is imperative for the prevention of colon cancer.
- Barrett's esophagus is a precancerous condition effecting 10-14% of the US population with gastro esophageal reflux disease (GERD) and is the proven precursor lesion of esophageal adenocarcinoma, the fastest rising cancer in the developed nations. The incidence of the cancer has risen over 6 fold in the last 2 decades and mortality has risen by 7 fold. The 5-year mortality from esophageal cancer is 85%. Ablation of Barrett's epithelium has shown to prevent its progression to esophageal cancer.
- Dysfunctional uterine bleeding (DUB), or menorrhagia, affects 30% of women in reproductive age. The associated symptoms have considerable impact on a woman's health and quality of life. The condition is typically treated with endometrial ablation or a hysterectomy. The rates of surgical intervention in these women are high. Almost 30% of women in the US will undergo hysterectomy by the age of 60, with menorrhagia or DUB being the cause for surgery in 50-70% of these women. Endometrial ablation techniques have been FDA approved for women with abnormal uterine bleeding and with intramural fibroids less than 2 cm. The presence of submucosal uterine fibroids and a large uterus size have been shown to decrease the efficacy of standard endometrial ablation. Of the five FDA approved global ablation devices (namely, Thermachoice, hydrothermal ablation, Novasure, Her Option, and microwave ablation) only microwave ablation (MEA) has been approved for use where the submucosal fibroids are less than 3 cm and are not occluding the endometrial cavity and, additionally, for large uteri up to 14 cm.
- The known ablation treatments for Barrett's esophagus include laser treatment (Ertan et al, Am. J. Gastro., 90:2201-2203 [1995]), ultrasonic ablation (Bremner et al, Gastro. Endo., 43:6 [1996]), photodynamic therapy (PDT) using photo-sensitizer drugs (Overholt et al, Semin. Surq. Oncol., 1:372-376 (1995), multipolar electrocoagulation, such as by use of a bicap probe (Sampliner et al,), argon plasma coagulation (APC;), radiofrequency ablation (Sharma et al. Gastrointest Endosc) and cryoablation (Johnston et al. Gastrointest Endosc). The treatments are delivered with the aid of an endoscope and devices passed through the channel of the endoscope or alongside the endoscope.
- Conventional techniques have inherent limitations, however, and have not found widespread clinical applications. First, most of the hand held ablation devices (bicap probe, APC, cryoablation) are point and shoot devices that create small foci of ablation. This ablation mechanism is operator dependent, cumbersome and time consuming. Second, because the target tissue is moving due to patient movement, respiration movement, normal peristalsis and vascular pulsations, the depth of ablation of the target tissue is inconsistent and results in a non-uniform ablation. Superficial ablation results in incomplete ablation with residual neoplastic tissue left behind. Deeper ablation results in complications such as bleeding, stricture formation and perforation. All of these limitations and complications have been reported with conventional devices.
- For example, radiofrequency ablation uses a rigid bipolar balloon based electrode and radiofrequency thermal energy. The thermal energy is delivered by direct contact of the electrode with the diseased Barrett's epithelium allowing for a relatively uniform, large area ablation. However, the rigid electrode does not accommodate for variations in esophageal size and is ineffective in ablating lesions within a tortuous esophagus, proximal esophageal lesions as an esophagus narrows toward the top, and lesions in the esophagus at the gastroesophageal junction due to changes in the esophageal diameter. Nodular disease in Barrett's esophagus also cannot be treated using the rigid bipolar RF electrode. Due to its size and rigidity, the electrode cannot be passed through the scope. In addition, sticking of sloughed tissue to the electrode impedes delivery of radiofrequency energy resulting in incomplete ablation. The electrode size is limited to 3 cm, thus requiring repeat applications to treat larger lengths of Barrett's esophagus.
- Photodynamic therapy (PDT) is a two part procedure that involves injecting a photo-sensitizer that is absorbed and retained by the neoplastic and pre-neoplastic tissue. The tissue is then exposed to a selected wavelength of light which activates the photo-sensitizer and results in tissue destruction. PDT is associated with complications such as stricture formation and photo-sensitivity which has limited its use to the most advanced stages of the disease. In addition, patchy uptake of the photosensitizer results in incomplete ablation and residual neoplastic tissue.
- Cryoablation of the esophageal tissues via direct contact with liquid nitrogen has been studied in both animal models and humans (Rodgers et al, Cryobiology, 22:86-92 (1985); Rodgers et al, Ann. Thorac. Surq. 55:52-7 [1983]) and has been used to treat Barrett's esophagus (Johnston et al. Gastrointest Endosc) and early esophageal cancer (Grana et al, Int. Surg., 66:295 [1981]). A spray catheter that directly sprays liquid N2 or CO2 (cryoablation) or argon (APC) to ablate Barrett's tissue in the esophagus has been described. These techniques suffer the shortcoming of the traditional hand-held devices. Treatment using this probe is cumbersome and requires operator control under direct endoscopic visualization. Continuous movement in the esophagus due to respiration or cardiac or aortic pulsations or movement causes an uneven distribution of the ablative agent and results in non-uniform and/or incomplete ablation. Close or direct contact of the catheter to the surface epithelium may cause deeper tissue injury, resulting in perforation, bleeding or stricture formation. Too distant a placement of the catheter due to esophageal movement will result in incomplete Barrett's ablation, requiring multiple treatment sessions or buried lesions with a continued risk of esophageal cancer. Expansion of cryogenic gas in the esophagus results in uncontrolled retching which may result in esophageal tear or perforation requiring continued suctioning of cryogen.
- Colon polyps are usually resected using snare resection with or without the use of monopolar cautery. Flat polyps or residual polyps after snare resection have been treated with argon plasma coagulation or laser treatment. Both of these treatments are inadequate due to the previously mentioned limitations. Hence, most large flat polyps undergo surgical resection due to high risk of bleeding, perforation and residual disease using traditional endoscopic resection or ablation techniques.
- Most of the conventional balloon catheters traditionally used for tissue ablation either heat or cool the balloon itself or a heating element such as radio frequency (RF) coils mounted on the balloon. This requires direct contact of the balloon catheter with the ablated surface. When the balloon catheter is deflated, the epithelium sticks to the catheter and sloughs off, thereby causing bleeding. Blood can interfere with the delivery of energy, and therefore acts as an energy sink. In addition, reapplication of energy will result in deeper burn in the area where superficial lining has sloughed. Further, balloon catheters cannot be employed for treatment in non-cylindrical organs, like the uterus or sinuses, and also do not provide non-circumferential or focal ablation in a hollow organ. Additionally, if used with cryogens as ablative agents, which expand exponentially upon being heated, balloon catheters may result in a closed cavity and trap the escape of cryogen, resulting in complications such as perforations and tears.
- Accordingly, there is a need in the art for an improved method and system for delivering ablative agents to a tissue surface, for providing a consistent, controlled, and uniform ablation of the target tissue, and for minimizing the adverse side effects of introducing ablative agents into a patient.
- In one embodiment, the present specification discloses a device to be used in conjunction with a tissue ablation system, comprising: a handle with a pressure-resistant port on its distal end, a flow channel through which an ablative agent can travel, and one or more connection ports on its proximal end for the inlet of said ablative agent and for an RF feed; an insulated catheter that attaches to said pressure-resistant port of said snare handle, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and one or more positioning elements attached to said catheter shaft at one or more separate positions, wherein said positioning element(s) is configured to position said catheter at a predefined distance from the tissue to be ablated.
- Optionally, the handle has one pressure-resistant port for the attachment of both an ablative agent inlet and an RF feed. The handle has one separate pressure-resistant port for the attachment of an ablative agent inlet and one separate port for the attachment of an RF feed or an electrical feed.
- In another embodiment, the present specification discloses a device to be used in conjunction with a tissue ablation system, comprising: a handle with a pressure-resistant port on its distal end, a flow channel passing through said handle which is continuous with a pre-attached cord through which an ablative agent can travel, and a connection port on its proximal end for an RF feed or an electrical field; an insulated catheter that attaches to said pressure-resistant port of said handle, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and one or more positioning elements attached to said catheter shaft at one or more separate positions, wherein said positioning element(s) is configured to position said catheter at a predefined distance from the tissue to be ablated. Optionally, the distal end of said catheter is designed to puncture the target.
- In another embodiment, the present specification discloses a device to be used in conjunction with a tissue ablation system, comprising: an esophageal probe with a pressure-resistant port on its distal end, a flow channel through which an ablative agent can travel, and one or more connection ports on its proximal end for the inlet of said ablative agent and for an RF feed or an electrical feed; an insulated catheter that attaches to said pressure-resistant port of said esophageal probe, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and one or more inflatable positioning balloons at either end of said catheter positioned beyond said one or more ports, wherein said positioning balloons are configured to position said catheter at a predefined distance from the tissue to be ablated.
- Optionally, the catheter is dual lumen, wherein a first lumen facilitates the transfer of ablative agent and a second lumen contains an electrode for RF ablation. The catheter has differential insulation along its length.
- The present specification is also directed toward a tissue ablation device, comprising: a liquid reservoir, wherein said reservoir includes an outlet connector that can resist at least 1 atm of pressure for the attachment of a reusable cord; a heating component comprising: a length of coiled tubing contained within a heating element, wherein activation of said heating element causes said coiled tubing to increase from a first temperature to a second temperature and wherein said increase causes a conversion of liquid within said coiled tubing to vapor; and an inlet connected to said coiled tubing; an outlet connected to said coiled tubing; and at least one pressure-resistant connection attached to the inlet and/or outlet; a cord connecting the outlet of said reservoir to the inlet of the heating component; a single use cord connecting a pressure-resistant inlet port of a vapor based ablation device to the outlet of said heating component.
- In one embodiment, the liquid reservoir is integrated within an operating room equipment generator. In one embodiment, the liquid is water and the vapor is steam.
- In one embodiment, the pressure-resistant connections are luer lock connections. In one embodiment, the coiled tubing is copper.
- In one embodiment, the tissue ablation device further comprises a foot pedal, wherein only when said foot pedal is pressed, vapor is generated and passed into said single use cord. In another embodiment, only when pressure is removed from said foot pedal, vapor is generated and passed into said single use cord.
- In another embodiment, the present specification discloses a vapor ablation system used for supplying vapor to an ablation device, comprising; a single use sterile fluid container with attached compressible tubing used to connect the fluid source to a heating unit in the handle of a vapor ablation catheter. The tubing passes through a pump that delivers the fluid into the heating unit at a predetermined speed. There is present a mechanism such as a unidirectional valve between the fluid container and the heating unit to prevent the backflow of vapor from the heating unit. The heating unit is connected to the ablation catheter to deliver the vapor from the heating unit to the ablation site. The flow of vapor is controlled by a microprocessor. The microprocessor uses a pre-programmed algorithm in an open-loop system or uses information from one or more sensors incorporated in the ablation system in a closed-loop system or both to control delivery of vapor.
- In one embodiment the handle of the ablation device is made of a thermally insulating material to prevent thermal injury to the operator. The heating unit is enclosed in the handle. The handle locks into the channel of an endoscope after the catheter is passed through the channel of the endoscope. The operator can than manipulate the catheter by holding the insulated handle or by manipulating the catheter proximal to the insulating handle.
- The present specification is also directed toward a vapor ablation system comprising: a container with a sterile liquid therein; a pump in fluid communication with said container; a first filter disposed between and in fluid communication with said container and said pump; a heating component in fluid communication with said pump; a valve disposed between and in fluid communication with said pump and heating container; a catheter in fluid communication with said heating component, said catheter comprising at least one opening at its operational end; and, a microprocessor in operable communication with said pump and said heating component, wherein said microprocessor controls the pump to control a flow rate of the liquid from said container, through said first filter, through said pump, and into said heating component, wherein said liquid is converted into vapor via the transfer of heat from said heating component to said fluid, wherein said conversion of said fluid into said vapor results is a volume expansion and a rise in pressure where said rise in pressure forces said vapor into said catheter and out said at least one opening, and wherein a temperature of said heating component is controlled by said microprocessor.
- In one embodiment, the vapor ablation system further comprises at least one sensor on said catheter, wherein information obtained by said sensor is transmitted to said microprocessor, and wherein said information is used by said microprocessor to regulate said pump and said heating component and thereby regulate vapor flow. In one embodiment, the at least one sensor includes one or more of a temperature sensor, flow sensor, or pressure sensor.
- In one embodiment, the vapor ablation system further comprises a screw cap on said liquid container and a puncture needle on said first filter, wherein said screw cap is punctured by said puncture needle to provide fluid communication between said container and said first filter.
- In one embodiment, the liquid container and catheter are disposable and configured for a single use.
- In one embodiment, the fluid container, first filter, pump, heating component, and catheter are connected by sterile tubing and the connections between said pump and said heating component and said heating component and said catheter are pressure resistant.
- The present specification is also directed toward a tissue ablation system comprising: a catheter with a proximal end and a distal end and a lumen therebetween, said catheter comprising: a handle proximate the proximal end of said catheter and housing a fluid heating chamber and a heating element enveloping said chamber, a wire extending distally from said heating element and leading to a controller; an insulating sheath extending and covering the length of said catheter and disposed between said handle and said heating element at said distal end of said catheter; and, at least one opening proximate the distal end of said catheter for the passage of vapor; and, a controller operably connected to said heating element via said wire, wherein said controller is capable of modulating energy supplied to said heating element and further wherein said controller is capable of adjusting a flow rate of liquid supplied to said catheter; wherein liquid is supplied to said heating chamber and then converted to vapor within said heating chamber by a transfer of heat from said heating element to said chamber, wherein said conversion of said liquid to vapor results in a volume expansion and a rise in pressure within said catheter, and wherein said rise in pressure pushes said vapor through said catheter and out said at least one opening.
- In one embodiment, the tissue ablation system further comprises a pressure resistant fitting attached to the fluid supply and a one-way valve in said pressure resistant fitting to prevent a backflow of vapor into the fluid supply.
- In one embodiment, the tissue ablation system further comprises at least one sensor on said catheter, wherein information obtained by said sensor is transmitted to said microprocessor, and wherein said information is used by said microprocessor to regulate said pump and said heating component and thereby regulate vapor flow.
- In one embodiment, the tissue ablation system further comprises a metal frame within said catheter, wherein said metal frame is in thermal contact with said heating chamber and conducts heat to said catheter lumen, thereby preventing condensation of said vapor. In various embodiments, the metal frame comprises a metal skeleton with outwardly extending fins at regularly spaced intervals, a metal spiral, or a metal mesh and the metal frame comprises at least one of copper, stainless steel, or another ferric material.
- In one embodiment, the heating element comprises a heating block, wherein said heating block is supplied power by said controller.
- In various embodiments, the heating element uses one of magnetic induction, microwave, high intensity focused ultrasound, or infrared energy to heat said heating chamber and the fluid therein.
- These and other features and advantages of the present invention will be further appreciated, as they become better understood by reference to the detailed description when considered in connection with the accompanying drawings, wherein:
-
FIG. 1 illustrates an ablation device, in accordance with an embodiment of the present invention; -
FIG. 2A illustrates a longitudinal section of an ablation device with ports distributed thereon; -
FIG. 2B illustrates a cross section of a port on the ablation device, in accordance with an embodiment of the present invention; -
FIG. 2C illustrates a cross section of a port on the ablation device, in accordance with another embodiment of the present invention; -
FIG. 2D illustrates a catheter of the ablation device, in accordance with an embodiment of the present invention; -
FIG. 2E illustrates an ablation device in the form of a catheter extending from a conventional snare handle, in accordance with an embodiment of the present invention; -
FIG. 2F illustrates a cross section of an ablation device in the form of a catheter extending from a conventional snare handle with a pre-attached cord, in accordance with another embodiment of the present invention; -
FIG. 2G illustrates an ablation device in the form of a catheter extending from a conventional esophageal probe, in accordance with an embodiment of the present invention; -
FIG. 3A illustrates the ablation device placed in an upper gastrointestinal tract with Barrett's esophagus to selectively ablate the Barrett's tissue, in accordance with an embodiment of the present invention; -
FIG. 3B illustrates the ablation device placed in an upper gastrointestinal tract with Barrett's esophagus to selectively ablate the Barrett's tissue, in accordance with another embodiment of the present invention; -
FIG. 3C is a flowchart illustrating the basic procedural steps for using the ablation device, in accordance with an embodiment of the present invention; -
FIG. 4A illustrates the ablation device placed in a colon to ablate a flat colon polyp, in accordance with an embodiment of the present invention; -
FIG. 4B illustrates the ablation device placed in a colon to ablate a flat colon polyp, in accordance with another embodiment of the present invention; -
FIG. 5A illustrates the ablation device with a coaxial catheter design, in accordance with an embodiment of the present invention; -
FIG. 5B illustrates a partially deployed positioning device, in accordance with an embodiment of the present invention; -
FIG. 5C illustrates a completely deployed positioning device, in accordance with an embodiment of the present invention; -
FIG. 5D illustrates the ablation device with a conical positioning element, in accordance with an embodiment of the present invention; -
FIG. 5E illustrates the ablation device with a disc shaped positioning element, in accordance with an embodiment of the present invention; -
FIG. 6 illustrates an upper gastrointestinal tract with a bleeding vascular lesion being treated by the ablation device, in accordance with an embodiment of the present invention; -
FIG. 7 illustrates endometrial ablation being performed in a female uterus by using the ablation device, in accordance with an embodiment of the present invention; -
FIG. 8 illustrates sinus ablation being performed in a nasal passage by using the ablation device, in accordance with an embodiment of the present invention; -
FIG. 9 illustrates bronchial and bullous ablation being performed in a pulmonary system by using the ablation device, in accordance with an embodiment of the present invention; -
FIG. 10 illustrates prostate ablation being performed on an enlarged prostrate in a male urinary system by using the device, in accordance with an embodiment of the present invention; -
FIG. 11 illustrates fibroid ablation being performed in a female uterus by using the ablation device, in accordance with an embodiment of the present invention; -
FIG. 12 illustrates a vapor delivery system using an RF heater for supplying vapor to the ablation device, in accordance with an embodiment of the present invention; -
FIG. 13 illustrates a vapor delivery system using a resistive heater for supplying vapor to the ablation device, in accordance with an embodiment of the present invention; -
FIG. 14 illustrates a vapor delivery system using a heating coil for supplying vapor to the ablation device, in accordance with an embodiment of the present invention; -
FIG. 15 illustrates the heating component and coiled tubing of the heating coil vapor delivery system ofFIG. 14 , in accordance with an embodiment of the present invention; -
FIG. 16A illustrates the unassembled interface connection between the ablation device and the single use cord of the heating coil vapor delivery system ofFIG. 14 , in accordance with an embodiment of the present invention; -
FIG. 16B illustrates the assembled interface connection between the ablation device and the single use cord of the heating coil vapor delivery system ofFIG. 14 , in accordance with an embodiment of the present invention; -
FIG. 17 illustrates a vapor ablation system using a heater or heat exchange unit for supplying vapor to the ablation device, in accordance with another embodiment of the present invention; -
FIG. 18 illustrates the fluid container, filter member, and pump of the vapor ablation system ofFIG. 17 ; -
FIG. 19 illustrates a first view of the fluid container, filter member, pump, heater or heat exchange unit, and microcontroller of the vapor ablation system ofFIG. 17 ; -
FIG. 20 illustrates a second view of the fluid container, filter member, pump, heater or heat exchange unit, and microcontroller of the vapor ablation system ofFIG. 17 ; -
FIG. 21 illustrates the unassembled filter member of the vapor ablation system ofFIG. 17 , depicting the filter positioned within; -
FIG. 22 illustrates one embodiment of the microcontroller of the vapor ablation system ofFIG. 17 ; -
FIG. 23 illustrates one embodiment of a catheter assembly for use with the vapor ablation system ofFIG. 17 ; -
FIG. 24 illustrates one embodiment of a heat exchange unit for use with the vapor ablation system ofFIG. 17 ; -
FIG. 25 illustrates another embodiment of a heat exchange unit for use with the vapor ablation system of the present invention; -
FIG. 26 illustrates the use of induction heating to heat a chamber; -
FIG. 27A illustrates one embodiment of a coil used with induction heating in the vapor ablation system of the present invention; -
FIG. 27B illustrates one embodiment of a catheter handle used with induction heating in the vapor ablation system of the present invention; -
FIG. 28A is a front view cross sectional diagram illustrating one embodiment of a catheter used with induction heating in the vapor ablation system of the present invention; -
FIG. 28B is a longitudinal view cross sectional diagram illustrating one embodiment of a catheter used with induction heating in the vapor ablation system of the present invention; -
FIG. 28C is a longitudinal view cross sectional diagram illustrating another embodiment of a catheter with a metal spiral used with induction heating in the vapor ablation system of the present invention; -
FIG. 28D is a longitudinal view cross sectional diagram illustrating another embodiment of a catheter with a mesh used with induction heating in the vapor ablation system of the present invention; and, -
FIG. 29 illustrates one embodiment of a heating unit using microwaves to convert fluid to vapor in the vapor ablation system of the present invention. - The present invention is directed toward an ablation device comprising a catheter with one or more centering or positioning attachments at one or more ends of the catheter to affix the catheter and its infusion port at a fixed distance from the ablative tissue which is not affected by the movements of the organ. The arrangement of one or more spray ports allows for uniform spray of the ablative agent producing a uniform ablation of a large area, such as encountered in Barrett's esophagus. The flow of ablative agent is controlled by the microprocessor and depends upon one or more of the length or area of tissue to be ablated, type and depth of tissue to be ablated, and distance of the infusion port from or in the tissue to be ablated.
- The present invention is also directed toward a device to be used in conjunction with a tissue ablation system, comprising: a handle with a pressure-resistant port on its distal end, a flow channel through which an ablative agent can travel, and one or more connection ports on its proximal end for the inlet of said ablative agent and for an RF feed or an electrical feed; an insulated catheter that attaches to said pressure-resistant port of said handle, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and, one or more positioning elements attached to said catheter shaft at one or more separate positions, wherein said positioning element(s) is configured to position said catheter at a predefined distance from or in the tissue to be ablated.
- In one embodiment, the handle has one pressure-resistant port for the attachment of both an ablative agent inlet and an RF feed. In another embodiment, the handle has one separate pressure-resistant port for the attachment of an ablative agent inlet and one separate port for the attachment of an RF feed or an electrical feed.
- The present invention is also directed toward a device to be used in conjunction with a tissue ablation system, comprising: a handle with a pressure-resistant port on its distal end, a flow channel passing through said handle which is continuous with a pre-attached cord through which an ablative agent can travel, and a connection port on its proximal end for an RF feed or an electrical feed; an insulated catheter that attaches to said pressure-resistant port of said handle, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and, one or more positioning elements attached to said catheter shaft at one or more separate positions, wherein said positioning element(s) is configured to position said catheter at a predefined distance from or in the tissue to be ablated. In one embodiment, the distal end of said catheter is designed to puncture the target tissue to deliver ablative agent to the correct depth and location.
- The present invention is also directed toward a device to be used in conjunction with a tissue ablation system, comprising: an esophageal probe with a pressure-resistant port on its distal end, a flow channel through which an ablative agent can travel, and one or more connection ports on its proximal end for the inlet of said ablative agent and for an RF feed; an insulated catheter that attaches to said pressure-resistant port of said esophageal probe, containing a shaft through which an ablative agent can travel and one or more ports along its length for the release of said ablative agent; and, one or more inflatable positioning balloons at either end of said catheter positioned beyond said one or more ports, wherein said positioning balloons are configured to position said catheter at a predefined distance from the tissue to be ablated.
- In one embodiment, the catheter is dual lumen, wherein a first lumen facilitates the transfer of ablative agent and a second lumen contains an electrode for RF ablation.
- In one embodiment, the catheter has differential insulation along its length.
- The present invention is also directed toward a vapor delivery system used for supplying vapor to an ablation device, comprising: a liquid reservoir, wherein said reservoir includes a pressure-resistant outlet connector for the attachment of a reusable cord; a reusable cord connecting the outlet of said reservoir to the inlet of a heating component; a powered heating component containing a length of coiled tubing within for the conversion of liquid to vapor and pressure-resistant connections on both the inlet and outlet ends of said heating component; and, a single use cord connecting a pressure-resistant inlet port of a vapor based ablation device to the outlet of said heating component.
- In one embodiment, the liquid reservoir is integrated within an operating room equipment generator.
- In one embodiment, the liquid is water and resultant said vapor is steam.
- In one embodiment, the pressure-resistant connections are of a luer lock type.
- In one embodiment, the coiled tubing is copper.
- In one embodiment, the vapor delivery system used for supplying vapor to an ablation device further comprises a foot pedal used by the operator to deliver more vapor to the ablation device.
- “Treat,” “treatment,” and variations thereof refer to any reduction in the extent, frequency, or severity of one or more symptoms or signs associated with a condition.
- “Duration” and variations thereof refer to the time course of a prescribed treatment, from initiation to conclusion, whether the treatment is concluded because the condition is resolved or the treatment is suspended for any reason. Over the duration of treatment, a plurality of treatment periods may be prescribed during which one or more prescribed stimuli are administered to the subject.
- “Period” refers to the time over which a “dose” of stimulation is administered to a subject as part of the prescribed treatment plan.
- The term “and/or” means one or all of the listed elements or a combination of any two or more of the listed elements.
- The terms “comprises” and variations thereof do not have a limiting meaning where these terms appear in the description and claims.
- Unless otherwise specified, “a,” “an,” “the,” “one or more,” and “at least one” are used interchangeably and mean one or more than one.
- For any method disclosed herein that includes discrete steps, the steps may be conducted in any feasible order. And, as appropriate, any combination of two or more steps may be conducted simultaneously.
- Also herein, the recitations of numerical ranges by endpoints include all numbers subsumed within that range (e.g., 1 to 5 includes 1, 1.5, 2, 2.75, 3, 3.80, 4, 5, etc.). Unless otherwise indicated, all numbers expressing quantities of components, molecular weights, and so forth used in the specification and claims are to be understood as being modified in all instances by the term “about.” Accordingly, unless otherwise indicated to the contrary, the numerical parameters set forth in the specification and claims are approximations that may vary depending upon the desired properties sought to be obtained by the present invention. At the very least, and not as an attempt to limit the doctrine of equivalents to the scope of the claims, each numerical parameter should at least be construed in light of the number of reported significant digits and by applying ordinary rounding techniques.
- Notwithstanding that the numerical ranges and parameters setting forth the broad scope of the invention are approximations, the numerical values set forth in the specific examples are reported as precisely as possible. All numerical values, however, inherently contain a range necessarily resulting from the standard deviation found in their respective testing measurements.
- Ablative agents such as steam, heated gas or cryogens, such as, but not limited to, liquid nitrogen are inexpensive and readily available and are directed via the infusion port onto the tissue, held at a fixed and consistent distance, targeted for ablation. This allows for uniform distribution of the ablative agent on the targeted tissue. The flow of the ablative agent is controlled by a microprocessor according to a predetermined method based on the characteristic of the tissue to be ablated, required depth of ablation, and distance of the port from the tissue. The microprocessor may use temperature, pressure or other sensing data to control the flow of the ablative agent. In addition, one or more suction ports are provided to suction the ablation agent from the vicinity of the targeted tissue. The targeted segment can be treated by a continuous infusion of the ablative agent or via cycles of infusion and removal of the ablative agent as determined and controlled by the microprocessor.
- It should be appreciated that the devices and embodiments described herein are implemented in concert with a controller that comprises a microprocessor executing control instructions. The controller can be in the form of any computing device, including desktop, laptop, and mobile device, and can communicate control signals to the ablation devices in wired or wireless form.
- The present invention is directed towards multiple embodiments. The following disclosure is provided in order to enable a person having ordinary skill in the art to practice the invention. Language used in this specification should not be interpreted as a general disavowal of any one specific embodiment or used to limit the claims beyond the meaning of the terms used therein. The general principles defined herein may be applied to other embodiments and applications without departing from the spirit and scope of the invention. Also, the terminology and phraseology used is for the purpose of describing exemplary embodiments and should not be considered limiting. Thus, the present invention is to be accorded the widest scope encompassing numerous alternatives, modifications and equivalents consistent with the principles and features disclosed. For purpose of clarity, details relating to technical material that is known in the technical fields related to the invention have not been described in detail so as not to unnecessarily obscure the present
-
FIG. 1 illustrates an ablation device, in accordance with an embodiment of the present invention. The ablation device comprises acatheter 10 having a distal centering or positioning attachment which is aninflatable balloon 11. Thecatheter 10 is made of or covered with an insulated material to prevent the escape of ablative energy from the catheter body. The ablation device comprises one ormore infusion ports 12 for the infusion of ablative agent and one ormore suction ports 13 for the removal of ablative agent. In one embodiment, theinfusion port 12 andsuction port 13 are the same. In one embodiment, theinfusion ports 12 can direct the ablative agent at different angles. Ablative agent is stored in areservoir 14 connected to thecatheter 10. Delivery of the ablative agent is controlled by amicroprocessor 15 and initiation of the treatment is controlled by a treating physician using an input device, such as a foot-paddle 16. In other embodiments, the input device could be a voice recognition system (that is responsive to commands such as “start”, “more”, “less”, etc.), a mouse, a switch, footpad, or any other input device known to persons of ordinary skill in the art. In one embodiment,microprocessor 15 translates signals from the input device, such as pressure being placed on the foot-paddle or vocal commands to provide “more” or “less” ablative agent, into control signals that determine whether more or less ablative agent is dispensed.Optional sensor 17 monitors changes in an ablative tissue or its vicinity to guide flow of ablative agent. In one embodiment,optional sensor 17 also includes a temperature sensor. Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters andsensors 18 measure the dimensions of the hollow organ. - In one embodiment, a user interface included with the
microprocessor 15 allows a physician to define device, organ, and condition which in turn creates default settings for temperature, cycling, volume (sounds), and standard RF settings. In one embodiment, these defaults can be further modified by the physician. The user interface also includes standard displays of all key variables, along with warnings if values exceed or go below certain levels. - The ablation device also includes safety mechanisms to prevent users from being burned while manipulating the catheter, including insulation, and optionally, cool air flush, cool water flush, and alarms/tones to indicate start and stop of treatment.
- In one embodiment, the inflatable balloon has a diameter of between 1 mm and 10 cm. In one embodiment, the inflatable balloon is separated from the ports by a distance of 1 mm to 10 cm. In one embodiment, the size of the port openings is between 1 μm and 1 cm. It should be appreciated that the inflatable balloon is used to fix the device and therefore is configured to not contact the ablated area. The inflatable balloon can be any shape that contacts the hollow organ at 3 or more points. One of ordinary skill in the art will recognize that, using triangulation, one can calculate the distance of the catheter from the lesion. Alternatively, the infrared, electromagnetic, acoustic or radiofrequency energy emitters and
sensors 18 can measure the dimensions of the hollow organ. The infrared, electromagnetic, acoustic or radiofrequency energy is emitted from theemitter 18 and is reflected back from the tissue to the detector in theemitter 18. The reflected data can be used to determine the dimension of the hollow cavity. It should be appreciated that the emitter andsensor 18 can be incorporated into a single transceiver that is capable of both emitting energy and detecting the reflected energy. -
FIG. 2A illustrates a longitudinal section of the ablation device, depicting a distribution of infusion ports.FIG. 2B illustrates a cross section of a distribution of infusion ports on the ablation device, in accordance with an embodiment of the present invention. The longitudinal and cross sectional view of thecatheter 10 as illustrated inFIGS. 2A and 2B respectively, show one arrangement of theinfusion ports 12 to produce a uniform distribution of ablative agent 21 (shown inFIG. 2B ) in order to provide a circumferential area of ablation in ahollow organ 20.FIG. 2C illustrates a cross section of a distribution of infusion ports on the ablation device, in accordance with another embodiment of the present invention. The arrangement of theinfusion ports 12 as illustrated inFIG. 2C produce a focal distribution ofablative agent 21 and a focal area of ablation in ahollow organ 20. - For all embodiments described herein, it should be appreciated that the size of the port, number of ports, and distance between the ports will be determined by the volume of ablative agent needed, pressure that the hollow organ can withstand, size of the hollow organ as measured by the distance of the surface from the port, length of the tissue to be ablated (which is roughly the surface area to be ablated), characteristics of the tissue to be ablated and depth of ablation needed. In one embodiment, there is at least one port opening that has a diameter between 1 μm and 1 cm. In another embodiment, there are two or more port openings that have a diameter between 1 μm and 1 cm and that are equally spaced around the perimeter of the device.
-
FIG. 2D illustrates another embodiment of the ablation device. The vapor ablation catheter comprises aninsulated catheter 21 with one ormore positioning attachments 22 of knownlength 23. The vapor ablation catheter has one or morevapor infusion ports 25. Thelength 24 of thevapor ablation catheter 21 withinfusion ports 25 is determined by the length or area of the tissue to be ablated.Vapor 29 is delivered through thevapor infusion ports 25. Thecatheter 21 is preferably positioned in the center of thepositioning attachment 22, and theinfusion ports 25 are arranged circumferentially for circumferential ablation and delivery of vapor. In another embodiment, thecatheter 21 can be positioned toward the periphery of thepositioning attachment 22 and theinfusion ports 25 can be arranged non-circumferentially, preferably linearly on one side for focal ablation and delivery of vapor. Thepositioning attachment 22 is one of an inflatable balloon, a wire mesh disc with or without an insulated membrane covering the disc, a cone shaped attachment, a ring shaped attachment or a freeform attachment designed to fit the desired hollow body organ or hollow body passage, as further described below. Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters andsensors 28 are incorporated to measure the dimensions of the hollow organ. - The vapor ablation catheter may also comprise an optional
coaxial sheet 27 to restrain thepositioning attachment 22 in a manner comparable to a coronary metal stent. In one embodiment, the sheet is made of memory metal or memory material with a compressed linear form and a non-compressed form in the shape of the positioning attachment. Alternatively, the channel of an endoscope may perform the function of restraining thepositioning attachment 22 by, for example, acting as a constraining sheath.Optional sensor 26 is deployed on the catheter to measure changes associated with vapor delivery or ablation. The sensor is one of temperature, pressure, photo or chemical sensor. - Optionally, one or more, infrared, electromagnetic, acoustic or radiofrequency energy emitters and
sensors 28 can measure the dimensions of the hollow organ. The infrared, electromagnetic, acoustic or radiofrequency energy is emitted from theemitter 28 and is reflected back from the tissue to the detector in theemitter 28. The reflected data can be used to determine the dimension of the hollow cavity. The measurement is performed at one or multiple points to get an accurate estimate of the dimension of the hollow organ. The data can also be used to create a topographic representation of the hollow organ. Additional data from diagnostic tests can be used to validate or add to the data from the above measurements. -
FIG. 2E illustrates anablation device 220 in the form of acatheter 221 extending from aconventional handle 222, in accordance with an embodiment of the present invention. Thecatheter 221 is of a type as described above and extends from and attaches to thehandle 222. In one embodiment, thecatheter 221 is insulated to protect the user from burns that could result from hot vapor heating the catheter. In one embodiment, the catheter is composed of a material that will ensure that the outer temperature of the catheter will remain below 60° C. during use. Thehandle 222 includes a pressure resistant port at the point of attachment with thecatheter 221. Thehandle 222 also includes a flow channel within that directs vapor through to thecatheter 221. - In one embodiment, the snare handle 222 includes a
single attachment port 223 for the connection of a vapor stream and an RF feed. In another embodiment (not shown), the snare handle includes two separate attachment ports for the connection of a vapor stream and an RF feed. Theattachment port 223 interfaces with the vapor supply cord via pressure-resistant connectors. In one embodiment, the connectors are of a luer lock type. In one embodiment, thecatheter 221 is a dual lumen catheter. The first lumen serves to deliver vapor to the site of ablation. In one embodiment, the vapor is released throughsmall ports 224 positioned proximate the distal end of thecatheter 221. The distal end of thecatheter 221 is designed so that it can puncture the tissue to deliver vapor to the desired depth and location within the target tissue. In one embodiment, the distal end of thecatheter 221 tapers to a point. The second lumen houses the electrode used for RF ablation. In one embodiment, the delivery of vapor or RF waves is achieved through the use of a microprocessor. In another embodiment, the user can release vapor or subject the target tissue to RF waves by the use of actuators (not shown) on thehandle 222. In one embodiment, the catheter has varying or differential insulation along its length. In one embodiment, theablation device 220 includes a mechanism in which a snare to grasp the tissue to be ablated and sizing the tissue in the snare is used to determine the amount of vapor to be delivered. -
FIG. 2F illustrates a cross section of anablation device 227 in the form of acatheter 231 extending from aconventional handle 232 with apre-attached cord 235, in accordance with another embodiment of the present invention. Thecord 235 attaches directly to the vapor delivery system, eliminating one interface between the system and the ablation device and thereby decreasing the chance of system failure as a result of disconnection. In this embodiment, thehandle 232 includes a separate attachment port (not shown) for the RF or an electric feed. -
FIG. 2G illustrates anablation device 229 in the form of acatheter 241 extending from a conventionalesophageal probe 226, in accordance with an embodiment of the present invention. In one embodiment, thecatheter 241 is insulated and receives vapor from a flow channel contained within theprobe 226. Thecatheter 241 includes a multitude ofsmall ports 244 for the delivery of vapor to the target tissue. The delivery of vapor is controlled by a microprocessor. In one embodiment, thecatheter 241 also includes twoinflatable balloons 228, one at its distal end beyond thelast vapor port 244, and one at its proximal end, proximate the catheter's 241 attachment to theprobe 226. All vapor ports are positioned between these two balloons. Once thedevice 229 is inserted within the esophagus, theballoons 228 are inflated to keep thecatheter 241 positioned and to contain the vapor within the desired treatment area. In one embodiment, the balloons must be separated from the ablation region by a distance of greater than 0 mm, preferably 1 mm and ideally 1 cm. In one embodiment, the diameter of each balloon when inflated is in the range of 10 to 100 mm, preferably 15-40 mm, although one of ordinary skill in the art would appreciate that the precise dimensions are dependent on the size of the patient's esophagus. - In one embodiment, the
catheter 241 attached to theesophageal probe 226 is a dual lumen catheter. The first lumen serves to deliver vapor to the site of ablation as described above. The second lumen houses the electrode used for RF ablation. -
FIG. 3A illustrates the ablation device placed in an upper gastrointestinal tract with Barrett's esophagus to selectively ablate the Barrett's tissue, in accordance with an embodiment of the present invention. The upper gastrointestinal tract comprises Barrett'sesophagus 31,gastric cardia 32,gastroesophageal junction 33 and displaced squamo-columnar junction 34. The area between thegastroesophageal junction 33 and the displaced squamo-columnar junction 34 is Barrett'sesophagus 31, which is targeted for ablation. Distal to thecardia 32 is thestomach 35 and proximal to thecardia 32 is theesophagus 36. The ablation device is passed into theesophagus 36 and thepositioning device 11 is placed in thegastric cardia 32 abutting thegastroesophageal junction 33. This affixes theablation catheter 10 and itsports 12 in the center of theesophagus 36 and allows for uniform delivery of theablative agent 21 to the Barrett'sesophagus 31. - In one embodiment, the positioning device is first affixed to an anatomical structure, not being subjected to ablation, before ablation occurs. Where the patient is undergoing circumferential ablation or first time ablation, the positioning attachment is preferably placed in the gastric cardia, abutting the gastroesophageal junction. Where the patient is undergoing a focal ablation of any residual disease, it is preferable to use the catheter system shown in
FIG. 4B , as discussed below. In one embodiment, the positioning attachment must be separated from the ablation region by a distance of greater than 0 mm, preferably 1 mm and ideally 1 cm. In one embodiment, the size of the positioning device is in the range of 10 to 100 mm, preferably 20-40 mm, although one of ordinary skill in the art would appreciate that the precise dimensions are dependent on the size of the patient's esophagus. - The delivery of
ablative agent 21 through theinfusion port 12 is controlled by themicroprocessor 15 coupled with the ablation device. The delivery of ablative agent is guided by predetermined programmatic instructions, depending on the tissue to be ablated and the depth of ablation required. In one embodiment, the target procedural temperature will need to be between −100 degrees Celsius and 200 degrees Celsius, preferably between 50 degrees Celsius and 75 degrees Celsius, as further shown in the dosimetery table below. In one embodiment, esophageal pressure should not exceed 5 atm, and is preferably below 0.5 atm. In one embodiment, the target procedural temperature is achieved in less than 1 minute, preferably in less than 5 seconds, and is capable of being maintained for up to 10 minutes, preferably 1 to 10 seconds, and then cooled to body temperature. One of ordinary skill in the art would appreciate that the treatment can be repeated until the desired ablation effect is achieved. -
Optional sensor 17 monitors intraluminal parameters such as temperature and pressure and can increase or decrease the flow ofablative agent 21 through theinfusion port 12 to obtain adequate heating or cooling, resulting in adequate ablation. Thesensor 17 monitors intraluminal parameters such as temperature and pressure and can increase or decrease the removal ofablative agent 21 through theoptional suction port 13 to obtain adequate heating or cooling resulting in adequate ablation of Barrett'sesophagus 31.FIG. 3B illustrates the ablation device placed in an upper gastrointestinal tract with Barrett's esophagus to selectively ablate the Barrett's tissue, in accordance with another embodiment of the present invention. As illustrated inFIG. 3B , thepositioning device 11 is a wire mesh disc. In one embodiment, the positioning attachment must be separated from the ablation region by a distance of greater than 0 mm, preferably 1 mm and ideally 1 cm. In one embodiment, the positioning attachment is removably affixed to the cardia or gastroesophageal (EG) junction (for the distal attachment) or in the esophagus by a distance of greater than 0.1 mm, preferably around 1 cm, above the proximal most extent of the Barrett's tissue (for the proximal attachment). -
FIG. 3B is another embodiment of the Barrett's ablation device where thepositioning element 11 is a wire mesh disc. The wire mesh may have an optional insulated membrane to prevent the escape of the ablative agent. In the current embodiment, two wire mesh discs are used to center the ablation catheter in the esophagus. The distance between the two discs is determined by the length of the tissue to be ablated which, in this case, would be the length of the Barrett's esophagus. Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters andsensors 18 are incorporated to measure the diameter of the esophagus. -
FIG. 3C is a flowchart illustrating the basic procedural steps for using the ablation device, in accordance with an embodiment of the present invention. Atstep 302, a catheter of the ablation device is inserted into an organ which is to be ablated. For example, in order to perform ablation in a Barrett's esophagus of a patient, the catheter is inserted into the Barrett's esophagus via the esophagus of the patient. - At
step 304, a positioning element of the ablation device is deployed and organ dimensions are measured. In an embodiment, where the positioning element is a balloon, the balloon is inflated in order to position the ablation device at a known fixed distance from the tissue to be ablated. In various embodiments, the diameter of the hollow organ may be predetermined by using radiological tests such as barium X-rays or computer tomography (CT) scan, or by using pressure volume cycle, i.e. by determining volume needed to raise pressure to a fixed level (for example, 1 atm) in a fixed volume balloon. In another embodiment, where the positioning device is disc shaped, circumferential rings are provided in order to visually communicate to an operating physician the diameter of the hollow organ. In various embodiments of the present invention, the positioning device enables centering of the catheter of the ablation device in a non-cylindrical body cavity, and the volume of the cavity is measured by the length of catheter or a uterine sound. - Optionally, one or more infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors can be used to measure the dimensions of the hollow organ. The infrared, electromagnetic, acoustic or radiofrequency energy is emitted from the emitter and is reflected back from the tissue to a detector in the emitter. The reflected data can be used to determine the dimensions of the hollow cavity. The measurement can be performed at one or multiple points to get an accurate estimate of the dimensions of the hollow organ. The data from multiple points can also be used to create a topographic representation of the hollow organ or to calculate the volume of the hollow organ.
- In one embodiment, the positioning attachment must be separated from the ports by a distance of 0 mm or greater, preferably greater than 0.1 mm, and more preferably 1 cm. The size of the positioning device depends on the hollow organ being ablated and ranges from 1 mm to 10 cm. In one embodiment, the diameter of the positioning element is between 0.01 mm and 100 mm. In one embodiment, the first positioning element comprises a circular body with a diameter between 0.01 mm and 10 cm.
- At
step 306, the organ is ablated by automated delivery of an ablative agent, such as steam, via infusion ports provided on the catheter. The delivery of the ablative agent through the infusion ports is controlled by a microprocessor coupled with the ablation device. The delivery of ablative agent is guided by predetermined programmatic instructions depending on the tissue to be ablated and the depth of ablation required. In an embodiment of the present invention where the ablative agent is steam, the dose of the ablative agent is determined by conducting dosimetery study to determine the dose to ablate endometrial tissue. The variable that enables determination of total dose of ablative agent is the volume (or mass) of the tissue to be treated which is calculated by using the length of the catheter and diameter of the organ (for cylindrical organs). The determined dose of ablative agent is then delivered using a micro-processor controlled steam generator. Optionally, the delivery of the ablative agent can be controlled by the operator using predetermined dosimetry parameters. - In one embodiment, the dose is provided by first determining what the disorder being treated is and what the desired tissue effect is, and then finding the corresponding temperature, as shown in Tables 1 and 2, below.
-
TABLE 1 Temp in ° C. Tissue Effect 37-40 No significant tissue effect 41-44 Reversible cell damage in few hours 45-49 Irreversible cell damage at shorter intervals 50-69 Irreversible cell damage -ablation necrosis at shorter intervals 70 Threshold temp for tissue shrinkage, H-bond breakage 70-99 Coagulation and Hemostasis 100-200 Desiccation and Carbonization of tissue >200 Charring of tissue glucose -
TABLE 2 Disorder Max. Temp in ° C. ENT/Pulmonary Nasal Polyp 60-80 Turbinectomy 70-85 Bullous Disease 70-85 Lung Reduction 70-85 Genitourinary Uterine Menorrhagia 80-90 Endometriosis 80-90 Uterine Fibroids 90-100 Benign Prostatic Hypertrophy 90-100 Gastroenterology Barrett's Esophagus 60-75 Esophageal Dysplasia 60-80 Vascular GI Disorders 55-75 Flat Polyps 60-80 - In addition, the depth of ablation desired determines the holding time at the maximum temperature. For superficial ablation (Barrett), the holding time at the maximum temperature is very short (flash burn) and does not allow for heat to transfer to the deeper layers. This will prevent damage to deeper normal tissue and hence prevent patient discomfort and complications. For deeper tissue ablation, the holding time at the maximum temperature will be longer, thereby allowing the heat to percolate deeper.
-
FIG. 4A illustrates the ablation device placed in a colon to ablate a flat colon polyp, in accordance with an embodiment of the present invention. Theablation catheter 10 is passed through acolonoscope 40. Thepositioning device 11 is placed proximal, with respect to the patient's GI tract, to a flatcolonic polyp 41 which is to be ablated, in thenormal colon 42. Thepositioning device 11 is one of an inflatable balloon, a wire mesh disc with or without an insulated membrane covering the disc, a cone shaped attachment, a ring shaped attachment or a freeform attachment designed to fit the colonic lumen. Thepositioning device 11 has thecatheter 10 located toward the periphery of thepositioning device 11 placing it closer to thepolyp 41 targeted for non-circumferential ablation. Hence, thepositioning device 11 fixes the catheter to thecolon 42 at a predetermined distance from thepolyp 41 for uniform and focused delivery of theablative agent 21. The delivery ofablative agent 21 through theinfusion port 12 is controlled by themicroprocessor 15 attached to the ablation device and depends on tissue and the depth of ablation required. The delivery ofablative agent 21 is guided by predetermined programmatic instructions depending on the tissue to be ablated and the area and depth of ablation required. Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters andsensors 18 are incorporated to measure the diameter of the colon. The ablation device allows for focal ablation of diseased polyp mucosa without damaging the normal colonic mucosa located away from the catheter ports. - In one embodiment, the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, ideally more than 5 mm. In one embodiment, the positioning element is proximal, with respect to the patient's GI tract, to the colon polyp.
-
FIG. 4B illustrates the ablation device placed in acolon 42 to ablate aflat colon polyp 41, in accordance with another embodiment of the present invention. As illustrated inFIG. 4B , thepositioning device 11 is a conical attachment at the tip of thecatheter 10. The conical attachment has a known length ‘l’ and diameter ‘d’ that is used to calculate the amount of thermal energy needed to ablate theflat colon polyp 41.Ablative agent 21 is directed from theinfusion port 12 to polyp 41 by thepositioning device 11. In one embodiment, thepositioning attachment 11 must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm. In one embodiment, the length ‘l’ is greater than 0.1 mm, preferably between 5 and 10 mm. In one embodiment, diameter ‘d’ depends on the size of the polyp and can be between 1 mm and 10 cm, preferably 1 to 5 cm. Optional infrared, electromagnetic, acoustic or radiofrequency energy emitters andsensors 18 are incorporated to measure the diameter of the colon. This embodiment can also be used to ablate residual neoplastic tissue at the edges after endoscopic snare resection of a large sessile colon polyp. -
FIG. 5A illustrates the ablation device with a coaxial catheter design, in accordance with an embodiment of the present invention. The coaxial design has ahandle 52 a, aninfusion port 53 a, aninner sheath 54 a and anouter sheath 55 a. Theouter sheath 55 a is used to constrain thepositioning device 56 a in the closed position and encompassesports 57 a.FIG. 5B shows a partially deployedpositioning device 56 b, with theports 57 b still within theouter sheath 55 b. Thepositioning device 56 b is partially deployed by pushing thecatheter 54 b out ofsheath 55 b. -
FIG. 5C shows a completely deployedpositioning device 56 c. Theinfusion ports 57 c are out of thesheath 55 c. The length ‘l’ of thecatheter 54 c that contains theinfusion ports 57 c and the diameter ‘d’ of thepositioning element 56 c are predetermined/known and are used to calculate the amount of thermal energy needed.FIG. 5D illustrates a conical design of the positioning element. The positioning element 56 d is conical with a known length ‘l’ and diameter ‘d’ that is used to calculate the amount of thermal energy needed for ablation.FIG. 5E illustrates a disc shaped design of thepositioning element 56 e comprising circumferential rings 59 e. The circumferential rings 59 e are provided at a fixed predetermined distance from thecatheter 54 e and are used to estimate the diameter of a hollow organ or hollow passage in a patient's body. -
FIG. 6 illustrates an upper gastrointestinal tract with a bleeding vascular lesion being treated by the ablation device, in accordance with an embodiment of the present invention. The vascular lesion is avisible vessel 61 in the base of anulcer 62. Theablation catheter 63 is passed through the channel of anendoscope 64. Theconical positioning element 65 is placed over thevisible vessel 61. Theconical positioning element 65 has a known length ‘l’ and diameter ‘d’, which are used to calculate the amount of thermal energy needed for coagulation of the visible vessel to achieve hemostasis. The conical positioning element has an optional insulated membrane that prevents escape of thermal energy or vapor away from the disease site. - In one embodiment, the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm. In one embodiment, the length ‘l’ is greater than 0.1 mm, preferably between 5 and 10 mm. In one embodiment, diameter ‘d’ depends on the size of the lesion and can be between 1 mm and 10 cm, preferably 1 to 5 cm.
-
FIG. 7 illustrates endometrial ablation being performed in a female uterus by using the ablation device, in accordance with an embodiment of the present invention. A cross-section of the female genital tract comprising avagina 70, acervix 71, auterus 72, anendometrium 73,fallopian tubes 74,ovaries 75 and the fundus of theuterus 76 is illustrated. Acatheter 77 of the ablation device is inserted into theuterus 72 through thecervix 71. In an embodiment, thecatheter 77 has two positioning elements, aconical positioning element 78 and a disc shapedpositioning element 79. Thepositioning element 78 is conical with an insulated membrane covering theconical positioning element 78. Theconical element 78 positions thecatheter 77 in the center of the cervix 71 and the insulated membrane prevents the escape of thermal energy or ablative agent through thecervix 71. The second disc shapedpositioning element 79 is deployed close to the fundus of theuterus 76 positioning thecatheter 77 in the middle of the cavity. Anablative agent 778 is passed throughinfusion ports 777 for uniform delivery of theablative agent 778 into the uterine cavity. Predetermined length “l” of the ablative segment of the catheter and diameter ‘d’ of thepositioning element 79 allows for estimation of the cavity size and is used to calculate the amount of thermal energy needed to ablate the endometrial lining.Optional temperature sensors 7 deployed close to the endometrial surface are used to control the delivery of theablative agent 778. Optional topographic mapping using multiple infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors can be used to define cavity size and shape in patients with an irregular or deformed uterine cavity due to conditions such as fibroids. Additionally data from diagnostic testing can be used to ascertain the uterine cavity size, shape or other characteristics. - In an embodiment, the ablative agent is vapor or steam which contracts on cooling. Steam turns to water which has a lower volume as compared to a cryogen that will expand or a hot fluid used in hydrothermal ablation whose volume stays constant. With both cryogens and hot fluids, increasing energy delivery is associated with increasing volume of the ablative agent which, in turn, requires mechanisms for removing the agent, otherwise the medical provider will run into complications, such as perforation. However, steam, on cooling, turns into water which occupies significantly less volume; therefore, increasing energy delivery is not associated with an increase in volume of the residual ablative agent, thereby eliminating the need for continued removal. This further decreases the risk of leakage of the thermal energy via the
fallopian tubes 74 or thecervix 71, thus reducing any risk of thermal injury to adjacent healthy tissue. - In one embodiment, the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm. In another embodiment, the positioning attachment can be in the ablated region as long as it does not cover a significant surface area. For endometrial ablation, 100% of the tissue does not need to be ablated to achieve the desired therapeutic effect.
- In one embodiment, the preferred distal positioning attachment is an uncovered wire mesh that is positioned proximate to the mid body region. In one embodiment, the preferred proximal positioning device is a covered wire mesh that is pulled into the cervix, centers the device, and occludes the cervix. One or more such positioning devices may be helpful to compensate for the anatomical variations in the uterus. The proximal positioning device is preferably oval, with a long axis between 0.1 mm and 10 cm (preferably 1 cm to 5 cm) and a short axis between 0.1 mm and 5 cm (preferably 0.5 cm to 1 cm). The distal positioning device is preferably circular with a diameter between 0.1 mm and 10 cm, preferably 1 cm to 5 cm.
-
FIG. 8 illustrates sinus ablation being performed in a nasal passage by using the ablation device, in accordance with an embodiment of the present invention. A cross-section of the nasal passage andsinuses comprising nares 81,nasal passages 82,frontal sinus 83,ethmoid sinus 84, anddiseased sinus epithelium 85 is illustrated. Thecatheter 86 is inserted into thefrontal sinus 83 or theethmoid sinus 84 through thenares 81 andnasal passages 82. - In an embodiment, the
catheter 86 has two positioning elements, aconical positioning element 87 and a disc shapedpositioning element 88. Thepositioning element 87 is conical and has an insulated membrane covering. Theconical element 87 positions thecatheter 86 in the center of thesinus opening 80 and the insulated membrane prevents the escape of thermal energy or ablative agent through the opening. The second disc shapedpositioning element 88 is deployed in thefrontal sinus cavity 83 orethmoid sinus cavity 84, positioning thecatheter 86 in the middle of either sinus cavity. Theablative agent 8 is passed through theinfusion port 89 for uniform delivery of theablative agent 8 into the sinus cavity. The predetermined length “l” of the ablative segment of the catheter and diameter of thepositioning element 88 allows for estimation of the sinus cavity size and is used to calculate the amount of thermal energy needed to ablate thediseased sinus epithelium 85.Optional temperature sensors 888 are deployed close to thediseased sinus epithelium 85 to control the delivery of theablative agent 8. In an embodiment, theablative agent 8 is steam which contracts on cooling. This further decreases the risk of leakage of the thermal energy thus reducing any risk of thermal injury to adjacent healthy tissue. In one embodiment, the dimensional ranges of the positioning elements are similar to those in the endometrial application, with preferred maximum ranges being half thereof. Optional topographic mapping using multiple infrared, electromagnetic, acoustic or radiofrequency energy emitters and sensors can be used to define cavity size and shape in patients with an irregular or deformed nasal cavity due to conditions such as nasal polyps. -
FIG. 9 illustrates bronchial and bullous ablation being performed in a pulmonary system by using the ablation device, in accordance with an embodiment of the present invention. A cross-section of the pulmonarysystem comprising bronchus 91,normal alveolus 92,bullous lesion 93, and abronchial neoplasm 94 is illustrated. - In one embodiment, the
catheter 96 is inserted through the channel of abronchoscope 95 into thebronchus 91 and advanced into abullous lesion 93. Thecatheter 96 has two positioning elements, aconical positioning element 97 and a disc shapedpositioning element 98. Thepositioning element 97 is conical having an insulated membrane covering. Theconical element 97 positions thecatheter 96 in the center of thebronchus 91 and the insulated membrane prevents the escape of thermal energy or ablative agent through the opening into the normal bronchus. The second disc shapedpositioning element 98 is deployed in thebullous cavity 93 positioning thecatheter 96 in the middle of thebullous cavity 93. Anablative agent 9 is passed through theinfusion port 99 for uniform delivery into the sinus cavity. Predetermined length “l” of the ablative segment of thecatheter 96 and diameter of thepositioning element 98 allow for estimation of the bullous cavity size and is used to calculate the amount of thermal energy needed to ablate the diseasedbullous cavity 93. Optionally, the size of the cavity can be calculated from radiological evaluation using a chest CAT scan or MRI. Optional temperature sensors are deployed close to the surface of thebullous cavity 93 to control the delivery of theablative agent 9. In an embodiment, the ablative agent is steam which contracts on cooling. This further decreases the risk of leakage of the thermal energy into the normal bronchus thus reducing any risk of thermal injury to adjacent normal tissue. - In one embodiment, the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm and more preferably 1 cm. In another embodiment, the positioning attachment can be in the ablated region as long as it does not cover a significant surface area.
- In one embodiment, there are preferably two positioning attachments. In another embodiment, the endoscope is used as one fixation point with one positioning element. The positioning device is between 0.1 mm and 5 cm (preferably 1 mm to 2 cm). The distal positioning device is preferably circular with a diameter between 0.1 mm and 10 cm, preferably 1 cm to 5 cm.
- In another embodiment for the ablation of a
bronchial neoplasm 94, thecatheter 96 is inserted through the channel of abronchoscope 95 into thebronchus 91 and advanced across thebronchial neoplasm 94. Thepositioning element 98 is disc shaped having an insulated membrane covering. Thepositioning element 98 positions the catheter in the center of thebronchus 91 and the insulated membrane prevents the escape of thermal energy or ablative agent through the opening into the normal bronchus. Theablative agent 9 is passed through theinfusion port 99 in a non-circumferential pattern for uniform delivery of the ablative agent to thebronchial neoplasm 94. The predetermined length “l” of the ablative segment of the catheter and diameter ‘d’ of thepositioning element 98 are used to calculate the amount of thermal energy needed to ablate thebronchial neoplasm 94. - The catheter could be advanced to the desired location of ablation using endoscopic, laparoscopic, stereotactic or radiological guidance. Optionally the catheter could be advanced to the desired location using magnetic navigation.
-
FIG. 10 illustrates prostate ablation being performed on an enlarged prostrate in a male urinary system by using the device, in accordance with an embodiment of the present invention. A cross-section of a male genitourinary tract having anenlarged prostate 1001,bladder 1002, and urethra 1003 is illustrated. The urethra 1003 is compressed by theenlarged prostate 1001. Theablation catheter 1005 is passed through thecystoscope 1004 positioned in the urethra 1003 distal to the obstruction. Thepositioning elements 1006 are deployed to center the catheter in the urethra 1003 and one or moreinsulated needles 1007 are passed to pierce theprostate 1001. The vaporablative agent 1008 is passed through theinsulated needles 1007 thus causing ablation of the diseased prostatic tissue resulting in shrinkage of the prostate. - The size of the enlarged prostate could be calculated by using the differential between the extra-prostatic and intra-prostatic urethra. Normative values could be used as baseline. Additional ports for infusion of a cooling fluid into the urethra can be provided to prevent damage to the urethra while the ablative energy is being delivered to the prostrate for ablation, thus preventing complications such as stricture formation.
- In one embodiment, the positioning attachment must be separated from the ablation region by a distance of greater than 0.1 mm, preferably 1 mm to 5 mm and no more than 2 cm. In another embodiment, the positioning attachment can be deployed in the bladder and pulled back into the urethral opening/neck of the bladder thus fixing the catheter. In one embodiment, the positioning device is between 0.1 mm and 10 cm in diameter.
-
FIG. 11 illustrates fibroid ablation being performed in a female uterus by using the ablation device, in accordance with an embodiment of the present invention. A cross-section of a female genitourinary tract comprising auterine fibroid 1111,uterus 1112, andcervix 1113 is illustrated. Theablation catheter 1115 is passed through thehysteroscope 1114 positioned in the uterus distal to thefibroid 1111. Theablation catheter 1115 has apuncturing tip 1120 that helps puncture into thefibroid 1111. Thepositioning elements 1116 are deployed to center the catheter in the fibroid andinsulated needles 1117 are passed to pierce thefibroid tissue 1111. The vaporablative agent 1118 is passed through theneedles 1117 thus causing ablation of theuterine fibroid 1111 resulting in shrinkage of the fibroid. -
FIG. 12 illustrates a vapor delivery system using an RF heater for supplying vapor to the ablation device, in accordance with an embodiment of the present invention. In an embodiment, the vapor is used as an ablative agent in conjunction with the ablation device described in the present invention.RF heater 1264 is located proximate apressure vessel 1242 containing a liquid 1244.RF heater 1264heats vessel 1242, in turn heating theliquid 1244. The liquid 1244 heats up and begins to evaporate causing an increase in pressure inside thevessel 1242. The pressure insidevessel 1242 can be kept fairly constant by providing athermal switch 1246 that controlsresistive heater 1264. Once the temperature of the liquid 1244 reaches a predetermined temperature, thethermal switch 1246 shuts offRF heater 1264. The vapor created inpressure vessel 1242 may be released via acontrol valve 1250. As the vapor exitsvessel 1242, a pressure drop is created in the vessel resulting in a reduction in temperature. The reduction of temperature is measured bythermal switch 1246, andRF heater 1264 is turned back on toheat liquid 1244. In one embodiment, the target temperature ofvessel 1242 may be set to approximately 108° C., providing a continuous supply of vapor. As the vapor is released, it undergoes a pressure drop, which reduces the temperature of the vapor to a range of approximately 90-100° C. As liquid 1244 invessel 1242 evaporates and the vapor exitsvessel 1242, the amount of liquid 1244 slowly diminishes. Thevessel 1242 is optionally connected toreservoir 1243 containing liquid 1244 via apump 1249 which can be turned on by thecontroller 1224 upon sensing a fall in pressure or temperature invessel 1242, delivering additional liquid 1244 to thevessel 1242. -
Vapor delivery catheter 1216 is connected tovessel 1242 via afluid connector 1256. Whencontrol valve 1250 is open,vessel 1242 is in fluid communication withdelivery catheter 1216 viaconnector 1256.Control switch 1260 may serve to turn vapor delivery on and off viaactuator 1248. For example,control switch 1260 may physically open and close thevalve 1250, viaactuator 1248, to control delivery of vapor stream from thevessel 1242.Switch 1260 may be configured to control other attributes of the vapor such as direction, flow, pressure, volume, spray diameter, or other parameters. - Instead of, or in addition to, physically controlling attributes of the vapor,
switch 1260 may electrically communicate with acontroller 1224.Controller 1224 controls theRF heater 1264, which in turn controls attributes of the vapor, in response to actuation ofswitch 1260 by the operator. In addition,controller 1224 may control valves temperature or pressure regulators associated withcatheter 1216 orvessel 1242. Aflow meter 1252 may be used to measure the flow, pressure, or volume of vapor delivery via thecatheter 1216. Thecontroller 1224 controls the temperature and pressure in thevessel 1242 and the time, rate, flow, and volume of vapor flow through thecontrol valve 1250. These parameters are set by theoperator 1211. The pressure created invessel 1242, using the target temperature of 108° C., may be in the order of 25 pounds per square inch (psi) (1.72 bars). -
FIG. 13 illustrates a vapor delivery system using a resistive heater for supplying vapor to the ablation device, in accordance with an embodiment of the present invention. In an embodiment, the generated vapor is used as an ablative agent in conjunction with the ablation device described in the present invention.Resistive heater 1340 is located proximate apressure vessel 1342.Vessel 1342 contains aliquid 1344.Resistive heater 1340heats vessel 1342, inturn heating liquid 1344. Accordingly, liquid 1344 heats and begins to evaporate. As liquid 1344 begins to evaporate, the vapor insidevessel 1342 causes an increase in pressure in the vessel. The pressure invessel 1342 can be kept fairly constant by providing athermal switch 1346 that controlsresistive heater 1340. When the temperature of liquid 1344 reaches a predetermined temperature,thermal switch 1346 shuts offresistive heater 1340. The vapor created inpressure vessel 1342 may be released via acontrol valve 1350. As the vapor exitsvessel 1342,vessel 1342 experiences a pressure drop. The pressure drop ofvessel 1342 results in a reduction of temperature. The reduction of temperature is measured bythermal switch 1346, andresistive heater 1340 is turned back on toheat liquid 1344. In one embodiment, the target temperature ofvessel 1342 may be set to approximately 108° C., providing a continuous supply of vapor. As the vapor is released, it undergoes a pressure drop, which reduces the temperature of the vapor to a range of approximately 90-100° C. As liquid 1344 invessel 1342 evaporates and the vapor exitsvessel 1342, the amount of liquid 1344 slowly diminishes. Thevessel 1342 is connected to anothervessel 1343 containing liquid 1344 via apump 1349 which can be turned on by thecontroller 1324 upon sensing a fall in pressure or temperature invessel 1342 delivering additional liquid 1344 to thevessel 1342. -
Vapor delivery catheter 1316 is connected tovessel 1342 via afluid connector 1356. Whencontrol valve 1350 is open,vessel 1342 is in fluid communication withdelivery catheter 1316 viaconnector 1356.Control switch 1360 may serve to turn vapor delivery on and off viaactuator 1348. For example,control switch 1360 may physically open and close thevalve 1350, viaactuator 1348, to control delivery of vapor stream from thevessel 1342.Switch 1360 may be configured to control other attributes of the vapor such as direction, flow, pressure, volume, spray diameter, or other parameters. Instead of, or in addition to, physically controlling attributes of the vapor,switch 1360 may electrically communicate with acontroller 1324.Controller 1324 controls theresistive heater 1340, which in turn controls attributes of the vapor, in response to actuation ofswitch 1360 by the operator. In addition,controller 1324 may control valves temperature or pressure regulators associated withcatheter 1316 orvessel 1342. Aflow meter 1352 may be used to measure the flow, pressure, or volume of vapor delivery via thecatheter 1316. Thecontroller 1324 controls the temperature and pressure in thevessel 1342 as well as time, rate, flow, and volume of vapor flow through thecontrol valve 1350. These parameters are set by theoperator 1311. The pressure created invessel 1342, using the target temperature of 108° C., may be on the order of 25 pounds per square inch (psi) (1.72 bars). -
FIG. 14 illustrates a vapor delivery system using a heating coil for supplying vapor to the ablation device, in accordance with an embodiment of the present invention. In an embodiment, the generated vapor is used as an ablative agent in conjunction with the ablation device described in the present invention. The vapor delivery system includes aconventional generator 1400 that is commonly used in operating rooms to provide power to specialized tools, i.e., cutters. Thegenerator 1400 is modified to include anintegrated liquid reservoir 1401. In one embodiment, thereservoir 1401 is filled with room temperature pure water. Thereservoir 1401 portion of thegenerator 1400 is connected to theheating component 1405 via a reusableactive cord 1403. In one embodiment, the reusableactive cord 1403 may be used up to 200 times. Thecord 1403 is fixedly attached via connections at both ends to withstand operational pressures, and preferably a maximum pressure, such that the cord does not become disconnected. In one embodiment, the connections can resist at least 1 atm of pressure. In one embodiment, the connections are of a luer lock type. Thecord 1403 has a lumen through which liquid flows to theheating component 1405. In one embodiment, theheating component 1405 contains a coiled length oftubing 1406. As liquid flows through the coiledtubing 1406, it is heated by the surroundingheating component 1405 in a fashion similar to a conventional heat exchanger. As the liquid is heated, it becomes vaporized. The heating component contains aconnector 1407 that accommodates the outlet of vapor from the coiledtubing 1406. One end of asingle use cord 1408 attaches to theheating component 1405 at theconnector 1407. Theconnector 1407 is designed to withstand pressures generated by the vapor inside the coiledtubing 1406 during operation. In one embodiment, theconnector 1407 is of a luer lock type. Anablation device 1409 is attached to the other end of thesingle use cord 1408 via a connection able to withstand the pressures generated by the system. In one embodiment, the ablation device is integrated with a catheter. In another embodiment, the ablation device is integrated with a probe. Thesingle use cord 1408 has a specific luminal diameter and is of a specific length to ensure that the contained vapor does not condense into liquid while simultaneously providing the user enough slack to operate. In addition, thesingle use cord 1408 provides sufficient insulation so that personnel will not suffer burns when coming into contact with the cord. In one embodiment, the single use cord has a luminal diameter of less than 3 mm, preferably less than 2.6 mm, and is longer than 1 meter in length. - In one embodiment, the system includes a
foot pedal 1402 by which the user can supply more vapor to the ablation device. Depressing thefoot pedal 1402 allows liquid to flow from thereservoir 1401 into theheating component 1405 where it changes into vapor within the coiledtubing 1406. The vapor then flows to the ablation device via thesingle use tube 1408. The ablation device includes an actuator by which the user can open small ports on the device, releasing the vapor and ablating the target tissue. -
FIG. 15 illustrates theheating component 1505 and coiledtubing 1506 of the heating coil vapor delivery system ofFIG. 14 , in accordance with an embodiment of the present invention. Liquid arrives through a reusable active cord (not shown) at aconnection 1502 on one side of theheating component 1505. The liquid then travels through the coiledtubing 1506 within theheating component 1505. The coiled tubing is composed of a material and configured specifically to provide optimal heat transfer to the liquid. In one embodiment, the coiledtubing 1506 is copper. The temperature of theheating component 1505 is set to a range so that the liquid is converted to vapor as it passes through the coiledtubing 1506. In one embodiment, the temperature of theheating component 1505 can be set by the user through the use of atemperature setting dial 1508. In one embodiment, the heating component contains an on/offswitch 1509 and is powered through the use of an attachedAC power cord 1503. In another embodiment, the heating component receives power through an electrical connection integrated into and/or facilitated by the active cord connection to the reservoir. The vapor passes through the end of the coiledtubing 1506 and out of theheating component 1505 through aconnector 1507. In one embodiment, theconnector 1507 is located on the opposite side of theheating component 1505 from theinlet connection 1502. A single use cord (not shown) attaches to theconnector 1507 and supplies vapor to the ablation device. -
FIG. 16A illustrates the unassembled interface connection between theablation device 1608 and thesingle use cord 1601 of the heating coil vapor delivery system ofFIG. 14 , in accordance with an embodiment of the present invention. In this embodiment, theablation device 1608 andsingle use cord 1601 are connected via a male-to-male doubleluer lock adapter 1605. The end of thesingle use cord 1601 is threaded to form afemale end 1602 of a luer lock interface and connects to one end of theadapter 1605. Theablation device 1608 includes a small protrusion at its non-operational end which is also threaded to form afemale end 1607 of a luer lock interface and connects to the other end of theadapter 1605. The threading luer lock interface provides a secure connection and is able to withstand the pressures generated by the heating coil vapor delivery system without becoming disconnected. -
FIG. 16B illustrates the assembled interface connection between theablation device 1608 and thesingle use cord 1601 of the heating coil vapor delivery system ofFIG. 14 , in accordance with an embodiment of the present invention. The male-to-male doubleluer lock adapter 1605 is pictured securing the two components together. The double luer lock interface provides a stable seal, allows interchangeability between ablation devices, and enables users to quickly replace single use cords. -
FIG. 17 illustrates a vapor ablation system using a heater or heat exchange unit for supplying vapor to the ablation device, in accordance with another embodiment of the present invention. In the pictured embodiment, water for conversion to vapor is supplied in a disposable, single usesterile fluid container 1705. Thecontainer 1705 is sealed with asterile screw top 1710 that is punctured by aneedle connector 1715 provided on a first end of afirst filter member 1720. The second end of thefirst filter member 1720, opposite the first end, is connected to apump 1725 for drawing the water from thefluid container 1705, through thefirst filter member 1720, and into the heater orheat exchange unit 1730. The system includes a microcontroller ormicroprocessor 1735 for controlling the actions of thepump 1725 and heater orheat exchange unit 1730. The heater orheat exchange unit 1730 converts the water into vapor (steam). The increase in pressure generated during the heating step drives the vapor through an optionalsecond filter member 1740 and into theablation catheter 1750. In one embodiment, the heater orheat exchange unit 1730 includes a one-way valve at its proximal end to prevent the passage of vapor back toward thepump 1725. In various embodiments,optional sensors 1745 positioned proximate the distal end of thecatheter 1750 measure one or more of temperature, pressure, or flow of vapor and transmit the information to themicrocontroller 1735, which in turn controls the rate of thepump 1725 and the level of vaporizing energy provided by the heater orheat exchange unit 1730. -
FIG. 18 illustrates thefluid container 1805,first filter member 1820, and pump 1825 of the vapor ablation system ofFIG. 17 . As can be seen in the pictured embodiment, the system includes a water-filled, disposable, single usesterile fluid container 1805 and apump 1825 with afirst filter member 1820 disposed therebetween. Thefirst filter member 1820 is connected to thecontainer 1805 and pump 1825 by two first and second lengths ofsterile tubing -
FIGS. 19 and 20 illustrate first and second views respectively, of thefluid container first filter member pump heat exchange unit microcontroller FIG. 17 . Thecontainer first filter member sterile tubing first filter member pump sterile tubing sterile tubing pump heat exchange unit microcontroller pump control wires heat exchange unit control wires arrows container first filter member pump heat exchange member Arrow heat exchange unit -
FIG. 21 illustrates the unassembledfirst filter member 2120 of the vapor ablation system ofFIG. 17 , depicting thefilter 2122 positioned within. In one embodiment, thefirst filter member 2120 includes aproximal portion 2121, adistal portion 2123, and afilter 2122. Theproximal portion 2121 anddistal portion 2123 secure together and hold thefilter 2122 within. Also depicted inFIG. 21 are the disposable, single usesterile fluid container 2105 and the first length ofsterile tubing 2107 connecting thecontainer 2105 to theproximal portion 2121 of thefirst filter member 2120. -
FIG. 22 illustrates one embodiment of themicrocontroller 2200 of the vapor ablation system ofFIG. 17 . In various embodiments, themicrocontroller 2200 includes a plurality ofcontrol wires 2228 connected to the pump and heater or heat exchange unit for controlling said components and a plurality oftransmission wires 2247 for receiving flow, pressure, and temperature information from optional sensors positioned proximate the distal end of the ablation catheter. -
FIG. 23 illustrates one embodiment of acatheter assembly 2350 for use with the vapor ablation system ofFIG. 17 . Vapor is delivered from the heater or heat exchange unit to thecatheter assembly 2350 via atube 2348 attached to the proximal end of aconnector component 2352 of theassembly 2350. Adisposable catheter 2356 with a fixedly attached disposable length offlexible tubing 2358 at its distal end is fitted over theconnector component 2352. Asecond filter member 2354 is positioned between theconnector component 2352 and thedisposable catheter 2356 for purifying the vapor supplied by the heater or heat exchange unit. Theconnector component 2352 includes twowashers 2353 positioned apart a short distance at its distal end to engage the overlayingdisposable catheter 2356 and form a double-stage seal, thereby preventing vapor leakage between the components. Once thedisposable catheter 2356 has been fitted to the distal end of theconnector component 2352, acatheter connector 2357 is slid over the disposableflexible tubing 2358 anddisposable catheter 2356 and is then snapped into place onto theconnector component 2352. Thecatheter connector 2357 acts to keep thedisposable catheter 2356 in place and also assists in preventing vapor leakage. In various embodiments, the disposableflexible tubing 2358 includes one or more holes orports 2359 at or proximate its distal end for the delivery of ablative vapor to target tissues. -
FIG. 24 illustrates one embodiment of aheat exchange unit 2430 for use with the vapor ablation system ofFIG. 17 . Theheat exchange unit 2430 comprises a length of coiledtubing 2435 surrounded by aheating element 2434.Water 2432 enters the coiledtubing 2435 of theheat exchange unit 2430 at anentrance port 2433 proximate a first end of saidheat exchange unit 2430. As thewater 2432 flows within the coiledtubing 2435, it is converted into vapor (steam) 2438 by the heat emanating from saidcoiled tubing 2435 which has been heated by theheating element 2434. Thevapor 2438 exits the coiledtubing 2435 of theheat exchange unit 2430 at anexit port 2437 proximate a second end of saidheat exchange unit 2430 and is then delivered to the ablation catheter (not shown) for use in the ablation procedure. -
FIG. 25 illustrates another embodiment of aheat exchange unit 2560 for use with the vapor ablation system of the present invention. In the pictured embodiment, theheat exchange unit 2560 comprises a cylindrically shaped, pen sized ‘clamshell’ style heating block. The heating block of theheat exchange unit 2560 includes afirst half 2561 and asecond half 2562 fixedly attached by ahinge 2563 along one side, wherein thehalves handle 2564 for manipulating theheat exchange unit 2560. When the halves are folded together, theheat exchange unit 2560 snugly envelopes a cylindrically shaped catheterfluid heating chamber 2551 attached to, in-line and in fluid communication with, the proximal end of theablation catheter 2550. Eachhalf heat exchange unit 2560 includes a plurality ofheating elements 2565 for heating the block. The positioning and fit of the heating block place it in close thermal contact with the catheterfluid heating chamber 2551. When in operation, theheating elements 2565 heat the heating block which transfers heat to the catheterfluid heating chamber 2551, which in turn heats the water inside thechamber 2551, converting said water to vapor. The heating block does not directly contact the water. In one embodiment, the catheterfluid heating chamber 2551 comprises a plurality of linear indentations 2591 stretching along the length of the component and in parallel with theheating elements 2565. Upon closing thehalves heating elements 2565, which optionally protrude from the internal surfaces of thehalves - A
luer fitting coupler 2549 is provided at the proximal end of the catheterfluid heating chamber 2551 for connecting a tube supplying sterile water. In one embodiment, a one-way valve is included at the proximal end of the catheterfluid heating chamber 2551, distal to theluer fitting 2549, to prevent the passage of vapor under pressure toward the water supply. - As described above, the catheter fluid heating chamber is designed as part of the ablation catheter and, along with the remainder of the catheter, is single use and disposable. In another embodiment, the chamber is reusable, in which case the luer fitting is positioned in between the catheter shaft and the chamber. The heating block is designed to be axially aligned with the heating chamber when in use, is reusable, and will not be damaged in the event that it falls to the floor. In one embodiment, the weight and dimensions of the heating block are designed such that it can be integrated into a pen-sized and shaped handle of the ablation catheter. The handle is thermally insulated to prevent injury to the operator.
- In one embodiment, the heating block receives its power from a console which is itself line powered and designed to provide 700-1000 W of power, as determined by the fluid vaporization rate. The heating block and all output connections are electrically isolated from line voltage. In one embodiment, the console includes a user interface allowing adjustment of power with a commensurate fluid flow rate. In addition, in one embodiment, a pump, such as a syringe pump, is used to control the flow of fluid to the heating chamber and heating element. In one embodiment, the volume of the syringe is at least 10 ml and is ideally 60 ml.
- In the above embodiment, the catheter to be used with the vapor ablation system is designed using materials intended to minimize cost. In one embodiment, the tubing used with the catheter is able to withstand a temperature of at least 125° C. and can flex through an endoscope's bend radius (approximately 1 inch) without collapse. In one embodiment, the section of the catheter that passes through an endoscope is 7 French (2.3 mm) diameter and has a minimum length of 215 cm. In one embodiment, thermal resistance is provided by the catheter shaft material which shields the endoscope from the super-heated vapor temperature. In one embodiment, the heat exchange unit is designed to interface directly with, or in very close proximity to, an endoscope's biopsy channel to minimize the likelihood of a physician handling heated components. Having the heat exchange unit in close proximity to the endoscope handle also minimizes the length of the catheter through which the vapor needs to travel, thus minimizing heat loss and premature condensation.
- In various embodiments, other means are used to heat the fluid within the catheter fluid heating chamber.
FIG. 26 illustrates the use of induction heating to heat achamber 2605. When an alternating electric current is passed through a coil of wire within thechamber 2605, the coil creates a magnetic field. The magnetic lines offlux 2610 cut through the air around the coil. When thechamber 2605 is composed of a ferrous material, such as, iron, stainless steel, or copper, electrical currents known as eddy currents are induced to flow in thechamber 2605, resulting in localized heating of thechamber 2605. -
FIG. 27A illustrates one embodiment of acoil 2770 used with induction heating in the vapor ablation system of the present invention. The coil is positioned surrounding the catheterfluid heating chamber 2751. An alternating current passing through the coil creates a magnetic field and results in heating of the catheterfluid heating chamber 2751. The heated chamber heats the fluid within, converting it into a vapor, which passes into thecatheter 2750 for use in the ablation procedure. The coil itself does not heat, making it safe to touch. Aluer fitting coupler 2749 is provided at the proximal end of the catheterfluid heating chamber 2751 for connecting a tube supplying sterile water. In one embodiment, a one-way valve (not shown) is included at the proximal end of the catheterfluid heating chamber 2751, distal to theluer fitting 2749, to prevent the passage of vapor toward the water supply. In one embodiment, thermal insulating material (not shown) is positioned between thecoil 2770 and theheating chamber 2751. In another embodiment, thechamber 2751 is suspended in the center of thecoil 2770 with no physical contact between the two. In this embodiment, the intervening air acts as a thermally insulating material. The design of the chamber is optimized to increase its surface area to maximize contact and heat transfer, in turn resulting in more efficient vapor generation. -
FIG. 27B illustrates one embodiment of acatheter handle 2772 used with induction heating in the vapor ablation system of the present invention. Thehandle 2772 is thermally insulated and incorporates an induction coil. In one embodiment, thehandle 2772 includes aninsulated tip 2773 at its distal end that engages with an endoscope channel after the catheter is inserted into the endoscope. Thecatheter 2750 is connected to theheating chamber 2751 which in turn is connected with the pump via aninsulated connector 2774. In one embodiment, theheating chamber 2751 length and diameter are less than those of thehandle 2772 and the induction coil, thus theheating chamber 2751 can slide inside thehandle 2772 in a coaxial fashion while maintaining a constant position within the magnetic field generated by the induction coil. The operator can manipulate thecatheter 2750 by grasping on theinsulated connector 2774 and moving it in and out of thehandle 2772 which in turn moves the catheter tip in and out of the distal end of the endoscope. In this design, the heated portions of thecatheter 2750 are within the channel of the endoscope and in theinsulated handle 2772, thus not coming into contact with the operator at anytime during the operation. Anoptional sensor 2775 on theinsulated tip 2773 can sense when the catheter is not engaged with the endoscope and temporarily disable the heating function of the catheter to prevent accidental activation and thermal injury to the operator. With respect toFIG. 27B , thecatheter 2750 andheating chamber 2751 are the heated components of the system while thehandle 2772, insulatedtip 2773, andinsulated connector 2774 are the cool components and therefore safe to touch by the user. -
FIGS. 28A and 28B are front and longitudinal view cross sectional diagrams respectively, illustrating one embodiment of acatheter 2880 used with induction heating in the vapor ablation system of the present invention. Thecatheter 2880 includes aninsulated handle 2886 that contains aheating chamber 2851 and aninduction coil 2884. Theheating chamber 2851 includes aluer lock 2849 at its proximal end. Theluer lock 2849 has a one-way valve that prevents the backward flow of vapor from thechamber 2851. Vaporization of fluid in the chamber results in volume expansion and an increase in pressure which pushes the vapor out of thechamber 2849 and into the catheter body. Theinduction coil 2884 includes awire 2886 that extends from the proximal end of thecatheter 2880 for the delivery of an alternating current. Thehandle 2886 is connected to thecatheter 2880 with an outer insulatingsheath 2881 made of a thermally insulating material. - In various embodiments, the insulating material is polyether ether ketone (PEEK), polytetrafluoroethylene (PTFE), fluorinated ethylene propylene (FEP), polyether block amide (PEBA), polyimide, or a similar material. In various embodiments,
optional sensors 2887 positioned proximate the distal end of thecatheter 2880 measure one or more of temperature, pressure, or flow of vapor and transmit the information to a microprocessor, which in turn controls the flow rate of the fluid and the level of vaporizing energy provided to thechamber 2851. The microcontroller adjusts fluid flow rate and chamber temperature based on the sensed information, thereby controlling the flow of vapor and in turn, the flow of ablative energy to the target tissue. - In one embodiment, the
catheter 2880 includes an innerflexible metal skeleton 2883. In various embodiments, theskeleton 2883 is composed of copper, stainless steel, or another ferric material. Theskeleton 2883 is in thermal contact with theheating chamber 2851 so that the heat from thechamber 2851 is passively conducted through themetal skeleton 2883 to heat the inside of thecatheter 2880, thus maintaining the steam in a vaporized state and at a relatively constant temperature. In various embodiments, theskeleton 2883 extends through a particular portion or the entire length of thecatheter 2880. In one embodiment, theskeleton 2883 includesfins 2882 at regular intervals that keep theskeleton 2883 in the center of thecatheter 2880 for uniform heating of the catheter lumen. - In another embodiment, as seen in
FIG. 28C , the catheter includes aninner metal spiral 2888 in place of the skeleton. In yet another embodiment, as seen inFIG. 28D , the catheter includes aninner metal mesh 2889 in place of the skeleton. Referring toFIGS. 28B, 28C, and 28D simultaneously,water 2832 enters theluer lock 2849 at a predetermined rate. It is converted tovapor 2838 in theheating chamber 2851. Themetal skeleton 2883,spiral 2888, andmesh 2889 all conduct heat from theheating chamber 2851 into the catheter lumen to prevent condensation of the vapor in the catheter and insure that ablating vapor will exit the catheter from one or more holes or ports at its distal end. -
FIG. 29 illustrates one embodiment of aheating unit 2990 usingmicrowaves 2991 to convert fluid to vapor in the vapor ablation system of the present invention. Themicrowaves 2991 are directed toward the catheterfluid heating chamber 2951, heating thechamber 2951 and converting the fluid within into vapor. The vapor passes into thecatheter 2950 for use in the ablation procedure. Aluer fitting coupler 2949 is provided at the proximal end of the catheterfluid heating chamber 2951 for connecting a tube supplying sterile water. In one embodiment, a one-way valve (not shown) is included at the proximal end of the catheterfluid heating chamber 2951, distal to theluer fitting 2949, to prevent the passage of vapor toward the water supply. - In various embodiments, other energy sources, such as, High Intensity Focused Ultrasound (HIFU) and infrared energy, are used to heat the fluid in the catheter fluid heating chamber.
- One advantage of a vapor delivery system utilizing a heating coil is that the vapor is generated closer to the point of use. Traditional vapor delivery systems often generate vapor close to or at the point in the system where the liquid is stored. The vapor must then travel through a longer length of tubing, sometimes over 2 meters, before reaching the point of use. As a result of the distance traveled, the system can sometimes deliver hot liquid as the vapor cools in the tubing from the ambient temperature.
- The device and method of the present invention can be used to cause controlled focal or circumferential ablation of targeted tissue to varying depth in a manner in which complete healing with re-epithelialization can occur. Additionally, the vapor could be used to treat/ablate benign and malignant tissue growths resulting in destruction, liquefaction and absorption of the ablated tissue. The dose and manner of treatment can be adjusted based on the type of tissue and the depth of ablation needed. The ablation device can be used not only for the treatment of Barrett's esophagus and esophageal dysplasia, flat colon polyps, gastrointestinal bleeding lesions, endometrial ablation, pulmonary ablation, but also for the treatment of any mucosal, submucosal or circumferential lesion, such as inflammatory lesions, tumors, polyps and vascular lesions. The ablation device can also be used for the treatment of focal or circumferential mucosal or submucosal lesions of any hollow organ or hollow body passage in the body. The hollow organ can be one of gastrointestinal tract, pancreaticobiliary tract, genitourinary tract, respiratory tract or a vascular structure such as blood vessels. The ablation device can be placed endoscopically, radiologically, surgically or under direct visualization. In various embodiments, wireless endoscopes or single fiber endoscopes can be incorporated as a part of the device. In another embodiment, magnetic or stereotactic navigation can be used to navigate the catheter to the desired location. Radio-opaque or sonolucent material can be incorporated into the body of the catheter for radiological localization. Ferro- or ferrimagnetic materials can be incorporated into the catheter to help with magnetic navigation.
- While the exemplary embodiments of the present invention are described and illustrated herein, it will be appreciated that they are merely illustrative. It will be understood by those skilled in the art that various changes in form and detail may be made therein without departing from or offending the spirit and scope of the invention.
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US17/073,972 US20210113257A1 (en) | 2008-10-06 | 2020-10-19 | Method and Apparatus for Tissue Ablation |
Applications Claiming Priority (6)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10288508P | 2008-10-06 | 2008-10-06 | |
US12/573,939 US20100094270A1 (en) | 2008-10-06 | 2009-10-06 | Method and Apparatus for Tissue Ablation |
US201161493344P | 2011-06-03 | 2011-06-03 | |
US13/486,980 US9561066B2 (en) | 2008-10-06 | 2012-06-01 | Method and apparatus for tissue ablation |
US15/400,759 US10842549B2 (en) | 2008-10-06 | 2017-01-06 | Vapor ablation system with a catheter having more than one positioning element and configured to treat pulmonary tissue |
US17/073,972 US20210113257A1 (en) | 2008-10-06 | 2020-10-19 | Method and Apparatus for Tissue Ablation |
Related Parent Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US15/400,759 Division US10842549B2 (en) | 2008-10-06 | 2017-01-06 | Vapor ablation system with a catheter having more than one positioning element and configured to treat pulmonary tissue |
Publications (1)
Publication Number | Publication Date |
---|---|
US20210113257A1 true US20210113257A1 (en) | 2021-04-22 |
Family
ID=47260424
Family Applications (5)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/486,980 Active - Reinstated 2031-09-24 US9561066B2 (en) | 2008-10-06 | 2012-06-01 | Method and apparatus for tissue ablation |
US15/386,229 Active 2032-05-16 US10842548B2 (en) | 2008-10-06 | 2016-12-21 | Vapor ablation system with a catheter having more than one positioning element |
US15/400,759 Active 2032-06-27 US10842549B2 (en) | 2008-10-06 | 2017-01-06 | Vapor ablation system with a catheter having more than one positioning element and configured to treat pulmonary tissue |
US17/073,972 Pending US20210113257A1 (en) | 2008-10-06 | 2020-10-19 | Method and Apparatus for Tissue Ablation |
US17/073,677 Pending US20210100600A1 (en) | 2008-10-06 | 2020-10-19 | Method and Apparatus for Tissue Ablation |
Family Applications Before (3)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US13/486,980 Active - Reinstated 2031-09-24 US9561066B2 (en) | 2008-10-06 | 2012-06-01 | Method and apparatus for tissue ablation |
US15/386,229 Active 2032-05-16 US10842548B2 (en) | 2008-10-06 | 2016-12-21 | Vapor ablation system with a catheter having more than one positioning element |
US15/400,759 Active 2032-06-27 US10842549B2 (en) | 2008-10-06 | 2017-01-06 | Vapor ablation system with a catheter having more than one positioning element and configured to treat pulmonary tissue |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US17/073,677 Pending US20210100600A1 (en) | 2008-10-06 | 2020-10-19 | Method and Apparatus for Tissue Ablation |
Country Status (5)
Country | Link |
---|---|
US (5) | US9561066B2 (en) |
EP (2) | EP2713923A4 (en) |
CN (2) | CN107242901B (en) |
HK (1) | HK1245054A1 (en) |
WO (1) | WO2012167213A2 (en) |
Families Citing this family (70)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US8322335B2 (en) | 2007-10-22 | 2012-12-04 | Uptake Medical Corp. | Determining patient-specific vapor treatment and delivery parameters |
US10695126B2 (en) | 2008-10-06 | 2020-06-30 | Santa Anna Tech Llc | Catheter with a double balloon structure to generate and apply a heated ablative zone to tissue |
US9561066B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
CN102238920B (en) * | 2008-10-06 | 2015-03-25 | 维兰德.K.沙马 | Method and apparatus for tissue ablation |
US9561068B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US10064697B2 (en) | 2008-10-06 | 2018-09-04 | Santa Anna Tech Llc | Vapor based ablation system for treating various indications |
US10603489B2 (en) | 2008-10-09 | 2020-03-31 | Virender K. Sharma | Methods and apparatuses for stimulating blood vessels in order to control, treat, and/or prevent a hemorrhage |
US9079028B2 (en) | 2008-10-09 | 2015-07-14 | Virender K. Sharma | Method and apparatus for stimulating the vascular system |
JP2012508068A (en) * | 2008-11-06 | 2012-04-05 | エヌエックスセラ インコーポレイテッド | System and method for treatment of prostate tissue |
US8251985B2 (en) | 2008-11-06 | 2012-08-28 | Nxthera, Inc. | Systems and methods for treatment of prostatic tissue |
BRPI0921421A2 (en) * | 2008-11-06 | 2016-01-05 | Nxthera Inc | prostate therapy system |
US9833277B2 (en) * | 2009-04-27 | 2017-12-05 | Nxthera, Inc. | Systems and methods for prostate treatment |
BR112012022132A2 (en) * | 2010-03-25 | 2016-10-25 | Nxthera Inc | steam therapy system |
WO2012064864A1 (en) | 2010-11-09 | 2012-05-18 | Aegea Medical Inc. | Positioning method and apparatus for delivering vapor to the uterus |
AU2012212492B2 (en) | 2011-02-01 | 2016-05-12 | Channel Medsystems, Inc. | Methods and apparatus for cryogenic treatment of a body cavity or lumen |
PL2755614T3 (en) | 2011-09-13 | 2018-04-30 | Nxthera, Inc. | Systems for prostate treatment |
CN104135960B (en) | 2011-10-07 | 2017-06-06 | 埃杰亚医疗公司 | A kind of uterine therapy device |
US9782583B2 (en) | 2012-02-21 | 2017-10-10 | Virender K. Sharma | System and method for electrical stimulation of anorectal structures to treat urinary dysfunction |
US8706234B2 (en) | 2012-02-21 | 2014-04-22 | Virender K. Sharma | System and method for electrical stimulation of anorectal structures to treat anal dysfunction |
US10576278B2 (en) | 2012-02-21 | 2020-03-03 | Virender K. Sharma | System and method for electrical stimulation of anorectal structures to treat urinary dysfunction |
EP3777738A1 (en) | 2012-04-03 | 2021-02-17 | Boston Scientific Scimed, Inc. | Induction coil vapor generator |
US20130267939A1 (en) * | 2012-04-10 | 2013-10-10 | Robert Lawrence Barry | Methods and Apparatus for Ablating Lung Nodules with Vapor |
EP2945556A4 (en) * | 2013-01-17 | 2016-08-31 | Virender K Sharma | Method and apparatus for tissue ablation |
AU2014236335A1 (en) * | 2013-03-14 | 2015-10-15 | Nxthera Inc. | Systems and methods for treating prostate cancer |
US10219724B2 (en) | 2013-05-02 | 2019-03-05 | VS Medtech, Inc. | Systems and methods for measuring and characterizing interior surfaces of luminal structures |
CA2913014C (en) * | 2013-05-23 | 2017-08-01 | Channel Medsystems, Inc. | Cryogenic treatment systems |
AU2014240225A1 (en) | 2013-10-01 | 2015-04-16 | Uptake Medical Technology Inc. | Preferential volume reduction of diseased segments of a heterogeneous lobe |
US9968395B2 (en) | 2013-12-10 | 2018-05-15 | Nxthera, Inc. | Systems and methods for treating the prostate |
CN108635041B (en) * | 2013-12-10 | 2021-04-13 | 恩克斯特拉公司 | Steam ablation system |
US9472545B2 (en) * | 2014-01-31 | 2016-10-18 | Taiwan Semiconductor Manufacturing Company Limited | Semiconductor arrangement with electrostatic discharge (ESD) protection |
FR3018443B1 (en) * | 2014-03-11 | 2018-05-25 | Miravas | DEVICE FOR GENERATING STEAM FOR INJECTION IN A HUMAN OR ANIMAL VESSEL |
WO2015179666A1 (en) | 2014-05-22 | 2015-11-26 | Aegea Medical Inc. | Systems and methods for performing endometrial ablation |
EP3145426B1 (en) | 2014-05-22 | 2023-03-22 | Aegea Medical, Inc. | Apparatus for delivering vapor to the uterus |
US10206705B2 (en) * | 2014-11-25 | 2019-02-19 | Ethicon Llc | Features for communication of fluid through shaft assembly of ultrasonic surgical instrument |
US10485604B2 (en) | 2014-12-02 | 2019-11-26 | Uptake Medical Technology Inc. | Vapor treatment of lung nodules and tumors |
CN107847259B (en) * | 2015-01-12 | 2021-11-16 | 维兰德.K.沙马 | Method and apparatus for tissue ablation |
US10342593B2 (en) * | 2015-01-29 | 2019-07-09 | Nxthera, Inc. | Vapor ablation systems and methods |
US10531906B2 (en) | 2015-02-02 | 2020-01-14 | Uptake Medical Technology Inc. | Medical vapor generator |
EP3760148B1 (en) * | 2015-05-13 | 2023-11-29 | Nxthera, Inc. | System for treating the bladder with condensable vapor |
US10448838B2 (en) * | 2015-10-19 | 2019-10-22 | Biosense Webster (Israel) Ltd. | Illustrating error in a temperature distribution map |
US11213344B2 (en) * | 2015-11-17 | 2022-01-04 | Biosense Webster (Israel) Ltd. | Guidewire with ablation and coagulation functionality |
WO2017143343A1 (en) | 2016-02-19 | 2017-08-24 | Aegea Medical Inc. | Methods and apparatus for determining the integrity of a bodily cavity |
US11331140B2 (en) | 2016-05-19 | 2022-05-17 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
US11871977B2 (en) | 2016-05-19 | 2024-01-16 | Csa Medical, Inc. | Catheter extension control |
CN109475378B (en) | 2016-05-19 | 2022-01-14 | 圣安娜技术有限公司 | Catheter with dual balloon structure for creating and applying a heated ablation area to tissue |
CA3030857C (en) | 2016-07-14 | 2023-12-19 | The Board Of Regents Of The University Of Texas System | Methods, apparatuses, and systems for inductive heating of foreign metallic implants |
US20180036058A1 (en) * | 2016-08-04 | 2018-02-08 | Csa Medical, Inc. | Rotational cryogen delivery device |
US11033720B2 (en) * | 2016-12-18 | 2021-06-15 | AQUEDUCT MEDICAL Ltd. | Cervical canal dilation device |
JP7129980B2 (en) | 2016-12-21 | 2022-09-02 | ボストン サイエンティフィック サイムド,インコーポレイテッド | Steam cautery system and method |
AU2018205314B2 (en) | 2017-01-06 | 2023-06-15 | Boston Scientific Scimed, Inc. | Transperineal vapor ablation systems and methods |
US11129673B2 (en) | 2017-05-05 | 2021-09-28 | Uptake Medical Technology Inc. | Extra-airway vapor ablation for treating airway constriction in patients with asthma and COPD |
CN111278375A (en) | 2017-06-20 | 2020-06-12 | 埃杰亚医疗公司 | Induction coil assembly and method for uterine ablation |
US11813070B2 (en) * | 2017-08-10 | 2023-11-14 | Vipun Medical Nv | Apparatus for measuring pressure changes in stomach |
US11344364B2 (en) | 2017-09-07 | 2022-05-31 | Uptake Medical Technology Inc. | Screening method for a target nerve to ablate for the treatment of inflammatory lung disease |
US11350988B2 (en) * | 2017-09-11 | 2022-06-07 | Uptake Medical Technology Inc. | Bronchoscopic multimodality lung tumor treatment |
USD845467S1 (en) | 2017-09-17 | 2019-04-09 | Uptake Medical Technology Inc. | Hand-piece for medical ablation catheter |
US11419658B2 (en) | 2017-11-06 | 2022-08-23 | Uptake Medical Technology Inc. | Method for treating emphysema with condensable thermal vapor |
US11490946B2 (en) | 2017-12-13 | 2022-11-08 | Uptake Medical Technology Inc. | Vapor ablation handpiece |
EP3517065A1 (en) * | 2018-01-26 | 2019-07-31 | Koninklijke Philips N.V. | Planning apparatus for determining an ablation probe parameter for a single probe or for multiple ablation probes |
US10786147B2 (en) * | 2018-02-27 | 2020-09-29 | Seoul National University Hospital | Treating prostate disorders |
JP2021525598A (en) | 2018-06-01 | 2021-09-27 | サンタ アナ テック エルエルシーSanta Anna Tech Llc | Multi-stage steam-based ablation processing method and steam generation and delivery system |
EP3849448A4 (en) | 2018-09-11 | 2022-06-15 | Aqua Heart, Inc. | Heated vapor ablation systems and methods for treating cardiac conditions |
EP3866715A4 (en) * | 2018-10-17 | 2022-11-16 | University of Florida Research Foundation | Controlling esophageal temperature during cardiac ablation |
EP3914203A4 (en) * | 2019-01-25 | 2022-10-12 | Virender K. Sharma | Devices for treating obstructive sleep apnea |
US11653927B2 (en) | 2019-02-18 | 2023-05-23 | Uptake Medical Technology Inc. | Vapor ablation treatment of obstructive lung disease |
US20210059749A1 (en) * | 2019-08-28 | 2021-03-04 | Santa Anna Tech Llc | Systems and Methods for Ablating Prostate Tissue |
CN112815287B (en) * | 2019-12-31 | 2023-04-14 | 杭州堃博生物科技有限公司 | Steam ablation equipment and inspection control method, controller, equipment and medium thereof |
CN112263320A (en) * | 2020-09-29 | 2021-01-26 | 杭州睿笛生物科技有限公司 | Cervical ablation device |
CN113069200B (en) * | 2021-04-02 | 2022-08-12 | 杭州堃博生物科技有限公司 | Steam ablation device and control method, controller, device and medium thereof |
CN114376723B (en) * | 2022-03-25 | 2022-07-15 | 北京微刀医疗科技有限公司 | Irreversible electroporation ablation needle, needle channel ablation device and ablation device |
Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5308347A (en) * | 1991-09-18 | 1994-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Transfusion device |
US20020177846A1 (en) * | 2001-03-06 | 2002-11-28 | Mulier Peter M.J. | Vaporous delivery of thermal energy to tissue sites |
US20090149846A1 (en) * | 2003-10-07 | 2009-06-11 | Tsunami Medtech, Llc | Medical system and method of use |
US20090216220A1 (en) * | 2008-02-20 | 2009-08-27 | Tsunami Medtech, Llc | Medical system and method of use |
Family Cites Families (578)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US408899A (en) | 1889-08-13 | Island | ||
US697181A (en) | 1901-08-20 | 1902-04-08 | Lundy B Smith | Instrument for cooling or for warming internal portions of the human body. |
US1719750A (en) | 1927-09-29 | 1929-07-02 | Charles E Parkhurst | Dental apparatus |
US3938502A (en) | 1972-02-22 | 1976-02-17 | Nicolaas Bom | Apparatus with a catheter for examining hollow organs or bodies with the ultrasonic waves |
US3818913A (en) | 1972-08-30 | 1974-06-25 | M Wallach | Surgical apparatus for removal of tissue |
US3924628A (en) | 1972-12-01 | 1975-12-09 | William Droegemueller | Cyrogenic bladder for necrosing tissue cells |
US3880168A (en) | 1973-12-21 | 1975-04-29 | Robert A Berman | Endotracheal tube |
US3930505A (en) | 1974-06-24 | 1976-01-06 | Hydro Pulse Corporation | Surgical apparatus for removal of tissue |
US4024866A (en) | 1974-12-02 | 1977-05-24 | Hydro Pulse Corporation | Surgical apparatus for removal of tissue |
US4083077A (en) | 1975-12-15 | 1978-04-11 | Knight Arlen M | Hand tool for cleaning fabric |
US4701587A (en) | 1979-08-31 | 1987-10-20 | Metcal, Inc. | Shielded heating element having intrinsic temperature control |
US5435805A (en) | 1992-08-12 | 1995-07-25 | Vidamed, Inc. | Medical probe device with optical viewing capability |
US5385544A (en) | 1992-08-12 | 1995-01-31 | Vidamed, Inc. | BPH ablation method and apparatus |
US5421819A (en) | 1992-08-12 | 1995-06-06 | Vidamed, Inc. | Medical probe device |
US5542915A (en) | 1992-08-12 | 1996-08-06 | Vidamed, Inc. | Thermal mapping catheter with ultrasound probe |
US5370675A (en) | 1992-08-12 | 1994-12-06 | Vidamed, Inc. | Medical probe device and method |
US4672962A (en) | 1983-09-28 | 1987-06-16 | Cordis Corporation | Plaque softening method |
US4682596A (en) | 1984-05-22 | 1987-07-28 | Cordis Corporation | Electrosurgical catheter and method for vascular applications |
US4828544A (en) | 1984-09-05 | 1989-05-09 | Quotidian No. 100 Pty Limited | Control of blood flow |
US4773410A (en) | 1984-10-09 | 1988-09-27 | Transpirator Technologies, Inc. | Method and apparatus for the treatment of the respiratory track with vapor-phase water |
US4672963A (en) | 1985-06-07 | 1987-06-16 | Israel Barken | Apparatus and method for computer controlled laser surgery |
DE3686621T2 (en) | 1985-07-31 | 1993-02-25 | Bard Inc C R | INFRARED LASER CATHETER DEVICE. |
US4917084A (en) | 1985-07-31 | 1990-04-17 | C. R. Bard, Inc. | Infrared laser catheter system |
US4748979A (en) | 1985-10-07 | 1988-06-07 | Cordis Corporation | Plaque resolving device |
US4793352A (en) | 1986-02-07 | 1988-12-27 | Eichenlaub John E | Limited heat transfer device and method |
DE3715418A1 (en) | 1986-05-08 | 1987-11-12 | Olympus Optical Co | LITHOTOM |
US4872920A (en) | 1987-11-25 | 1989-10-10 | Flynn Tom S | Asbestos removal method and system |
JPH01139081A (en) | 1987-11-27 | 1989-05-31 | Olympus Optical Co Ltd | Apparatus for radiating laser beam |
US5112328A (en) | 1988-01-25 | 1992-05-12 | Refractive Laser Research & Development Program, Ltd. | Method and apparatus for laser surgery |
US5328471A (en) | 1990-02-26 | 1994-07-12 | Endoluminal Therapeutics, Inc. | Method and apparatus for treatment of focal disease in hollow tubular organs and other tissue lumens |
US4915113A (en) | 1988-12-16 | 1990-04-10 | Bio-Vascular, Inc. | Method and apparatus for monitoring the patency of vascular grafts |
US5011566A (en) | 1989-03-15 | 1991-04-30 | The United States Of America As Represented By The Secretary Of The Air Force | Method of manufacturing microscopic tube material |
US5352512A (en) | 1989-03-15 | 1994-10-04 | The United States Of America As Represented By The Secretary Of The Air Force | Microscopic tube material and its method of manufacture |
US4976711A (en) | 1989-04-13 | 1990-12-11 | Everest Medical Corporation | Ablation catheter with selectively deployable electrodes |
US5263951A (en) | 1989-04-21 | 1993-11-23 | Kerus Medical Systems | Correction of the optical focusing system of the eye using laser thermal keratoplasty |
US5006119A (en) | 1989-05-25 | 1991-04-09 | Engineering & Research Associates, Inc. | Hollow core coaxial catheter |
US5084044A (en) | 1989-07-14 | 1992-01-28 | Ciron Corporation | Apparatus for endometrial ablation and method of using same |
WO1991003267A1 (en) | 1989-08-28 | 1991-03-21 | Sekins K Michael | Lung cancer hyperthermia via ultrasound and/or convection with perfluorocarbon liquids |
US5562608A (en) | 1989-08-28 | 1996-10-08 | Biopulmonics, Inc. | Apparatus for pulmonary delivery of drugs with simultaneous liquid lavage and ventilation |
US5045056A (en) | 1989-09-15 | 1991-09-03 | Behl Robert S | Method and device for thermal ablation of hollow body organs |
US5222938A (en) | 1989-09-15 | 1993-06-29 | Interventional Thermodynamics, Inc. | Method for thermal ablation of hollow body organs |
FR2655548A1 (en) | 1989-12-11 | 1991-06-14 | Cleef Jean Francois Van | Catheter with walls which are not smooth (catheter with walls which are moulded) |
US5084043A (en) | 1990-01-12 | 1992-01-28 | Laserscope | Method for performing a percutaneous diskectomy using a laser |
US4985027A (en) | 1990-02-26 | 1991-01-15 | Dressel Thomas D | Soft tissue aspiration device and method |
US5102410A (en) | 1990-02-26 | 1992-04-07 | Dressel Thomas D | Soft tissue cutting aspiration device and method |
US5624392A (en) | 1990-05-11 | 1997-04-29 | Saab; Mark A. | Heat transfer catheters and methods of making and using same |
US5190539A (en) | 1990-07-10 | 1993-03-02 | Texas A & M University System | Micro-heat-pipe catheter |
US5417686A (en) | 1990-07-10 | 1995-05-23 | The Texas A&M University System | Temperature control mechanisms for a micro heat pipe catheter |
CA2048120A1 (en) | 1990-08-06 | 1992-02-07 | William J. Drasler | Thrombectomy method and device |
AU647533B2 (en) | 1990-10-16 | 1994-03-24 | Summit Technology, Inc. | Laser thermokeratoplasty methods and apparatus |
US5122138A (en) | 1990-11-28 | 1992-06-16 | Manwaring Kim H | Tissue vaporizing accessory and method for an endoscope |
WO1992010142A1 (en) | 1990-12-10 | 1992-06-25 | Howmedica Inc. | A device and method for interstitial laser energy delivery |
US5409453A (en) | 1992-08-12 | 1995-04-25 | Vidamed, Inc. | Steerable medical probe with stylets |
EP0578771B1 (en) | 1991-04-05 | 1999-12-29 | Metcal, Inc. | Instrument for cutting, coagulating and ablating tissue |
US6194066B1 (en) | 1991-04-24 | 2001-02-27 | The United States Of America As Represented By The Secretary Of The Air Force | Microscopic tube devices and method of manufacture |
US6113722A (en) | 1991-04-24 | 2000-09-05 | The United States Of America As Represented By The Secretary Of Air Force | Microscopic tube devices and method of manufacture |
US5242390A (en) | 1991-05-03 | 1993-09-07 | Goldrath Milton H | Endometrium coagulating surgical method for thermal destruction of the endometrium |
US5542928A (en) | 1991-05-17 | 1996-08-06 | Innerdyne, Inc. | Method and device for thermal ablation having improved heat transfer |
WO1992020290A1 (en) | 1991-05-17 | 1992-11-26 | Innerdyne Medical, Inc. | Method and device for thermal ablation |
US5217459A (en) | 1991-08-27 | 1993-06-08 | William Kamerling | Method and instrument for performing eye surgery |
US5697909A (en) | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | Methods and apparatus for surgical cutting |
US5697281A (en) | 1991-10-09 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US6461296B1 (en) | 1998-06-26 | 2002-10-08 | 2000 Injectx, Inc. | Method and apparatus for delivery of genes, enzymes and biological agents to tissue cells |
US5524620A (en) | 1991-11-12 | 1996-06-11 | November Technologies Ltd. | Ablation of blood thrombi by means of acoustic energy |
DE4138115A1 (en) | 1991-11-19 | 1993-05-27 | Delma Elektro Med App | MEDICAL HIGH FREQUENCY COAGULATION INSTRUMENT |
US6086585A (en) | 1995-06-07 | 2000-07-11 | Arthrocare Corporation | System and methods for electrosurgical treatment of sleep obstructive disorders |
US6159194A (en) | 1992-01-07 | 2000-12-12 | Arthrocare Corporation | System and method for electrosurgical tissue contraction |
US6102046A (en) | 1995-11-22 | 2000-08-15 | Arthrocare Corporation | Systems and methods for electrosurgical tissue revascularization |
US6024733A (en) | 1995-06-07 | 2000-02-15 | Arthrocare Corporation | System and method for epidermal tissue ablation |
US6770071B2 (en) | 1995-06-07 | 2004-08-03 | Arthrocare Corporation | Bladed electrosurgical probe |
US6053172A (en) | 1995-06-07 | 2000-04-25 | Arthrocare Corporation | Systems and methods for electrosurgical sinus surgery |
US5843019A (en) | 1992-01-07 | 1998-12-01 | Arthrocare Corporation | Shaped electrodes and methods for electrosurgical cutting and ablation |
US6109268A (en) | 1995-06-07 | 2000-08-29 | Arthrocare Corporation | Systems and methods for electrosurgical endoscopic sinus surgery |
US6210402B1 (en) | 1995-11-22 | 2001-04-03 | Arthrocare Corporation | Methods for electrosurgical dermatological treatment |
US5902272A (en) | 1992-01-07 | 1999-05-11 | Arthrocare Corporation | Planar ablation probe and method for electrosurgical cutting and ablation |
US6974453B2 (en) | 1993-05-10 | 2005-12-13 | Arthrocare Corporation | Dual mode electrosurgical clamping probe and related methods |
US6063079A (en) | 1995-06-07 | 2000-05-16 | Arthrocare Corporation | Methods for electrosurgical treatment of turbinates |
US6179824B1 (en) | 1993-05-10 | 2001-01-30 | Arthrocare Corporation | System and methods for electrosurgical restenosis of body lumens |
US5683366A (en) | 1992-01-07 | 1997-11-04 | Arthrocare Corporation | System and method for electrosurgical tissue canalization |
US6355032B1 (en) | 1995-06-07 | 2002-03-12 | Arthrocare Corporation | Systems and methods for selective electrosurgical treatment of body structures |
US6296638B1 (en) | 1993-05-10 | 2001-10-02 | Arthrocare Corporation | Systems for tissue ablation and aspiration |
US7297145B2 (en) | 1997-10-23 | 2007-11-20 | Arthrocare Corporation | Bipolar electrosurgical clamp for removing and modifying tissue |
US6500173B2 (en) | 1992-01-07 | 2002-12-31 | Ronald A. Underwood | Methods for electrosurgical spine surgery |
US6142992A (en) | 1993-05-10 | 2000-11-07 | Arthrocare Corporation | Power supply for limiting power in electrosurgery |
US7429262B2 (en) | 1992-01-07 | 2008-09-30 | Arthrocare Corporation | Apparatus and methods for electrosurgical ablation and resection of target tissue |
US5697882A (en) | 1992-01-07 | 1997-12-16 | Arthrocare Corporation | System and method for electrosurgical cutting and ablation |
US6183469B1 (en) | 1997-08-27 | 2001-02-06 | Arthrocare Corporation | Electrosurgical systems and methods for the removal of pacemaker leads |
US5681282A (en) | 1992-01-07 | 1997-10-28 | Arthrocare Corporation | Methods and apparatus for ablation of luminal tissues |
US6190381B1 (en) | 1995-06-07 | 2001-02-20 | Arthrocare Corporation | Methods for tissue resection, ablation and aspiration |
US5217465A (en) | 1992-02-28 | 1993-06-08 | Alcon Surgical, Inc. | Flexible and steerable aspiration tip for microsurgery |
US5330518A (en) | 1992-03-06 | 1994-07-19 | Urologix, Inc. | Method for treating interstitial tissue associated with microwave thermal therapy |
US5443470A (en) | 1992-05-01 | 1995-08-22 | Vesta Medical, Inc. | Method and apparatus for endometrial ablation |
US5331947A (en) | 1992-05-01 | 1994-07-26 | Shturman Cardiology Systems, Inc. | Inflatable sheath for introduction of ultrasonic catheter through the lumen of a fiber optic endoscope |
US5344397A (en) | 1992-06-26 | 1994-09-06 | Advanced Surgical, Inc. | Cholangiogram catheter |
WO1994002077A2 (en) | 1992-07-15 | 1994-02-03 | Angelase, Inc. | Ablation catheter system |
US5354331A (en) | 1992-07-15 | 1994-10-11 | Schachar Ronald A | Treatment of presbyopia and other eye disorders |
US5470308A (en) | 1992-08-12 | 1995-11-28 | Vidamed, Inc. | Medical probe with biopsy stylet |
US5667488A (en) | 1992-08-12 | 1997-09-16 | Vidamed, Inc. | Transurethral needle ablation device and method for the treatment of the prostate |
US5630794A (en) | 1992-08-12 | 1997-05-20 | Vidamed, Inc. | Catheter tip and method of manufacturing |
US5720718A (en) | 1992-08-12 | 1998-02-24 | Vidamed, Inc. | Medical probe apparatus with enhanced RF, resistance heating, and microwave ablation capabilities |
US5484400A (en) | 1992-08-12 | 1996-01-16 | Vidamed, Inc. | Dual channel RF delivery system |
US5720719A (en) | 1992-08-12 | 1998-02-24 | Vidamed, Inc. | Ablative catheter with conformable body |
US5556377A (en) | 1992-08-12 | 1996-09-17 | Vidamed, Inc. | Medical probe apparatus with laser and/or microwave monolithic integrated circuit probe |
US5672153A (en) | 1992-08-12 | 1997-09-30 | Vidamed, Inc. | Medical probe device and method |
US5542916A (en) | 1992-08-12 | 1996-08-06 | Vidamed, Inc. | Dual-channel RF power delivery system |
US5425931A (en) * | 1992-09-04 | 1995-06-20 | Nippon Steel Corporation | Small diameter pitch-based carbon fiber bundle and production method thereof |
US5318014A (en) | 1992-09-14 | 1994-06-07 | Coraje, Inc. | Ultrasonic ablation/dissolution transducer |
US5312399A (en) | 1992-09-29 | 1994-05-17 | Hakky Said I | Laser resectoscope with mechanical cutting means and laser coagulating means |
DE4338758C2 (en) | 1992-11-13 | 2001-08-09 | Scimed Life Systems Inc | Catheter assembly |
CN1119418A (en) | 1993-02-02 | 1996-03-27 | 怀达医疗公司 | Transurethral needle ablation device and method |
US6117109A (en) | 1995-11-22 | 2000-09-12 | Arthrocare Corporation | Systems and methods for electrosurgical incisions on external skin surfaces |
US6915806B2 (en) | 1993-05-10 | 2005-07-12 | Arthrocare Corporation | Method for harvesting graft vessel |
US6896674B1 (en) | 1993-05-10 | 2005-05-24 | Arthrocare Corporation | Electrosurgical apparatus having digestion electrode and methods related thereto |
US5766153A (en) | 1993-05-10 | 1998-06-16 | Arthrocare Corporation | Methods and apparatus for surgical cutting |
US6749604B1 (en) | 1993-05-10 | 2004-06-15 | Arthrocare Corporation | Electrosurgical instrument with axially-spaced electrodes |
US6235020B1 (en) | 1993-05-10 | 2001-05-22 | Arthrocare Corporation | Power supply and methods for fluid delivery in electrosurgery |
US6832996B2 (en) | 1995-06-07 | 2004-12-21 | Arthrocare Corporation | Electrosurgical systems and methods for treating tissue |
US6391025B1 (en) | 1993-05-10 | 2002-05-21 | Arthrocare Corporation | Electrosurgical scalpel and methods for tissue cutting |
US6254600B1 (en) | 1993-05-10 | 2001-07-03 | Arthrocare Corporation | Systems for tissue ablation and aspiration |
EP0703756B1 (en) | 1993-06-10 | 2004-12-15 | IMRAN, Mir, A. | Transurethral radio frequency ablation apparatus |
US5405376A (en) | 1993-08-27 | 1995-04-11 | Medtronic, Inc. | Method and apparatus for ablation |
US5980516A (en) | 1993-08-27 | 1999-11-09 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5431649A (en) | 1993-08-27 | 1995-07-11 | Medtronic, Inc. | Method and apparatus for R-F ablation |
US5449380A (en) | 1993-09-17 | 1995-09-12 | Origin Medsystems, Inc. | Apparatus and method for organ ablation |
US6056738A (en) | 1997-01-31 | 2000-05-02 | Transmedica International, Inc. | Interstitial fluid monitoring |
KR0141224B1 (en) | 1993-10-11 | 1998-06-01 | 김광호 | Rapid display device |
US5797903A (en) | 1996-04-12 | 1998-08-25 | Ep Technologies, Inc. | Tissue heating and ablation systems and methods using porous electrode structures with electrically conductive surfaces |
US5433739A (en) | 1993-11-02 | 1995-07-18 | Sluijter; Menno E. | Method and apparatus for heating an intervertebral disc for relief of back pain |
DE4338866C1 (en) | 1993-11-13 | 1995-06-14 | Wolf Gmbh Richard | Medical instrument for the application of hot gas |
US5462521A (en) | 1993-12-21 | 1995-10-31 | Angeion Corporation | Fluid cooled and perfused tip for a catheter |
US5503638A (en) | 1994-02-10 | 1996-04-02 | Bio-Vascular, Inc. | Soft tissue stapling buttress |
ATE271403T1 (en) * | 1994-04-14 | 2004-08-15 | Xylog Corp | FLUID DELIVERY SYSTEM IN HYSTEROSCOPY SURGERY |
US5437629A (en) | 1994-04-14 | 1995-08-01 | Bei Medical Systems | Fluid delivery system for hysteroscopic endometrial ablation |
US5743870A (en) | 1994-05-09 | 1998-04-28 | Somnus Medical Technologies, Inc. | Ablation apparatus and system for removal of soft palate tissue |
US5674191A (en) | 1994-05-09 | 1997-10-07 | Somnus Medical Technologies, Inc. | Ablation apparatus and system for removal of soft palate tissue |
US5707349A (en) | 1994-05-09 | 1998-01-13 | Somnus Medical Technologies, Inc. | Method for treatment of air way obstructions |
US5730719A (en) | 1994-05-09 | 1998-03-24 | Somnus Medical Technologies, Inc. | Method and apparatus for cosmetically remodeling a body structure |
US5824703A (en) | 1994-05-13 | 1998-10-20 | Synthetic Blood International, Inc. | Method of assisting normal breathing in a mammal having a lung disorder |
US6002968A (en) | 1994-06-24 | 1999-12-14 | Vidacare, Inc. | Uterine treatment apparatus |
US5540658A (en) | 1994-06-27 | 1996-07-30 | Innerdyne, Inc. | Transcervical uterine access and sealing device |
US5591157A (en) | 1994-09-07 | 1997-01-07 | Hennings; David R. | Method and apparatus for tympanic membrane shrinkage |
US5609151A (en) | 1994-09-08 | 1997-03-11 | Medtronic, Inc. | Method for R-F ablation |
US8025661B2 (en) | 1994-09-09 | 2011-09-27 | Cardiofocus, Inc. | Coaxial catheter instruments for ablation with radiant energy |
US5545171A (en) | 1994-09-22 | 1996-08-13 | Vidamed, Inc. | Anastomosis catheter |
US5601591A (en) | 1994-09-23 | 1997-02-11 | Vidamed, Inc. | Stent for use in prostatic urethra, apparatus and placement device for same and method |
US5558673A (en) | 1994-09-30 | 1996-09-24 | Vidamed, Inc. | Medical probe device and method having a flexible resilient tape stylet |
WO1996010366A1 (en) | 1994-10-03 | 1996-04-11 | Heart Technology, Inc. | Transluminal thrombectomy apparatus |
US5783046A (en) | 1994-11-28 | 1998-07-21 | Gentech, Inc. | Process and apparatus for the destructive distillation of rubber |
US5588960A (en) | 1994-12-01 | 1996-12-31 | Vidamed, Inc. | Transurethral needle delivery device with cystoscope and method for treatment of urinary incontinence |
US6676629B2 (en) | 1995-02-06 | 2004-01-13 | Mark S. Andrew | Tissue liquefaction and aspiration for dental treatment |
US6544211B1 (en) | 1995-02-06 | 2003-04-08 | Mark S. Andrew | Tissue liquefaction and aspiration |
US5616120A (en) | 1995-02-06 | 1997-04-01 | Andrew; Mark S. | Method and apparatus for lenticular liquefaction and aspiration |
US5669907A (en) | 1995-02-10 | 1997-09-23 | Valleylab Inc. | Plasma enhanced bipolar electrosurgical system |
US6063081A (en) | 1995-02-22 | 2000-05-16 | Medtronic, Inc. | Fluid-assisted electrocautery device |
US5897553A (en) | 1995-11-02 | 1999-04-27 | Medtronic, Inc. | Ball point fluid-assisted electrocautery device |
US6176842B1 (en) * | 1995-03-08 | 2001-01-23 | Ekos Corporation | Ultrasound assembly for use with light activated drugs |
US5672290A (en) | 1995-03-13 | 1997-09-30 | Raychem Corporation | Power source and method for induction heating of articles |
US6264650B1 (en) | 1995-06-07 | 2001-07-24 | Arthrocare Corporation | Methods for electrosurgical treatment of intervertebral discs |
US6159208A (en) | 1995-06-07 | 2000-12-12 | Arthocare Corporation | System and methods for electrosurgical treatment of obstructive sleep disorders |
US6203542B1 (en) | 1995-06-07 | 2001-03-20 | Arthrocare Corporation | Method for electrosurgical treatment of submucosal tissue |
US6602248B1 (en) | 1995-06-07 | 2003-08-05 | Arthro Care Corp. | Methods for repairing damaged intervertebral discs |
US5800493A (en) | 1995-04-26 | 1998-09-01 | Gynecare, Inc. | Intrauterine ablation system |
US5755753A (en) | 1995-05-05 | 1998-05-26 | Thermage, Inc. | Method for controlled contraction of collagen tissue |
US5554172A (en) | 1995-05-09 | 1996-09-10 | The Larren Corporation | Directed energy surgical method and assembly |
US20050004634A1 (en) | 1995-06-07 | 2005-01-06 | Arthrocare Corporation | Methods for electrosurgical treatment of spinal tissue |
US6149620A (en) | 1995-11-22 | 2000-11-21 | Arthrocare Corporation | System and methods for electrosurgical tissue treatment in the presence of electrically conductive fluid |
US7179255B2 (en) | 1995-06-07 | 2007-02-20 | Arthrocare Corporation | Methods for targeted electrosurgery on contained herniated discs |
US6632193B1 (en) | 1995-06-07 | 2003-10-14 | Arthrocare Corporation | Systems and methods for electrosurgical tissue treatment |
US5944686A (en) | 1995-06-07 | 1999-08-31 | Hydrocision, Inc. | Instrument for creating a fluid jet |
US5741248A (en) | 1995-06-07 | 1998-04-21 | Temple University-Of The Commonwealth System Of Higher Education | Fluorochemical liquid augmented cryosurgery |
US6022346A (en) * | 1995-06-07 | 2000-02-08 | Ep Technologies, Inc. | Tissue heating and ablation systems and methods using self-heated electrodes |
US6363937B1 (en) | 1995-06-07 | 2002-04-02 | Arthrocare Corporation | System and methods for electrosurgical treatment of the digestive system |
US6837887B2 (en) | 1995-06-07 | 2005-01-04 | Arthrocare Corporation | Articulated electrosurgical probe and methods |
US6837888B2 (en) | 1995-06-07 | 2005-01-04 | Arthrocare Corporation | Electrosurgical probe with movable return electrode and methods related thereto |
US6772012B2 (en) | 1995-06-07 | 2004-08-03 | Arthrocare Corporation | Methods for electrosurgical treatment of spinal tissue |
US6238391B1 (en) | 1995-06-07 | 2001-05-29 | Arthrocare Corporation | Systems for tissue resection, ablation and aspiration |
US5992769A (en) | 1995-06-09 | 1999-11-30 | The Regents Of The University Of Michigan | Microchannel system for fluid delivery |
US6607529B1 (en) | 1995-06-19 | 2003-08-19 | Medtronic Vidamed, Inc. | Electrosurgical device |
US5849011A (en) | 1995-06-19 | 1998-12-15 | Vidamed, Inc. | Medical device with trigger actuation assembly |
EP0771176B2 (en) | 1995-06-23 | 2006-01-04 | Gyrus Medical Limited | An electrosurgical instrument |
AU703433B2 (en) | 1995-06-23 | 1999-03-25 | Gyrus Medical Limited | An electrosurgical instrument |
US6293942B1 (en) | 1995-06-23 | 2001-09-25 | Gyrus Medical Limited | Electrosurgical generator method |
US6015406A (en) | 1996-01-09 | 2000-01-18 | Gyrus Medical Limited | Electrosurgical instrument |
US6780180B1 (en) | 1995-06-23 | 2004-08-24 | Gyrus Medical Limited | Electrosurgical instrument |
US5785521A (en) | 1995-08-31 | 1998-07-28 | Biolase Technology, Inc. | Fluid conditioning system |
US6669685B1 (en) | 1997-11-06 | 2003-12-30 | Biolase Technology, Inc. | Tissue remover and method |
US5741247A (en) | 1995-08-31 | 1998-04-21 | Biolase Technology, Inc. | Atomized fluid particles for electromagnetically induced cutting |
US6231567B1 (en) | 1995-08-31 | 2001-05-15 | Biolase Technology Inc. | Material remover and method |
US6254597B1 (en) | 1995-08-31 | 2001-07-03 | Biolase Technology, Inc. | Tissue remover and method |
US5700262A (en) | 1995-10-16 | 1997-12-23 | Neuro Navigational, L.L.C. | Bipolar electrode with fluid channels for less invasive neurosurgery |
US6122549A (en) | 1996-08-13 | 2000-09-19 | Oratec Interventions, Inc. | Apparatus for treating intervertebral discs with resistive energy |
US7270661B2 (en) | 1995-11-22 | 2007-09-18 | Arthocare Corporation | Electrosurgical apparatus and methods for treatment and removal of tissue |
US6228078B1 (en) | 1995-11-22 | 2001-05-08 | Arthrocare Corporation | Methods for electrosurgical dermatological treatment |
US6896672B1 (en) | 1995-11-22 | 2005-05-24 | Arthrocare Corporation | Methods for electrosurgical incisions on external skin surfaces |
US6461350B1 (en) | 1995-11-22 | 2002-10-08 | Arthrocare Corporation | Systems and methods for electrosurgical-assisted lipectomy |
US6228082B1 (en) | 1995-11-22 | 2001-05-08 | Arthrocare Corporation | Systems and methods for electrosurgical treatment of vascular disorders |
US6805130B2 (en) | 1995-11-22 | 2004-10-19 | Arthrocare Corporation | Methods for electrosurgical tendon vascularization |
US5735811A (en) | 1995-11-30 | 1998-04-07 | Pharmasonics, Inc. | Apparatus and methods for ultrasonically enhanced fluid delivery |
US6013076A (en) | 1996-01-09 | 2000-01-11 | Gyrus Medical Limited | Electrosurgical instrument |
US6036713A (en) | 1996-01-24 | 2000-03-14 | Archimedes Surgical, Inc. | Instruments and methods for minimally invasive vascular procedures |
US5800379A (en) | 1996-02-23 | 1998-09-01 | Sommus Medical Technologies, Inc. | Method for ablating interior sections of the tongue |
US5820580A (en) | 1996-02-23 | 1998-10-13 | Somnus Medical Technologies, Inc. | Method for ablating interior sections of the tongue |
US5800482A (en) | 1996-03-06 | 1998-09-01 | Cardiac Pathways Corporation | Apparatus and method for linear lesion ablation |
US6032077A (en) | 1996-03-06 | 2000-02-29 | Cardiac Pathways Corporation | Ablation catheter with electrical coupling via foam drenched with a conductive fluid |
US5830179A (en) | 1996-04-09 | 1998-11-03 | Endocare, Inc. | Urological stent therapy system and method |
US7604633B2 (en) | 1996-04-12 | 2009-10-20 | Cytyc Corporation | Moisture transport system for contact electrocoagulation |
US6813520B2 (en) | 1996-04-12 | 2004-11-02 | Novacept | Method for ablating and/or coagulating tissue using moisture transport |
US5769880A (en) | 1996-04-12 | 1998-06-23 | Novacept | Moisture transport system for contact electrocoagulation |
US5989249A (en) | 1996-04-29 | 1999-11-23 | Kirwan Surgical Products, Inc. | Bipolar suction coagulator |
US6077257A (en) | 1996-05-06 | 2000-06-20 | Vidacare, Inc. | Ablation of rectal and other internal body structures |
US6419673B1 (en) | 1996-05-06 | 2002-07-16 | Stuart Edwards | Ablation of rectal and other internal body structures |
US20050245894A1 (en) | 1996-05-20 | 2005-11-03 | Medtronic Vascular, Inc. | Methods and apparatuses for drug delivery to an intravascular occlusion |
IT1283090B1 (en) | 1996-06-04 | 1998-04-07 | Imr Srl | LOW PRESSURE SHELL CASTING PLANT, WITH INCREASED POTENTIALITY |
GB2314274A (en) | 1996-06-20 | 1997-12-24 | Gyrus Medical Ltd | Electrode construction for an electrosurgical instrument |
GB9612993D0 (en) | 1996-06-20 | 1996-08-21 | Gyrus Medical Ltd | Electrosurgical instrument |
US7104986B2 (en) | 1996-07-16 | 2006-09-12 | Arthrocare Corporation | Intervertebral disc replacement method |
US6726684B1 (en) | 1996-07-16 | 2004-04-27 | Arthrocare Corporation | Methods for electrosurgical spine surgery |
US6620155B2 (en) | 1996-07-16 | 2003-09-16 | Arthrocare Corp. | System and methods for electrosurgical tissue contraction within the spine |
US7357798B2 (en) | 1996-07-16 | 2008-04-15 | Arthrocare Corporation | Systems and methods for electrosurgical prevention of disc herniations |
US6468274B1 (en) | 1996-07-16 | 2002-10-22 | Arthrocare Corporation | Systems and methods for treating spinal pain |
US5976123A (en) | 1996-07-30 | 1999-11-02 | Laser Aesthetics, Inc. | Heart stabilization |
US6102885A (en) | 1996-08-08 | 2000-08-15 | Bass; Lawrence S. | Device for suction-assisted lipectomy and method of using same |
US6126682A (en) | 1996-08-13 | 2000-10-03 | Oratec Interventions, Inc. | Method for treating annular fissures in intervertebral discs |
US5891134A (en) | 1996-09-24 | 1999-04-06 | Goble; Colin | System and method for applying thermal energy to tissue |
EP1602338B1 (en) | 1996-10-02 | 2011-12-07 | Medtronic, Inc. | Fluid-assisted electrocautery device |
US5986662A (en) | 1996-10-16 | 1999-11-16 | Vital Images, Inc. | Advanced diagnostic viewer employing automated protocol selection for volume-rendered imaging |
US5752965A (en) | 1996-10-21 | 1998-05-19 | Bio-Vascular, Inc. | Apparatus and method for producing a reinforced surgical fastener suture line |
US6719755B2 (en) | 1996-10-22 | 2004-04-13 | Epicor Medical, Inc. | Methods and devices for ablation |
US5827268A (en) | 1996-10-30 | 1998-10-27 | Hearten Medical, Inc. | Device for the treatment of patent ductus arteriosus and method of using the device |
US5954714A (en) | 1996-11-20 | 1999-09-21 | Gynecare, Inc. | Heated balloon having rotary fluid impeller |
US5782914A (en) | 1996-11-29 | 1998-07-21 | Bio-Vascular, Inc. | Method for preparing heterogeneous tissue grafts |
US5885243A (en) | 1996-12-11 | 1999-03-23 | Alcon Laboratories, Inc. | Liquefaction handpiece |
US6394996B1 (en) | 1997-01-07 | 2002-05-28 | C. R. Bard, Inc. | System for aspirating and irrigating tract wounds |
US5879329A (en) | 1997-01-22 | 1999-03-09 | Radiant Medical, Inc. | Infusion systems and methods for introducing fluids into the body within a desired temperature range |
US5861005A (en) | 1997-02-11 | 1999-01-19 | X-Site, L.L.C. | Arterial stapling device |
US6699244B2 (en) | 1997-02-12 | 2004-03-02 | Oratec Interventions, Inc. | Electrosurgical instrument having a chamber to volatize a liquid |
US6017361A (en) | 1997-03-13 | 2000-01-25 | Endo Care, Inc. | Urethral warming catheter |
US6086582A (en) | 1997-03-13 | 2000-07-11 | Altman; Peter A. | Cardiac drug delivery system |
USRE41801E1 (en) | 1997-03-31 | 2010-10-05 | Nextreme Thermal Solutions, Inc. | Thin-film thermoelectric device and fabrication method of same |
US6083255A (en) | 1997-04-07 | 2000-07-04 | Broncus Technologies, Inc. | Bronchial stenter |
US6273907B1 (en) | 1997-04-07 | 2001-08-14 | Broncus Technologies, Inc. | Bronchial stenter |
US6634363B1 (en) | 1997-04-07 | 2003-10-21 | Broncus Technologies, Inc. | Methods of treating lungs having reversible obstructive pulmonary disease |
US6488673B1 (en) | 1997-04-07 | 2002-12-03 | Broncus Technologies, Inc. | Method of increasing gas exchange of a lung |
US5972026A (en) | 1997-04-07 | 1999-10-26 | Broncus Technologies, Inc. | Bronchial stenter having diametrically adjustable electrodes |
US6200333B1 (en) | 1997-04-07 | 2001-03-13 | Broncus Technologies, Inc. | Bronchial stenter |
US5871481A (en) | 1997-04-11 | 1999-02-16 | Vidamed, Inc. | Tissue ablation apparatus and method |
US5873877A (en) | 1997-04-11 | 1999-02-23 | Vidamed, Inc. | Medical probe device with transparent distal extremity |
US5964756A (en) | 1997-04-11 | 1999-10-12 | Vidamed, Inc. | Transurethral needle ablation device with replaceable stylet cartridge |
US5891457A (en) | 1997-05-12 | 1999-04-06 | Neuwirth; Robert S. | Intrauterine chemical necrosing method, composition, and apparatus |
US5913856A (en) | 1997-05-19 | 1999-06-22 | Irvine Biomedical, Inc. | Catheter system having a porous shaft and fluid irrigation capabilities |
US7025762B2 (en) | 1997-05-23 | 2006-04-11 | Crymed Technologies, Inc. | Method and apparatus for cryogenic spray ablation of gastrointestinal mucosa |
AU7141198A (en) | 1997-06-13 | 1998-12-30 | Arthrocare Corporation | Electrosurgical systems and methods for recanalization of occluded body lumens |
US5938660A (en) | 1997-06-27 | 1999-08-17 | Daig Corporation | Process and device for the treatment of atrial arrhythmia |
US5957919A (en) | 1997-07-02 | 1999-09-28 | Laufer; Michael D. | Bleb reducer |
US6652515B1 (en) | 1997-07-08 | 2003-11-25 | Atrionix, Inc. | Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall |
IL133901A (en) * | 1997-07-08 | 2005-09-25 | Univ Emory | Circumferential ablation device assembly and method |
US6139571A (en) | 1997-07-09 | 2000-10-31 | Fuller Research Corporation | Heated fluid surgical instrument |
US6096037A (en) | 1997-07-29 | 2000-08-01 | Medtronic, Inc. | Tissue sealing electrosurgery device and methods of sealing tissue |
US6080151A (en) | 1997-07-21 | 2000-06-27 | Daig Corporation | Ablation catheter |
EP1014873A4 (en) | 1997-09-22 | 2003-07-09 | Ethicon Inc | Cryosurgical system and method |
US6045549A (en) | 1997-09-30 | 2000-04-04 | Somnus Medical Technologies, Inc. | Tissue ablation apparatus and device for use therein and method |
US6238389B1 (en) | 1997-09-30 | 2001-05-29 | Boston Scientific Corporation | Deflectable interstitial ablation device |
US7094215B2 (en) | 1997-10-02 | 2006-08-22 | Arthrocare Corporation | Systems and methods for electrosurgical tissue contraction |
US6139538A (en) | 1997-10-06 | 2000-10-31 | Iotek, Inc. | Iontophoretic agent delivery to the female reproductive tract |
CA2308290A1 (en) | 1997-10-30 | 1999-05-14 | Sonique Surgical Systems, Inc. | Laser-assisted liposuction method and apparatus |
US6130671A (en) | 1997-11-26 | 2000-10-10 | Vital Images, Inc. | Volume rendering lighting using dot product methodology |
US5964752A (en) | 1998-02-02 | 1999-10-12 | Stone; Kevin R. | Articular cartilage surface shaping apparatus and method |
US6440127B2 (en) | 1998-02-11 | 2002-08-27 | Cosman Company, Inc. | Method for performing intraurethral radio-frequency urethral enlargement |
US6258087B1 (en) | 1998-02-19 | 2001-07-10 | Curon Medical, Inc. | Expandable electrode assemblies for forming lesions to treat dysfunction in sphincters and adjoining tissue regions |
US6273886B1 (en) * | 1998-02-19 | 2001-08-14 | Curon Medical, Inc. | Integrated tissue heating and cooling apparatus |
US6045532A (en) | 1998-02-20 | 2000-04-04 | Arthrocare Corporation | Systems and methods for electrosurgical treatment of tissue in the brain and spinal cord |
AU3007299A (en) | 1998-03-17 | 1999-10-11 | Gary S. Kochamba | Method and apparatus for stabilizing tissue |
EP1064031B1 (en) | 1998-03-23 | 2002-02-06 | Bio-Vascular, Inc. | Implants and method of making |
GB9807303D0 (en) | 1998-04-03 | 1998-06-03 | Gyrus Medical Ltd | An electrode assembly for an electrosurgical instrument |
US8016823B2 (en) | 2003-01-18 | 2011-09-13 | Tsunami Medtech, Llc | Medical instrument and method of use |
US6508816B2 (en) | 1998-03-27 | 2003-01-21 | John H. Shadduck | Medical instrument working end creating very high pressure gradients |
US6210404B1 (en) | 1998-10-28 | 2001-04-03 | John H. Shadduck | Microjoule electrical discharge catheter for thrombolysis in stroke patients |
US6911028B2 (en) | 1998-10-28 | 2005-06-28 | John H. Shadduck | Medical instrument working end and method for endoluminal treatments |
US7674259B2 (en) | 2000-12-09 | 2010-03-09 | Tsunami Medtech | Medical instruments and techniques for thermally-mediated therapies |
US6053909A (en) | 1998-03-27 | 2000-04-25 | Shadduck; John H. | Ionothermal delivery system and technique for medical procedures |
US7892229B2 (en) | 2003-01-18 | 2011-02-22 | Tsunami Medtech, Llc | Medical instruments and techniques for treating pulmonary disorders |
US6669694B2 (en) | 2000-09-05 | 2003-12-30 | John H. Shadduck | Medical instruments and techniques for highly-localized thermally-mediated therapies |
US6047700A (en) | 1998-03-30 | 2000-04-11 | Arthrocare Corporation | Systems and methods for electrosurgical removal of calcified deposits |
US6522930B1 (en) | 1998-05-06 | 2003-02-18 | Atrionix, Inc. | Irrigated ablation device assembly |
US6327505B1 (en) | 1998-05-07 | 2001-12-04 | Medtronic, Inc. | Method and apparatus for rf intraluminal reduction and occlusion |
US6493589B1 (en) | 1998-05-07 | 2002-12-10 | Medtronic, Inc. | Methods and apparatus for treatment of pulmonary conditions |
US6216703B1 (en) | 1998-05-08 | 2001-04-17 | Thermatrx, Inc. | Therapeutic prostatic thermotherapy |
US6740082B2 (en) | 1998-12-29 | 2004-05-25 | John H. Shadduck | Surgical instruments for treating gastro-esophageal reflux |
US6763836B2 (en) | 1998-06-02 | 2004-07-20 | Arthrocare Corporation | Methods for electrosurgical tendon vascularization |
US6206848B1 (en) | 1998-06-04 | 2001-03-27 | Alcon Laboratories, Inc. | Liquefracture handpiece |
US6676628B2 (en) | 1998-06-04 | 2004-01-13 | Alcon Manufacturing, Ltd. | Pumping chamber for a liquefracture handpiece |
US6080128A (en) | 1998-06-04 | 2000-06-27 | Alcon Laboratories, Inc. | Liquefaction handpiece |
US6860868B1 (en) | 1998-06-04 | 2005-03-01 | Alcon Manufacturing, Ltd. | Surgical handpiece |
US5989212A (en) | 1998-06-04 | 1999-11-23 | Alcon Laboratories, Inc. | Pumping chamber for a liquefaction handpiece having a countersink electrode |
US5997499A (en) | 1998-06-04 | 1999-12-07 | Alcon Laboratories, Inc. | Tip for a liquefaction handpiece |
US6579270B2 (en) | 1998-06-04 | 2003-06-17 | Alcon Manufacturing, Ltd. | Liquefracture handpiece tip |
US6196989B1 (en) | 1998-06-04 | 2001-03-06 | Alcon Laboratories, Inc. | Tip for liquefracture handpiece |
US6331171B1 (en) | 1998-06-04 | 2001-12-18 | Alcon Laboratories, Inc. | Tip for a liquefracture handpiece |
US6398759B1 (en) | 1998-06-04 | 2002-06-04 | Alcon Manufacturing, Ltd. | Liquefracture handpiece tip |
US6589201B1 (en) | 1998-06-04 | 2003-07-08 | Alcon Manufacturing, Ltd. | Liquefracture handpiece tip |
US20020161326A1 (en) | 1998-06-04 | 2002-10-31 | Glenn Sussman | Tip for a liquefracture handpiece |
US6179805B1 (en) | 1998-06-04 | 2001-01-30 | Alcon Laboratories, Inc. | Liquefracture handpiece |
US6315755B1 (en) | 1998-06-04 | 2001-11-13 | Alcon Manufacturing, Ltd. | Method of controlling a liquefracture handpiece |
US6599311B1 (en) | 1998-06-05 | 2003-07-29 | Broncus Technologies, Inc. | Method and assembly for lung volume reduction |
US6066132A (en) | 1998-06-30 | 2000-05-23 | Ethicon, Inc. | Articulating endometrial ablation device |
US6099251A (en) | 1998-07-06 | 2000-08-08 | United Technologies Corporation | Coolable airfoil for a gas turbine engine |
US6112123A (en) | 1998-07-28 | 2000-08-29 | Endonetics, Inc. | Device and method for ablation of tissue |
US7276063B2 (en) | 1998-08-11 | 2007-10-02 | Arthrocare Corporation | Instrument for electrosurgical tissue treatment |
US7435247B2 (en) | 1998-08-11 | 2008-10-14 | Arthrocare Corporation | Systems and methods for electrosurgical tissue treatment |
WO2000019926A1 (en) | 1998-10-05 | 2000-04-13 | Scimed Life Systems, Inc. | Large area thermal ablation |
DE69929528T2 (en) | 1998-11-17 | 2006-09-14 | Henri Mehier | DEVICE FOR INTRODUCING A MEDICAMENT IN A TISSUE MEMBRANE, IMPLANTING DEVICE AND INJECTION DEVICE |
GB9828696D0 (en) | 1998-12-29 | 1999-02-17 | Houston J G | Blood-flow tubing |
US6113593A (en) | 1999-02-01 | 2000-09-05 | Tu; Lily Chen | Ablation apparatus having temperature and force sensing capabilities |
US6458231B1 (en) | 1999-03-17 | 2002-10-01 | The United States Of America As Represented By The Secretary Of The Air Force | Method of making microtubes with axially variable geometries |
US6299620B1 (en) | 1999-03-18 | 2001-10-09 | Aq Technologies, Inc. | Instruments and techniques for inducing neocollagenesis in skin treatments |
US6162232A (en) | 1999-03-18 | 2000-12-19 | Shadduck; John H. | Instruments and techniques for high-velocity fluid abrasion of epidermal layers with skin cooling |
DE19912844A1 (en) | 1999-03-22 | 2000-09-28 | Saphir Medical Products Gmbh | Use of a cutting device, which uses a fluid as cutting medium, for surgical treatment |
US6409723B1 (en) | 1999-04-02 | 2002-06-25 | Stuart D. Edwards | Treating body tissue by applying energy and substances |
US6527766B1 (en) | 1999-04-28 | 2003-03-04 | Georgia Tech Research Corporation | Instrument and method for phacoemulsification by direct thermal irradiation |
DE60033232T2 (en) | 1999-05-11 | 2007-11-15 | Atrionix Inc., Palo Alto | BALLOON ANCHOR WIRE |
US6375635B1 (en) | 1999-05-18 | 2002-04-23 | Hydrocision, Inc. | Fluid jet surgical instruments |
GB9911956D0 (en) | 1999-05-21 | 1999-07-21 | Gyrus Medical Ltd | Electrosurgery system and method |
US6156036A (en) | 1999-06-11 | 2000-12-05 | Alcon Laboratories, Inc. | Surgical handpiece tip |
US7022088B2 (en) | 1999-08-05 | 2006-04-04 | Broncus Technologies, Inc. | Devices for applying energy to tissue |
EP1151729A1 (en) | 1999-08-05 | 2001-11-07 | Broncus Technologies, Inc. | Methods and devices for creating collateral channels in the lungs |
US6712812B2 (en) | 1999-08-05 | 2004-03-30 | Broncus Technologies, Inc. | Devices for creating collateral channels |
US6610043B1 (en) | 1999-08-23 | 2003-08-26 | Bistech, Inc. | Tissue volume reduction |
US20020087155A1 (en) | 1999-08-30 | 2002-07-04 | Underwood Ronald A. | Systems and methods for intradermal collagen stimulation |
US6312474B1 (en) | 1999-09-15 | 2001-11-06 | Bio-Vascular, Inc. | Resorbable implant materials |
US6379350B1 (en) | 1999-10-05 | 2002-04-30 | Oratec Interventions, Inc. | Surgical instrument for ablation and aspiration |
AU775490B2 (en) | 1999-10-05 | 2004-08-05 | Omnisonics Medical Technologies, Inc. | Method and apparatus for ultrasonic medical treatment, in particular, for debulking the prostate |
AU7985700A (en) | 1999-10-14 | 2001-04-23 | Trustees Of Boston University | Variable peak pressure ventilation method and system |
US6398775B1 (en) | 1999-10-21 | 2002-06-04 | Pulmonx | Apparatus and method for isolated lung access |
US20060095032A1 (en) * | 1999-11-16 | 2006-05-04 | Jerome Jackson | Methods and systems for determining physiologic characteristics for treatment of the esophagus |
US6558379B1 (en) | 1999-11-18 | 2003-05-06 | Gyrus Medical Limited | Electrosurgical system |
US6575932B1 (en) | 1999-12-02 | 2003-06-10 | Ottawa Heart Institute | Adjustable multi-balloon local delivery device |
US6277130B1 (en) | 1999-12-14 | 2001-08-21 | John H. Shadduck | Electrical discharge surgical fastener for meniscal repairs |
US20020013601A1 (en) | 2000-01-28 | 2002-01-31 | Nobles Anthony A. | Cavity enlarger method and apparatus |
US6758846B2 (en) | 2000-02-08 | 2004-07-06 | Gyrus Medical Limited | Electrosurgical instrument and an electrosurgery system including such an instrument |
US6558314B1 (en) | 2000-02-11 | 2003-05-06 | Iotek, Inc. | Devices and method for manipulation of organ tissue |
US6629974B2 (en) | 2000-02-22 | 2003-10-07 | Gyrus Medical Limited | Tissue treatment method |
US6673071B2 (en) | 2000-02-24 | 2004-01-06 | Vandusseldorp Gregg A. | Partial ablation procedure and device therefor |
US6551274B2 (en) | 2000-02-29 | 2003-04-22 | Biosense Webster, Inc. | Cryoablation catheter with an expandable cooling chamber |
US6443947B1 (en) | 2000-03-01 | 2002-09-03 | Alexei Marko | Device for thermal ablation of a cavity |
US20030070683A1 (en) | 2000-03-04 | 2003-04-17 | Deem Mark E. | Methods and devices for use in performing pulmonary procedures |
US6679264B1 (en) | 2000-03-04 | 2004-01-20 | Emphasys Medical, Inc. | Methods and devices for use in performing pulmonary procedures |
WO2001066026A2 (en) | 2000-03-06 | 2001-09-13 | Tissuelink Medical, Inc. | Fluid delivery system and controller for electrosurgical devices |
US6558385B1 (en) | 2000-09-22 | 2003-05-06 | Tissuelink Medical, Inc. | Fluid-assisted medical device |
US6575929B2 (en) | 2000-03-14 | 2003-06-10 | Alcon Manufacturing, Ltd. | Pumping chamber for a liquefaction handpiece |
US6510854B2 (en) | 2000-03-16 | 2003-01-28 | Gyrus Medical Limited | Method of treatment of prostatic adenoma |
US6770070B1 (en) | 2000-03-17 | 2004-08-03 | Rita Medical Systems, Inc. | Lung treatment apparatus and method |
US7470228B2 (en) | 2000-04-14 | 2008-12-30 | Attenuex Technologies, Inc. | Method of treating benign hypertrophy of the prostate |
US6755794B2 (en) | 2000-04-25 | 2004-06-29 | Synovis Life Technologies, Inc. | Adjustable stylet |
EP1278480A2 (en) | 2000-04-25 | 2003-01-29 | Impres Medical, Inc. | Method and apparatus for creating intrauterine adhesions |
US6652517B1 (en) | 2000-04-25 | 2003-11-25 | Uab Research Foundation | Ablation catheter, system, and method of use thereof |
US6488680B1 (en) | 2000-04-27 | 2002-12-03 | Medtronic, Inc. | Variable length electrodes for delivery of irrigated ablation |
US6837886B2 (en) | 2000-05-03 | 2005-01-04 | C.R. Bard, Inc. | Apparatus and methods for mapping and ablation in electrophysiology procedures |
EP1289415A4 (en) | 2000-05-18 | 2008-12-03 | Nuvasive Inc | Tissue discrimination and applications in medical procedures |
WO2001095820A1 (en) | 2000-06-13 | 2001-12-20 | Atrionix, Inc. | Surgical ablation probe for forming a circumferential lesion |
US6726708B2 (en) | 2000-06-14 | 2004-04-27 | Innercool Therapies, Inc. | Therapeutic heating and cooling via temperature management of a colon-inserted balloon |
US6716252B2 (en) | 2000-06-30 | 2004-04-06 | Wit Ip Corporation | Prostatic stent with localized tissue engaging anchoring means and methods for inhibiting obstruction of the prostatic urethra |
WO2002004061A1 (en) | 2000-07-12 | 2002-01-17 | Mitsubishi Pencil Kabushiki Kaisha | Safe retained needle |
US6647300B1 (en) | 2000-07-28 | 2003-11-11 | Rockwell Automation Technologies, Inc. | Bidding partner cache for autonomous cooperative control system |
US6679879B2 (en) | 2000-08-16 | 2004-01-20 | John H. Shadduck | Electrical discharge catheter system for extracting emboli in endovascular interventions |
US6569146B1 (en) | 2000-08-18 | 2003-05-27 | Scimed Life Systems, Inc. | Method and apparatus for treating saphenous vein graft lesions |
US6669692B1 (en) | 2000-08-21 | 2003-12-30 | Biosense Webster, Inc. | Ablation catheter with cooled linear electrode |
JP2002078809A (en) | 2000-09-07 | 2002-03-19 | Shutaro Satake | Balloon catheter for electrically isolating pulmonary vein |
US7031504B1 (en) | 2000-09-26 | 2006-04-18 | Vital Images, Inc. | Image data based retrospective temporal selection of medical images |
US20030158545A1 (en) | 2000-09-28 | 2003-08-21 | Arthrocare Corporation | Methods and apparatus for treating back pain |
US6551300B1 (en) | 2000-10-04 | 2003-04-22 | Vidamed, Inc. | Device and method for delivery of topically applied local anesthetic to wall forming a passage in tissue |
US6527761B1 (en) | 2000-10-27 | 2003-03-04 | Pulmonx, Inc. | Methods and devices for obstructing and aspirating lung tissue segments |
US6585639B1 (en) | 2000-10-27 | 2003-07-01 | Pulmonx | Sheath and method for reconfiguring lung viewing scope |
US6455825B1 (en) | 2000-11-21 | 2002-09-24 | Sandia Corporation | Use of miniature magnetic sensors for real-time control of the induction heating process |
US7225040B2 (en) | 2001-11-14 | 2007-05-29 | Exxon Mobil Oil Corporation | Method and system for reducing lead-time in the packaging industry |
US7549987B2 (en) | 2000-12-09 | 2009-06-23 | Tsunami Medtech, Llc | Thermotherapy device |
US9433457B2 (en) | 2000-12-09 | 2016-09-06 | Tsunami Medtech, Llc | Medical instruments and techniques for thermally-mediated therapies |
US6681998B2 (en) | 2000-12-22 | 2004-01-27 | Chrysalis Technologies Incorporated | Aerosol generator having inductive heater and method of use thereof |
US20020087151A1 (en) | 2000-12-29 | 2002-07-04 | Afx, Inc. | Tissue ablation apparatus with a sliding ablation instrument and method |
WO2002056794A2 (en) | 2001-01-18 | 2002-07-25 | The Brigham And Women's Hospital, Inc. | Prosthetic device for respiratory patients |
US6695839B2 (en) | 2001-02-08 | 2004-02-24 | Oratec Interventions, Inc. | Method and apparatus for treatment of disrupted articular cartilage |
US7087040B2 (en) | 2001-02-28 | 2006-08-08 | Rex Medical, L.P. | Apparatus for delivering ablation fluid to treat lesions |
US6666862B2 (en) | 2001-03-01 | 2003-12-23 | Cardiac Pacemakers, Inc. | Radio frequency ablation system and method linking energy delivery with fluid flow |
US7798147B2 (en) | 2001-03-02 | 2010-09-21 | Pulmonx Corporation | Bronchial flow control devices with membrane seal |
US6623444B2 (en) | 2001-03-21 | 2003-09-23 | Advanced Medical Applications, Inc. | Ultrasonic catheter drug delivery method and device |
US6726696B1 (en) | 2001-04-24 | 2004-04-27 | Advanced Catheter Engineering, Inc. | Patches and collars for medical applications and methods of use |
US6551271B2 (en) | 2001-04-30 | 2003-04-22 | Biosense Webster, Inc. | Asymmetrical bidirectional steerable catheter |
JP4252316B2 (en) | 2001-05-10 | 2009-04-08 | リタ メディカル システムズ インコーポレイテッド | RF tissue excision apparatus and method |
DE60230261D1 (en) | 2001-05-23 | 2009-01-22 | Vital Images Inc | COVER MASKING FOR VOLUME PRESENTATION AN OBJECT ORDER |
US6837884B2 (en) | 2001-06-18 | 2005-01-04 | Arthrocare Corporation | Electrosurgical apparatus having compound return electrode |
US6860847B2 (en) | 2001-07-10 | 2005-03-01 | Spiration, Inc. | Constriction device viewable under X ray fluoroscopy |
US20030097035A1 (en) | 2001-07-18 | 2003-05-22 | Tucker Robert D. | Combination radiation and thermal energy source |
JP2004536650A (en) | 2001-07-27 | 2004-12-09 | ダブリュ アイ ティー アイ ピー コーポレーション | How to treat prostatitis |
US7130697B2 (en) | 2002-08-13 | 2006-10-31 | Minnesota Medical Physics Llc | Apparatus and method for the treatment of benign prostatic hyperplasia |
US6827718B2 (en) | 2001-08-14 | 2004-12-07 | Scimed Life Systems, Inc. | Method of and apparatus for positioning and maintaining the position of endoscopic instruments |
US6776765B2 (en) | 2001-08-21 | 2004-08-17 | Synovis Life Technologies, Inc. | Steerable stylet |
AU2002336575A1 (en) | 2001-09-14 | 2003-04-01 | Arthrocare Corporation | Electrosurgical apparatus and methods for tissue treatment and removal |
AU2002362310A1 (en) | 2001-09-14 | 2003-04-01 | Arthrocare Corporation | Methods and apparatus for treating intervertebral discs |
JP3607231B2 (en) | 2001-09-28 | 2005-01-05 | 有限会社日本エレクテル | High frequency heating balloon catheter |
EP1437977B1 (en) | 2001-10-02 | 2014-05-21 | ArthroCare Corporation | Apparatus for electrosurgical removal and digestion of tissue |
EP1433208A4 (en) | 2001-10-05 | 2008-02-20 | Nextreme Thermal Solutions Inc | Phonon-blocking, electron-transmitting low-dimensional structures |
WO2003030975A2 (en) | 2001-10-11 | 2003-04-17 | Emphasys Medical, Inc. | Bronchial flow control devices and methods of use |
EP1434530A2 (en) | 2001-10-12 | 2004-07-07 | AMS Research Corporation | Surgical instrument and method |
US6592594B2 (en) | 2001-10-25 | 2003-07-15 | Spiration, Inc. | Bronchial obstruction device deployment system and method |
US20030130738A1 (en) | 2001-11-08 | 2003-07-10 | Arthrocare Corporation | System and method for repairing a damaged intervertebral disc |
US7004941B2 (en) | 2001-11-08 | 2006-02-28 | Arthrocare Corporation | Systems and methods for electrosurigical treatment of obstructive sleep disorders |
US8444636B2 (en) | 2001-12-07 | 2013-05-21 | Tsunami Medtech, Llc | Medical instrument and method of use |
US6740081B2 (en) | 2002-01-25 | 2004-05-25 | Applied Medical Resources Corporation | Electrosurgery with improved control apparatus and method |
EP1474203B1 (en) | 2002-02-13 | 2016-06-15 | ArthroCare Corporation | Electrosurgical apparatus for treating joint tissue |
FR2836047B1 (en) | 2002-02-21 | 2004-04-02 | Henri Mehier | FACILITY FOR DELIVERING CALORIES IN ALL OR PART OF A HUMAN OR ANIMAL CELLULAR FABRIC |
US6929637B2 (en) | 2002-02-21 | 2005-08-16 | Spiration, Inc. | Device and method for intra-bronchial provision of a therapeutic agent |
US6896675B2 (en) | 2002-03-05 | 2005-05-24 | Baylis Medical Company Inc. | Intradiscal lesioning device |
US6528771B1 (en) | 2002-03-08 | 2003-03-04 | The Boeing Company | System and method for controlling an induction heating process |
US20030181922A1 (en) | 2002-03-20 | 2003-09-25 | Spiration, Inc. | Removable anchored lung volume reduction devices and methods |
US7128748B2 (en) | 2002-03-26 | 2006-10-31 | Synovis Life Technologies, Inc. | Circular stapler buttress combination |
US7288109B2 (en) | 2002-04-04 | 2007-10-30 | Innercool Therapies. Inc. | Method of manufacturing a heat transfer element for in vivo cooling without undercuts |
US7653438B2 (en) | 2002-04-08 | 2010-01-26 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US8145316B2 (en) * | 2002-04-08 | 2012-03-27 | Ardian, Inc. | Methods and apparatus for renal neuromodulation |
US6955674B2 (en) | 2002-04-11 | 2005-10-18 | Medtronic, Inc. | Medical ablation catheter control |
EP3189781A1 (en) | 2002-04-17 | 2017-07-12 | Covidien LP | Endoscope structures and techniques for navigating to a target in branched structure |
US7503904B2 (en) | 2002-04-25 | 2009-03-17 | Cardiac Pacemakers, Inc. | Dual balloon telescoping guiding catheter |
US6780178B2 (en) | 2002-05-03 | 2004-08-24 | The Board Of Trustees Of The Leland Stanford Junior University | Method and apparatus for plasma-mediated thermo-electrical ablation |
US6588613B1 (en) | 2002-05-13 | 2003-07-08 | The United States Of America As Represented By The Secretary Of The Air Force | Baby-feeding nipple |
US6852108B2 (en) | 2002-05-14 | 2005-02-08 | Spiration, Inc. | Apparatus and method for resecting and removing selected body tissue from a site inside a patient |
US20030216729A1 (en) | 2002-05-20 | 2003-11-20 | Marchitto Kevin S. | Device and method for wound healing and uses therefor |
TWI328164B (en) | 2002-05-29 | 2010-08-01 | Tokyo Electron Ltd | Method and apparatus for monitoring tool performance |
JP4808961B2 (en) | 2002-06-04 | 2011-11-02 | オフィス オブ テクノロジー ライセンシング スタンフォード ユニバーシティ | Device for rapidly aspirating and collecting body tissue from an encapsulated body space |
US6967315B2 (en) | 2002-06-12 | 2005-11-22 | Steris Inc. | Method for vaporizing a fluid using an electromagnetically responsive heating apparatus |
US6734405B2 (en) | 2002-06-12 | 2004-05-11 | Steris Inc. | Vaporizer using electrical induction to produce heat |
WO2003105676A2 (en) | 2002-06-17 | 2003-12-24 | Bistech, Inc. | Compositions and methods for reducing lung volume |
US6960203B2 (en) | 2002-06-26 | 2005-11-01 | Ethicon, Inc. | Thermal ablation with deployable cage |
US6929642B2 (en) | 2002-06-28 | 2005-08-16 | Ethicon, Inc. | RF device for treating the uterus |
US7458967B2 (en) | 2003-10-31 | 2008-12-02 | Angiodynamics, Inc. | Endovascular treatment apparatus and method |
US6730079B2 (en) | 2002-07-22 | 2004-05-04 | Medtronic Vidamed, Inc. | Method for calculating impedance and apparatus utilizing same |
US6866662B2 (en) | 2002-07-23 | 2005-03-15 | Biosense Webster, Inc. | Ablation catheter having stabilizing array |
US6921385B2 (en) | 2002-08-05 | 2005-07-26 | Alcon, Inc. | Apparatus for delivery of fluid to opthalmic surgical handpiece |
US20040116922A1 (en) | 2002-09-05 | 2004-06-17 | Arthrocare Corporation | Methods and apparatus for treating intervertebral discs |
US7101367B2 (en) | 2002-09-30 | 2006-09-05 | Ethicon, Inc. | Deployable cryosurgical catheter |
US7004940B2 (en) | 2002-10-10 | 2006-02-28 | Ethicon, Inc. | Devices for performing thermal ablation having movable ultrasound transducers |
US7192400B2 (en) | 2002-10-24 | 2007-03-20 | Synovis Life Technologies, Inc. | Device and method for vascular monitoring |
US6905496B1 (en) | 2002-11-01 | 2005-06-14 | Alan G. Ellman | RF electrosurgery cryogenic system |
AU2003295853A1 (en) | 2002-11-21 | 2004-06-18 | Timothy B. Hibler | Cervical medical device, system and method |
US6918869B2 (en) | 2002-12-02 | 2005-07-19 | Scimed Life Systems | System for administering a combination of therapies to a body lumen |
WO2004050171A2 (en) | 2002-12-03 | 2004-06-17 | Arthrocare Corporation | Devices and methods for selective orientation of electrosurgical devices |
US6972014B2 (en) | 2003-01-04 | 2005-12-06 | Endocare, Inc. | Open system heat exchange catheters and methods of use |
US7083612B2 (en) | 2003-01-15 | 2006-08-01 | Cryodynamics, Llc | Cryotherapy system |
US7144588B2 (en) | 2003-01-17 | 2006-12-05 | Synovis Life Technologies, Inc. | Method of preventing surgical adhesions |
JP4067976B2 (en) | 2003-01-24 | 2008-03-26 | 有限会社日本エレクテル | High frequency heating balloon catheter |
EP1596705B1 (en) | 2003-02-05 | 2018-09-12 | Arthrocare Corporation | Temperature indicating electrosurgical apparatus |
AU2003301144A1 (en) | 2003-02-14 | 2004-09-09 | Alcon, Inc. | Apparatus and method for determining that a surgical fluid container is near empty |
WO2004073546A2 (en) | 2003-02-14 | 2004-09-02 | Alcon, Inc., | Apparatus and method for determining that a surgical fluid container is near empty |
US6875194B2 (en) | 2003-02-25 | 2005-04-05 | Alcon, Inc. | Reduction or elimination of the introduction of air within fluid introduced into a surgical field |
US20040230316A1 (en) | 2003-05-12 | 2004-11-18 | Iulian Cioanta | Method for treating the prostate and inhibiting obstruction of the prostatic urethra using biodegradable stents |
US20040230188A1 (en) | 2003-05-12 | 2004-11-18 | Iulian Cioanta | Treatment catheters with thermally insulated regions |
US7144402B2 (en) | 2003-06-16 | 2006-12-05 | Synovis Life Technologies, Inc. | Vascular clamp |
US7235070B2 (en) | 2003-07-02 | 2007-06-26 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Ablation fluid manifold for ablation catheter |
US8012153B2 (en) | 2003-07-16 | 2011-09-06 | Arthrocare Corporation | Rotary electrosurgical apparatus and methods thereof |
US7220252B2 (en) | 2003-07-18 | 2007-05-22 | Polyzen, Inc. | Inflatable dual balloon catheter |
EP2316328B1 (en) | 2003-09-15 | 2012-05-09 | Super Dimension Ltd. | Wrap-around holding device for use with bronchoscopes |
ATE556643T1 (en) | 2003-09-15 | 2012-05-15 | Super Dimension Ltd | COVERING DEVICE FOR FIXING BRONCHOSCOPES |
WO2005039390A2 (en) | 2003-10-20 | 2005-05-06 | Arthrocare Corporation | Electrosurgical method and apparatus for removing tissue within a bone body |
US7347859B2 (en) | 2003-12-18 | 2008-03-25 | Boston Scientific, Scimed, Inc. | Tissue treatment system and method for tissue perfusion using feedback control |
US7381208B2 (en) | 2003-12-22 | 2008-06-03 | Ams Research Corporation | Cryosurgical devices for endometrial ablation |
JP4391221B2 (en) | 2003-12-22 | 2009-12-24 | 有限会社日本エレクテル | High frequency heating balloon catheter |
US7585295B2 (en) | 2003-12-23 | 2009-09-08 | Itos International Ltd. | Thermal airflow tool and system |
US6991028B2 (en) | 2004-01-29 | 2006-01-31 | Comeaux Vernal J | Thermal reservoir for two-pipe hydronic air-conditioning system |
US7476242B2 (en) | 2004-01-30 | 2009-01-13 | Ams Research Corporation | Electrically heated/phase change probe temperature control |
US7727228B2 (en) | 2004-03-23 | 2010-06-01 | Medtronic Cryocath Lp | Method and apparatus for inflating and deflating balloon catheters |
EP1755721A2 (en) | 2004-04-23 | 2007-02-28 | Leonard Edward Forrest | Device for treatment or evacuation of intervertebral disc |
EP1738052B1 (en) | 2004-04-23 | 2008-04-16 | Shell International Research Maatschappij B.V. | Inhibiting reflux in a heated well of an in situ conversion system |
US20050288684A1 (en) | 2004-06-16 | 2005-12-29 | Aronson Nathan A | Method of reducing collateral flow in a portion of a lung |
SE0401708D0 (en) | 2004-06-30 | 2004-06-30 | Wallsten Medical Sa | Balloon Catheter |
EP1814466A4 (en) | 2004-07-07 | 2010-11-10 | Super Dimension Ltd | Methods for localized intra-body treatment of tissue |
EP1786502A2 (en) * | 2004-07-15 | 2007-05-23 | Incumed | Device and method for treating a blood vessel |
US20060047291A1 (en) | 2004-08-20 | 2006-03-02 | Uptake Medical Corporation | Non-foreign occlusion of an airway and lung collapse |
US20060130830A1 (en) | 2004-09-07 | 2006-06-22 | Uptake Medical Corporation | Intra-bronchial implants for improved attachment |
EP1796568A1 (en) | 2004-09-09 | 2007-06-20 | Vnus Medical Technologies, Inc. | Methods and apparatus for treatment of hollow anatomical structures |
US9974607B2 (en) | 2006-10-18 | 2018-05-22 | Vessix Vascular, Inc. | Inducing desirable temperature effects on body tissue |
US7335197B2 (en) | 2004-10-13 | 2008-02-26 | Medtronic, Inc. | Transurethral needle ablation system with flexible catheter tip |
US7261710B2 (en) | 2004-10-13 | 2007-08-28 | Medtronic, Inc. | Transurethral needle ablation system |
US7261709B2 (en) | 2004-10-13 | 2007-08-28 | Medtronic, Inc. | Transurethral needle ablation system with automatic needle retraction |
US7913698B2 (en) | 2004-11-16 | 2011-03-29 | Uptake Medical Corp. | Device and method for lung treatment |
CN2757751Y (en) * | 2004-12-22 | 2006-02-15 | 赵巧 | Ablation device for solid endometrium |
EP1853188B1 (en) * | 2005-01-18 | 2020-03-11 | S.D.M.H. Pty. Ltd. | Device for thermal ablation of biological tissue using spherical ablation patterns |
FR2884149B1 (en) | 2005-04-12 | 2007-06-08 | Henri Mehier | IMPLANTABLE TUBE FOR THE INJECTION IN PARTICULAR OF HEAT PUMP FLUID IN ALL OR PART OF A HUMAN OR ANIMAL TISSUE |
US7575052B2 (en) | 2005-04-22 | 2009-08-18 | Shell Oil Company | In situ conversion process utilizing a closed loop heating system |
WO2006116130A1 (en) | 2005-04-22 | 2006-11-02 | Shell Internationale Research Maatschappij B.V. | Varying properties along lengths of temperature limited heaters |
US7896891B2 (en) | 2005-05-20 | 2011-03-01 | Neotract, Inc. | Apparatus and method for manipulating or retracting tissue and anatomical structure |
US7758594B2 (en) | 2005-05-20 | 2010-07-20 | Neotract, Inc. | Devices, systems and methods for treating benign prostatic hyperplasia and other conditions |
US8945152B2 (en) | 2005-05-20 | 2015-02-03 | Neotract, Inc. | Multi-actuating trigger anchor delivery system |
US8157815B2 (en) | 2005-05-20 | 2012-04-17 | Neotract, Inc. | Integrated handle assembly for anchor delivery system |
US7645286B2 (en) | 2005-05-20 | 2010-01-12 | Neotract, Inc. | Devices, systems and methods for retracting, lifting, compressing, supporting or repositioning tissues or anatomical structures |
US7909836B2 (en) | 2005-05-20 | 2011-03-22 | Neotract, Inc. | Multi-actuating trigger anchor delivery system |
US20070032785A1 (en) | 2005-08-03 | 2007-02-08 | Jennifer Diederich | Tissue evacuation device |
US7563010B2 (en) * | 2005-10-07 | 2009-07-21 | Karl Storz Endovision, Inc. | Endoscopic light source safety and control system with optical sensor |
JP5570723B2 (en) | 2005-10-24 | 2014-08-13 | シエル・インターナシヨネイル・リサーチ・マーチヤツピイ・ベー・ウイ | Method for producing additional crude product by cracking crude product |
EP1946712B1 (en) | 2005-11-01 | 2012-08-29 | Japan Electel Inc. | Balloon catheter system |
CN100402005C (en) * | 2005-12-22 | 2008-07-16 | 尹格平 | Multifunctional thermal coagulation therapeutic instrument for gynaecologic disease |
US7713216B2 (en) | 2006-04-10 | 2010-05-11 | Intrapartum, Llc | Method for cervical dilation and/or measurement |
US20110077628A1 (en) | 2006-01-10 | 2011-03-31 | Tsunami Medtech, Llc | Medical system and method of use |
US20070179496A1 (en) | 2006-01-31 | 2007-08-02 | Medtronic, Inc. | Flexible catheter for ablation therapy |
US20070225750A1 (en) | 2006-03-10 | 2007-09-27 | Brooke Ren | Embolic protection systems |
WO2007149622A2 (en) | 2006-04-21 | 2007-12-27 | Shell Oil Company | Sulfur barrier for use with in situ processes for treating formations |
JP4890991B2 (en) | 2006-07-31 | 2012-03-07 | 株式会社リコー | Fixing device and image forming apparatus using the same |
US8298145B2 (en) | 2006-08-01 | 2012-10-30 | Gynesonics, Inc. | Peri-capsular fibroid treatment |
AU2007310991B2 (en) | 2006-10-18 | 2013-06-20 | Boston Scientific Scimed, Inc. | System for inducing desirable temperature effects on body tissue |
US7993323B2 (en) | 2006-11-13 | 2011-08-09 | Uptake Medical Corp. | High pressure and high temperature vapor catheters and systems |
US8585645B2 (en) | 2006-11-13 | 2013-11-19 | Uptake Medical Corp. | Treatment with high temperature vapor |
US20080183036A1 (en) | 2006-12-18 | 2008-07-31 | Voyage Medical, Inc. | Systems and methods for unobstructed visualization and ablation |
CN100434047C (en) * | 2007-01-18 | 2008-11-19 | 上海交通大学 | Focal prostate cancer conformal radiofrequency ablation electrode |
US8475452B2 (en) | 2007-02-21 | 2013-07-02 | Electromedical Associates, Llc | Instruments and methods for thermal tissue treatment |
US7896871B2 (en) | 2007-02-22 | 2011-03-01 | Medtronic, Inc. | Impedance computation for ablation therapy |
US20080275440A1 (en) | 2007-05-03 | 2008-11-06 | Medtronic, Inc. | Post-ablation verification of lesion size |
FR2915872B1 (en) | 2007-05-10 | 2009-07-10 | Ct D Etude Et De Rech Medicale | INSTALLATION FOR THE INJECTION OF WATER VAPOR IN A HUMAN OR ANIMAL BLOOD VESSEL |
US20080300571A1 (en) | 2007-05-30 | 2008-12-04 | Lepivert Patrick | Process and device for selectively treating interstitial tissue |
US20090125010A1 (en) | 2007-07-06 | 2009-05-14 | Sharkey Hugh R | Uterine Therapy Device and Method |
US8758366B2 (en) | 2007-07-09 | 2014-06-24 | Neotract, Inc. | Multi-actuating trigger anchor delivery system |
ATE505147T1 (en) | 2007-08-23 | 2011-04-15 | Aegea Medical Inc | UTERUS THERAPY DEVICE |
CN101854977B (en) * | 2007-09-14 | 2015-09-09 | 拉热尔技术有限公司 | Prostate cancer ablation |
US20090082837A1 (en) | 2007-09-20 | 2009-03-26 | Gellman Barry N | Hand-held Thermal Ablation Device |
US8322335B2 (en) | 2007-10-22 | 2012-12-04 | Uptake Medical Corp. | Determining patient-specific vapor treatment and delivery parameters |
ES2456965T3 (en) | 2007-10-22 | 2014-04-24 | Uptake Medical Corp. | Determination of the parameters of the steam treatment and administration specific to the patient |
US8251991B2 (en) | 2007-11-14 | 2012-08-28 | Halt Medical Inc. | Anchored RF ablation device for the destruction of tissue masses |
WO2009074844A1 (en) * | 2007-12-12 | 2009-06-18 | Vectec | Single use, disposable, uterine manipulator and method of use |
EP2231048B1 (en) * | 2007-12-27 | 2016-06-22 | Boston Scientific Scimed, Inc. | System for controllably delivering liquid coolant to a cryo-ablation device |
EP2259742B1 (en) | 2008-03-06 | 2020-01-01 | AquaBeam LLC | Tissue ablation and cautery with optical energy carried in fluid stream |
US8272383B2 (en) | 2008-05-06 | 2012-09-25 | Nxthera, Inc. | Systems and methods for male sterilization |
US8721632B2 (en) | 2008-09-09 | 2014-05-13 | Tsunami Medtech, Llc | Methods for delivering energy into a target tissue of a body |
CN102112063A (en) | 2008-06-06 | 2011-06-29 | 瓦里克斯医疗公司 | Vein therapy device and method |
US8579888B2 (en) | 2008-06-17 | 2013-11-12 | Tsunami Medtech, Llc | Medical probes for the treatment of blood vessels |
JP2010002603A (en) | 2008-06-19 | 2010-01-07 | Konica Minolta Business Technologies Inc | Fixing device and image forming apparatus |
US8932207B2 (en) | 2008-07-10 | 2015-01-13 | Covidien Lp | Integrated multi-functional endoscopic tool |
US9597145B2 (en) | 2008-08-20 | 2017-03-21 | Prostacare Pty Ltd | Non-thermal ablation system for treating tissue |
CN102238920B (en) | 2008-10-06 | 2015-03-25 | 维兰德.K.沙马 | Method and apparatus for tissue ablation |
US9561066B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
US9561068B2 (en) | 2008-10-06 | 2017-02-07 | Virender K. Sharma | Method and apparatus for tissue ablation |
JP2012508068A (en) | 2008-11-06 | 2012-04-05 | エヌエックスセラ インコーポレイテッド | System and method for treatment of prostate tissue |
BRPI0921421A2 (en) | 2008-11-06 | 2016-01-05 | Nxthera Inc | prostate therapy system |
US8251985B2 (en) | 2008-11-06 | 2012-08-28 | Nxthera, Inc. | Systems and methods for treatment of prostatic tissue |
CA2733241C (en) | 2008-12-19 | 2016-08-16 | Japan Electel Inc. | Balloon catheter system |
US8388611B2 (en) | 2009-01-14 | 2013-03-05 | Nxthera, Inc. | Systems and methods for treatment of prostatic tissue |
US20100179416A1 (en) * | 2009-01-14 | 2010-07-15 | Michael Hoey | Medical Systems and Methods |
US11284931B2 (en) | 2009-02-03 | 2022-03-29 | Tsunami Medtech, Llc | Medical systems and methods for ablating and absorbing tissue |
US8229588B2 (en) | 2009-03-03 | 2012-07-24 | Taiwan Semiconductor Manufacturing Company, Ltd. | Method and system for tuning advanced process control parameters |
US9833277B2 (en) | 2009-04-27 | 2017-12-05 | Nxthera, Inc. | Systems and methods for prostate treatment |
US20100298948A1 (en) | 2009-04-27 | 2010-11-25 | Michael Hoey | Systems and Methods for Prostate Treatment |
US8437870B2 (en) | 2009-06-05 | 2013-05-07 | Taiwan Semiconductor Manufacturing Company, Ltd. | System and method for implementing a virtual metrology advanced process control platform |
CN201453373U (en) * | 2009-08-12 | 2010-05-12 | 河南华南医电科技有限公司 | Radiofrequency ablation therapy instrument capable of controlling cold brine perfusion automatically |
US8900223B2 (en) | 2009-11-06 | 2014-12-02 | Tsunami Medtech, Llc | Tissue ablation systems and methods of use |
US9161801B2 (en) | 2009-12-30 | 2015-10-20 | Tsunami Medtech, Llc | Medical system and method of use |
BR112012022132A2 (en) | 2010-03-25 | 2016-10-25 | Nxthera Inc | steam therapy system |
US9918787B2 (en) * | 2010-05-05 | 2018-03-20 | St. Jude Medical, Atrial Fibrillation Division, Inc. | Monitoring, managing and/or protecting system and method for non-targeted tissue |
WO2011143468A2 (en) | 2010-05-12 | 2011-11-17 | Shifamed, Llc | Low profile electrode assembly |
US9943353B2 (en) | 2013-03-15 | 2018-04-17 | Tsunami Medtech, Llc | Medical system and method of use |
CN101919729A (en) * | 2010-09-10 | 2010-12-22 | 刘小平 | Temperature-controlled ablation device and use thereof |
WO2012039829A1 (en) | 2010-09-24 | 2012-03-29 | C.R. Bard | Means for securing a catheter into a vessel |
JP2013544565A (en) | 2010-10-20 | 2013-12-19 | メドトロニック アーディアン ルクセンブルク ソシエテ ア レスポンサビリテ リミテ | Catheter device with expandable mesh structure for renal nerve modulation and related systems and methods |
US20120232409A1 (en) | 2010-12-15 | 2012-09-13 | Stahmann Jeffrey E | System and method for renal artery occlusion during renal denervation therapy |
KR102291972B1 (en) | 2011-01-19 | 2021-08-23 | 프랙틸 헬쓰, 인코포레이티드 | Devices and methods for the treatment of tissue |
AU2012212492B2 (en) | 2011-02-01 | 2016-05-12 | Channel Medsystems, Inc. | Methods and apparatus for cryogenic treatment of a body cavity or lumen |
JP2012168403A (en) | 2011-02-15 | 2012-09-06 | Ricoh Co Ltd | Fixing device and image forming apparatus |
US8512326B2 (en) | 2011-06-24 | 2013-08-20 | Arqos Surgical, Inc. | Tissue extraction devices and methods |
JP5853426B2 (en) | 2011-06-08 | 2016-02-09 | 東レ株式会社 | Ablation catheter with balloon |
PL2755614T3 (en) | 2011-09-13 | 2018-04-30 | Nxthera, Inc. | Systems for prostate treatment |
US20130116683A1 (en) | 2011-11-09 | 2013-05-09 | Tsunami Medtech, Llc | Medical system and method of use |
EP2788078B1 (en) | 2011-12-09 | 2020-09-02 | Metavention, Inc. | Therapeutic neuromodulation of the hepatic system |
CA2865567C (en) | 2012-02-27 | 2022-10-11 | Fractyl Laboratories, Inc. | Heat ablation systems, devices and methods for the treatment of tissue |
EP3777738A1 (en) | 2012-04-03 | 2021-02-17 | Boston Scientific Scimed, Inc. | Induction coil vapor generator |
US20130267939A1 (en) | 2012-04-10 | 2013-10-10 | Robert Lawrence Barry | Methods and Apparatus for Ablating Lung Nodules with Vapor |
EP2662991B1 (en) * | 2012-05-10 | 2019-06-26 | Alcatel Lucent | Multiple-input-multiple-output (MIMO) communication |
WO2014006730A1 (en) | 2012-07-05 | 2014-01-09 | 有限会社日本エレクテル | Balloon catheter system |
EP2945556A4 (en) | 2013-01-17 | 2016-08-31 | Virender K Sharma | Method and apparatus for tissue ablation |
US9179973B2 (en) | 2013-03-15 | 2015-11-10 | St. Jude Medical, Cardiology Division, Inc. | Feedback systems and methods for renal denervation utilizing balloon catheter |
CN105228547B (en) | 2013-04-08 | 2019-05-14 | 阿帕玛医疗公司 | Cardiac ablation catheter |
EP3003461B1 (en) | 2013-06-04 | 2019-05-01 | Fractyl Laboratories, Inc. | Systems and devices for reducing the luminal surface area of the gastrointestinal tract |
US10952790B2 (en) | 2013-09-13 | 2021-03-23 | Boston Scientific Scimed, Inc. | Ablation balloon with vapor deposited cover layer |
US9855089B2 (en) | 2014-03-21 | 2018-01-02 | Medtronic Cryocath Lp | Shape changing ablation balloon |
US9844641B2 (en) | 2014-07-16 | 2017-12-19 | Fractyl Laboratories, Inc. | Systems, devices and methods for performing medical procedures in the intestine |
CN109475378B (en) * | 2016-05-19 | 2022-01-14 | 圣安娜技术有限公司 | Catheter with dual balloon structure for creating and applying a heated ablation area to tissue |
-
2012
- 2012-06-01 US US13/486,980 patent/US9561066B2/en active Active - Reinstated
- 2012-06-03 EP EP12793307.5A patent/EP2713923A4/en not_active Withdrawn
- 2012-06-03 CN CN201710150101.0A patent/CN107242901B/en active Active
- 2012-06-03 WO PCT/US2012/040639 patent/WO2012167213A2/en active Application Filing
- 2012-06-03 CN CN201280027522.XA patent/CN103747753B/en active Active
- 2012-06-03 EP EP20211717.2A patent/EP3824801A1/en active Pending
-
2016
- 2016-12-21 US US15/386,229 patent/US10842548B2/en active Active
-
2017
- 2017-01-06 US US15/400,759 patent/US10842549B2/en active Active
-
2018
- 2018-04-13 HK HK18104844.0A patent/HK1245054A1/en unknown
-
2020
- 2020-10-19 US US17/073,972 patent/US20210113257A1/en active Pending
- 2020-10-19 US US17/073,677 patent/US20210100600A1/en active Pending
Patent Citations (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5308347A (en) * | 1991-09-18 | 1994-05-03 | Fujisawa Pharmaceutical Co., Ltd. | Transfusion device |
US20020177846A1 (en) * | 2001-03-06 | 2002-11-28 | Mulier Peter M.J. | Vaporous delivery of thermal energy to tissue sites |
US20090149846A1 (en) * | 2003-10-07 | 2009-06-11 | Tsunami Medtech, Llc | Medical system and method of use |
US20090216220A1 (en) * | 2008-02-20 | 2009-08-27 | Tsunami Medtech, Llc | Medical system and method of use |
Also Published As
Publication number | Publication date |
---|---|
CN103747753B (en) | 2017-04-05 |
US10842548B2 (en) | 2020-11-24 |
EP2713923A4 (en) | 2014-10-29 |
US20170231677A1 (en) | 2017-08-17 |
CN107242901A (en) | 2017-10-13 |
CN107242901B (en) | 2021-03-05 |
CN103747753A (en) | 2014-04-23 |
US10842549B2 (en) | 2020-11-24 |
US9561066B2 (en) | 2017-02-07 |
US20170231676A1 (en) | 2017-08-17 |
EP3824801A1 (en) | 2021-05-26 |
HK1245054A1 (en) | 2018-08-24 |
US20130006231A1 (en) | 2013-01-03 |
WO2012167213A2 (en) | 2012-12-06 |
US20210100600A1 (en) | 2021-04-08 |
EP2713923A2 (en) | 2014-04-09 |
WO2012167213A3 (en) | 2013-02-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US20210113257A1 (en) | Method and Apparatus for Tissue Ablation | |
US20210346088A1 (en) | Methods of Ablating Tissue Using Time-Limited Treatment Periods | |
US11813014B2 (en) | Methods and systems for directed tissue ablation | |
JP7311658B2 (en) | Ablation Catheter with Integrated Cooling | |
US20210113264A1 (en) | Method and Apparatus for Tissue Ablation | |
US11589920B2 (en) | Catheter with a double balloon structure to generate and apply an ablative zone to tissue | |
EP3244820B1 (en) | Apparatus for tissue ablation | |
US20240108392A1 (en) | Method and Apparatus for Tissue Ablation | |
US20230277238A1 (en) | Catheter with a Double Balloon Structure to Generate and Apply a Heated Ablative Zone to Tissue |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: ENDOCHOICE, GEORGIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:PARKS, WILLIAM;REEL/FRAME:054097/0163 Effective date: 20120814 Owner name: SHARMA, VIRENDER K., ARIZONA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:ENDOCHOICE, INC.;REEL/FRAME:054097/0225 Effective date: 20120815 Owner name: SANTA ANNA TECH LLC, CALIFORNIA Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHARMA, VIRENDER K.;REEL/FRAME:054097/0284 Effective date: 20170206 |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION |
|
STPP | Information on status: patent application and granting procedure in general |
Free format text: NON FINAL ACTION MAILED |